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ABSTRACT
The physical and physicochemical properties of drug particles were 
studied in terms of their observable effects on the nature and strength of the 
interactive forces between the drug particles and lactose, in dry powder 
mixes. The relationship between physico-chemical properties and particle 
interactions was studied from two different perspectives and scales, each 
requiring different instrumentation and techniques. At a microscopic level, 
the surface energy characteristics of the drug were determined and then 
related to the macroscopic properties of the mix such as ease of metering 
and dispersing.
The drug used in this study exists in two well-characterised 
polymorphic forms. This type of system was chosen in order to investigate 
the interactive properties of two different surfaces of the same chemical 
composition. The basic hypothesis of this study was that two polymorphs of 
the same drug, will exhibit measurable differences in their interparticle 
cohesive/adhesive interactions. The differences in interparticle interactions 
between the two polymorphs, which manifest themselves macroscopically 
as processing performance qualities of the mix, should in turn, at a 
molecular level, be the result of differences between the surface energetics 
of the two polymorphs.
The choice of crystal polymorph was found to have a significant effect 
on the detachment and deposition characteristics of the resulting blend when 
actuated from a dry powder inhaler (DPI) device. The differences between 
the two polymorphs were found to be significant enough as to be directly
observable by different experimental techniques used to study drug-lactose 
blends. Such experimental techniques include detachment measurements by 
the centrifuge method, static and dynamic electrostatic measurements, and 
deposition form from the actual DPI device. In addition, the sorption and 
calorimetric methods were used to study the particle surface characteristics, 
and to differentiate between the two crystal forms. Polymorph A was found to 
exert stronger cohesive and adhesive interactions. In addition to being 
consistent with the device deposition results, data form the centrifuge method 
and electrostatic measurements are also capable of differentiating between 
the two crystal forms. Study of the surface energy properties of the two 
polymorphs revealed that polymorph A exhibits the energetic equivalent of 
surface fuzziness: a greater number of weaker interactive sites. The net 
result being greater cohesion and/or adhesion energy for the particle as a 
whole in the case of polymorph A.
Despite efforts to eliminate the effects of surface geometry, the 
results suggest that the shape of the drug particles continues to play a 
significant, although not necessarily dominant role in the aerosol deposition 
properties of powder mixes. Nevertheless, a major purpose of this study 
was to explore the relationship between the energetics of interaction of dry 
powder inhaler particles and deposition in a realistic pharmaceutical 
situation. The system chosen for this study is a true pharmaceutical new 
chemical entity for pulmonary delivery, tested in the clinic, and the results of 
the present study should provide a pharmaceutically relevant, representative 
picture of the power and limitations of the type of analysis employed.
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The interaction among particles is one of the fundamental properties 
of dry powder mixes that influence many processing properties including: 
homogeneity, flow, metering, dispersion, compression and dissolution. The 
interaction forces between drug and carrier particles are critical factors to be 
considered for the optimal formulation of powders for inhalation. 
Formulations of powders for inhalation are often made of binary blends 
consisting of micronised drug and usually coarser a-lactose monohydrate. 
For such drug-a-lactose monohydrate systems to be therapeutically effective, 
a significant number of drug particles must detach from a-lactose 
monohydrate carrier particles upon the application of a removal force. 
However, the drug-carrier adhesion forces must also be strong enough to 
prevent disruption under processing conditions, storage and transport. 
Staniforth [1987] studied in detail the powder properties relevant in the 
formation of stable homogeneous powder blends. A controlled modification 
of these properties may result in optimal interactive forces for powders for 
inhalation. The adjustment of these properties on formulation of dry 
powders for inhalation have been studied by several workers [Ganderton and 
Kassem, 1992; Ganderton, 1992; Timsina et a/., 1994; Martin et al., 1994; 
Podczeck, 1998].
The interactive forces responsible for the adhesion of particles have 
been characterised in a number of studies. The interactions involved in 
drug-carrier blends are affected by environmental factors and by carrier 
properties. Some studies have aimed exclusively at studying the role of
carrier ce-lactose monohydrate morphology as a general factor influencing the 
aerosol drug deposition behaviour of dry powders for inhalation [Wong and 
Pilpel, 1988 and 1990a; Ganderton and Kassem, 1992; Chawla et al., 1994; 
Robertson, 1997; Steckel and Muller, 1997; Kawashima et al., 1998; 
Podczeck, 1998; Zeng et al., 2000a and b]. Others were general studies 
that investigated those factors that affect adhesion between particles and 
substrates such as the size, shape and texture of particles [Com, 1961; 
Zimon, 1982; Otsuka et al., 1988; Schaefer et al., 1995]. The forces of 
adhesion involved among particles of different size, shape and texture have 
been usually assessed by determining the force required for detachment by 
centrifugation [Staniforth et al., 1982b; Kulvanich and Stewart, 1987c; 
Staniforth, 1987; Lord, 1993; Podczeck et al., 1995; Kawashima, 1998; 
Boerefijn et al., 1998]. Other investigators have considered the effects that 
environmental conditions such as humidity and temperature have on the 
electrostatic behaviour of powders and the formation of capillary forces 
[Zimon, 1963; Stephenson and Thiel, 1980; van den Berj, 1981, Kulvanich 
and Stewart, 1988; Balachandran et al., 1991; Hickey and Martonen, 1993; 
Hashish et al., 1994; Peart, 1996]. Some authors have studied 
combinations of dry powder formulation properties, device characteristics 
and in vitro testing conditions [Gerrity, 1990; Meakin et al., 1995; O’Byme, 
1995; Marple eta!., 1995; Hindle eta!., 1996].
The variety of parameters and techniques for studying the behaviour 
of powders and their performance in the formulation during aerosolisation is 
almost as wide as the variety of studies conducted. Clark and Hollingworth 
[1993] studied the implications of in-vitro testing in the relationship between
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powder inhaler resistance and peak inspiratory conditions in healthy 
volunteers. Timsina et al. [1994] studied drug delivery to the respiratory 
tract using dry powder inhalers under different experimental approaches and 
concluded, as others before, that for efficient lung deposition, particle size is 
an important parameter. Olsson et al., [1996b] studied the effect of inlet 
throat on fine particle dose; Niven [1993] explored aerodynamic particle size 
using a time-of-flight aerosol beam spectrometer whereas Hindle etal. [1996] 
used cascade impaction methods. One feature common to all methods, 
techniques and studies is that they all had the objective of producing efficient 
dry powders for inhalation in terms of the extent and reproducibility of drug 
delivery. The level of success was assessed by focusing on patients’ 
response, device performance and formulation earner characteristics. To 
this effect, much of the earlier work focused on a-lactose monohydrate and 
part of it focused on a few studies used model drug compounds. Although 
significant progress has been achieved in this area, the relationship of drug 
physicochemical properties, such as surface characteristics, affecting drug 
interactions with a-lactose monohydrate for powders for inhalation, has only 
been sparingly evaluated.
The interactive forces responsible for adhesion between drug particles 
and other surfaces (including a-lactose monohydrate) could in principle be 
associated with the compound’s physical properties at different scales: at the 
molecular level, at the particulate level or at the bulk level. Each of these 
scales provides different characterisation parameters that in turn should 
allow optimum parametisation, depending on the process/property under 
scrutiny.
The characterisation of the interactive forces responsible for adhesion 
of particles has been addressed by analysing properties at the particulate 
scale such as particle morphology and particle size distribution [Wong and 
Pilpel, 1990a,b]. At the powder bulk scale, Gonda and Chan [1989]; 
Ganderton [1992] and Hickey et al. [1994] have analysed the effect of 
surface area on powder flow and dispersion characteristics. At present, 
work characterising behaviour at the molecular scale is lacking in the 
literature. The few studies reported thus far do not focus on drug surface 
characteristics, but rather on excipient surface characteristics [Ahmed, 1989; 
Ticehurst et a/., 1994; Ahfat et al., 1997].
Adamson [1990] categorises the intermolecular forces in powders as:
a) structural and dynamic aspects related to the position and orientation of 
powder particles with respect to each other.
b) thermodynamic aspects related to:
i) the powder surface energy with its surroundings
ii) details of motions of particles and their contributions to the energy of 
the system
a) Structural aspects can be analysed by spectroscopic techniques such as 
infrared, Raman, X-ray powder diffraction, single crystal X-ray diffraction (to 
obtain information molecular position). Dynamic aspects include rotational and 
orientational contributions that can be measured by NMR. Spectroscopy and 
diffraction methods have been extensively used for the study of solid surfaces 
at the molecular level.
b) The thermodynamic aspects of surface phenomena can be related to forces 
between particles and to the imbalance of forces at an interface. In the study 
of the surface of a solid, the solid-vapour interface offers a system well suited
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for the experimental assessment of surface energetics. The solid-vapour 
interface allows some direct energy measurements as well as other 
experimental determinations from which thermodynamic parameters can be 
derived.
1.1 Relevance of interactive forces in solid-solid mixes.
In powder mixes for pharmaceutical systems, drug fines adhere to 
surface asperities, irregularities and lattice defects of the carrier [Crooks and 
Ho, 1976; Staniforth, 1980]. The fine particles possess greater surface area 
per unit weight and present more sites for adherence [Lord and Staniforth, 
1996]. Some regions of the coarse earner surface are rich while some regions 
are poor in drug, despite efforts to produce a completely homogeneous mixture 
[Staniforth et al., 1981b]. In fact, in all probability most fine particles exist on 
the surface of the earner not as a single monolayer but rather in complete 
multilayers [Bryan et al., 1979]. Free fine particles tend to form agglomerates 
in order to reduce the material’s (excess) free energy by producing more 
stable, i.e. larger, units (particles) [Yip and Hersey, 1977]. The delivery of fine 
particles adhered to a carrier in a binary powder blend is at the core of 
pharmaceutical dry powder inhaler (DPI) development. In fact, the majority of 
the current commercially available pharmaceutical powders for inhalation 
consist of fine, cohesive micronised drug mixed with coarse of-lactose 
monohydrate as a carrier to form adhesive mixes [Zanen etal., 1992].
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The overall interactive force in powder blends, composed of micronised 
drug particles and coarse a-lactose monohydrate particles predominantly 
consists of van der Waals (vdW) and electrostatic interactions [Visser, 1989]. 
The strength of the interactive forces is crucial to the performance of the final 
product. The interactive forces in a powder blend intended for inhalation need 
to be strong enough to hold particles together during handling, yet weak 
enough to fall apart and allow the fine particles to separate into a fine powder 
and disperse in the airstream produced upon actuation of the aerosol device.
The dispersion of micronised drug particles in the inspired air depends 
on the energy required to overcome the strength of the cohesive forces 
between drug particles and adhesive forces between carrier and drug particles 
[Byron 1986]. Hickey et al. [1994] and Martin et al. [1994] described some of 
the factors that are likely to influence the relative strength of the interparticulate 
bonds, and consequently, affect the dispersion of dry powders.
Dispersion of powders in a DPI is controlled by the interaction energy 
between the drug particles, i.e., by the adhesion of fine drug particles onto the 
surface of larger particle substrates. The method for assessing the 
aerodynamic properties of pharmaceutical aerosols generally consists in 
measuring the extent of powder dispersion in terms of the fine respirable dose, 
which in turn is quantifiable by an in vitro impaction technique [Hindle and 
Byron, 1995; Hindle etal., 1996; Olsson etal., 1996a].
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1.2 Interaction forces.
The interactive forces between powders, either of the same 
(cohesion) or different materials (adhesion) play an important role during the 
handling, processing, packaging and stability of pharmaceutical materials 
[Byron, 1986]. Interactions between components in pharmaceutical powder 
blends are both unavoidable and necessary. The key lies on controlling such 
interactions by means of a process that produces a physically stable, 
homogeneous powder mix. The behaviour of pharmaceutical powder blends 
often depends on the quality of the powder mixing, which is a reflection of the 
interactive forces involved, and their manipulation [Staniforth, 1987].
In a pharmaceutical dry powder blend, particles of different materials 
must interact to an appreciable extent in order to form a homogeneous mixture. 
This interaction is essentially of an attractive nature [Visser, 1989]. Attraction 
forces are caused by differences in physicochemical properties of powders at 
their surfaces. Formulations of dry powders intended for inhalation often 
consist of mixtures of powders of different size: micronised drug particles 
combined with coarse carrier a-lactose monohydrate particles. In such drug- 
carrier systems, the acting attraction forces are both adhesion and cohesion. 
Particle interaction occurs when the attractive forces between particle 
components are greater than the detachment forces exerted on the particles 
[Stewart, 1986].
Interactive forces responsible for particle adhesion and cohesion can be 
broadly classified into two categories, long and short range interactions [Krupp, 
1967; Zimon, 1982], depending on their macroscopic effects. Long-range
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interaction forces contribute to the formation of particle agglomerates. The 
particles come close enough to establish interaction without actually making 
interfacial contact. Examples of these interactions include gravitational forces, 
Coulombic forces or electrostatic interaction and magnetism. Conversely, 
short-range interaction forces only exist when the particles have actual 
interfacial contact. This set of forces includes van der Waals forces (vdW, 
repulsive or attractive, dipole forces), electrical double layer, dipole forces, 
hydrogen bonding and surface tensional/capillary forces.
The adhesion of solid particles is the result of a combination of the 
various interactive forces present in a particular system. The relative 
contributions of different types of interaction forces in the overall adhesion will 
be affected by material properties, as well as environmental and processing 
conditions [Staniforth, 1993]. Drug particles must interact to an appreciable 
extent with the carrier excipient to form adhesive mixes. Staniforth [1987] has 
considered some practical examples of the interactive forces involved in the 
formation of these adhesive mixes.
Interactive forces affect the physical adsorption and magnitude of 
adhesion of drug particles on excipient carrier particles in a powder blend. 
Physical adsorption and adhesion phenomena are also known to influence 
physical and mechanical properties of powders including blend stability, 
flowability, dispersibility, compressibility and dissolution characteristics. The 
physical properties of powders are also affected by crystalline form of a drug 
entity. For instance, crystals may show preferred orientation during 
compression [York, 1983]. Some crystals also have the tendency to orient 
themselves parallel to the upper flat punch face, causing tablets to laminate
[York, 1983], which results in variable dissolution rates [Tuladhar et al., 1983; 
Shah et al., 1994; Mosharraf and Nystrom, 1995]. Staniforth et al., [1981b] 
investigated the use of excipients prepared with different crystal habits. The 
use of different crystal habits resulted in variations in tablet compression and 
non-segregating properties in low dose mixes with small-sized drug particles.
Particle interactions in pharmaceutical systems are the combination of 
various interactive forces that can result from a number of discrete 
mechanisms, the total adhesion force (F) will consist of the sum of 
component forces present in a given system [Stewart, 1986]:
F  -  FVdw + Fe + Fim+Fs (1)
where Fvdw are vdW forces, Fe are the contact potential forces, Fim are the 
Coulombic interactions and Fs are the surface tensional forces. The relative 
contribution of these forces to the overall adhesion in a particular system will 
depend on the material properties and the environmental and processing 
factors.
The interparticle forces acting between small drug particles and large 
carrier particles in an ordered mix include London van der Waals [Staniforth 
et. al., 1982b; Miller, 1988], electrostatic forces [Staniforth et. al., 1982a] and 
surface tensional or capillary forces [Stephenson and Thiel, 1980]. Because 
of the particle size scale typically found in drug-carrier systems, vdW 
interactions and electrostatic forces play important roles.
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1.2.1 van der Waals interactions
Intermolecular forces are usually visualised as pairwise interactions 
between any two molecules where at least one of the entities is either ionic 
or polar, e.g., ion-ion, ion-dipole, dipole-dipole, ion-induced dipole, hydrogen 
bonding, donor-acceptor. Although often overlooked, intermolecular forces 
do exist between neutral or non-polar molecules, the reason being that the 
electrons are in constant random movement that causes the formation of 
transient dipoles [Hendricks, 1973]. The instantaneous dipole moment of 
one molecule induces a dipole in the neighbouring molecule (A induces a 
dipole in B, and B induces a dipole in A): the interaction between the two 
induced dipole moments accounts for the attractive forces between non-polar 
molecules. The magnitude of the energy E  of this interaction is given by:
where a  represents the polarisability of the two molecules, h Planck’s 
constant, v0 frequency and d the separation distance. These forces are 
known as London-van der Waals, dispersion or induced dipole-induce dipole 
forces [Vemulapalli, 1993].
vdW forces operate at very short ranges and are the major cause of 
particle-particle adhesion, strength of solids, surface tension, wetting and 
physical adsorption. This type of forces is always present in all the 
molecules when two particles are in contact [Israelachvili, 1992].
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vdW forces have bond energies that vary with the specific type of 
interaction and depend on temperature, but are typically in the range of 1-10 
Kcal mol"1. vdW forces are in turn divided into three categories [Martin, 1993]: 
1) Dipole-dipole interaction or orientation forces, molecules must have 
permanent dipole moments. The opposite poles attract even though random 
molecular motion keeps the attraction weak. The magnitude of the interaction 
energy depends on the mutual alignment of the dipoles; 2) Induction forces 
may exist when a dipole is induced on a nonpolar molecule. The magnitude of 
these forces depends on the polarisability of the nonpolar molecule; 3) 
Dispersion forces or London forces, this type of forces is present in all 
molecules and result from instantaneous configurations produced by 
perturbations of the electronic clouds of neighbouring atoms. In all three types 
of vdW forces, the potential energy of attraction varies inversely with the 
distance of separation, r, raised to the sixth power, r6.
Because of the difference in size between drug and carrier, assuming 
that the powder blend consists of spherical particles adhered to a plane 
surface is an adequate approximation for purposes theoretical study. In their 
theoretical treatment of vdW attractive forces, Hamaker and Visser [1989] 
defined the force between a sphere and a plane as:
f« n r = ^ T T ~  (3>oz
where AH is the Hamaker coefficient, z distance between two bodies and rr is 
the radius of the particle. The interactive energy for the vdW attraction is of
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the order of 0.1 eV, and these forces have a diminishing effect as the particle 
size increases. In addition to van der Waals forces of attraction, 
electrostatic and capillary forces operate between particles. Pharmaceutical 
compounds behave as insulators and electrostatic charges therefore play an 
important role in particle interactions [Hickey e t at., 1994].
1.2.2 Electrostatic interactions
Electrostatic properties of pharmaceutical powders are considered 
important because of the presence of charges, either moving or stationary 
may influence the behaviour and consequent performance of these powders.
Electrostatic charges present in a powder can be of different nature: 
electric double layer and Coulombic interactions. Coulombic interactions 
result from the contact of charged particles with uncharged surfaces. 
Electric double layers are the result of the formation upon particle contact, of 
a shell of oppositely charged electronic layers located at the interface. The 
two types of electrostatic interactions may be involved in the adhesion of 
ordered powder mixes.
1.2.2.1 Electrical double layer
The formation of an electric double layer at a contact point of two 
particles depends on the properties of the contacting surfaces, e.g., on the 
chemical nature of the surface of the materials involved. The chemical
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properties of the material affect the forces at the interface depending on 
whether the material acts as an electron donor or electron acceptor [Zimon, 
1982]. Specific functional groups confer electron donor/acceptor 
characteristics on a given material [Derjaguin et ai, 1978]:
Donor: -NH4 > -OH > -OR > -COOR > -CH3 > -Ph > -X > -COOH > =CO > CN Acceptor
Considering particle charges on detachment from a carrier surface, the 
magnitude of the contact force, Fe, is calculated from the particle charge on 
detachment from the carrier, q, and the contact area, A, between the particle 
and the carrier surface [Stewart, 1986].
1.2.2.2 Coulombic forces
Coulombic forces sometimes are also called electrostatic forces. 
Electrostatic attraction forces can be generated from charges on the surface 
and their effects are subject to environmental conditions such as humidity.
Coulombic interactions between solid materials occur when a charged 
particle induces an equal but opposite charge on an uncharged surface 
[Stewart, 1986]. Coulomb’s law embodies this adhesive type of interaction:
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(5)
Coulomb’s equation (5) shows that the repulsive or attractive force Fim 
between the two charges qi and q2 falls off as a function of the square of the 
distance, r2, between them; £ is a proportionality constant, and since the SI 
unit of charge is defined in relation to current, 1 coulomb (C) = 1 ampere 
second (A-s). With this definition, the proportionality constant becomes:
where So is the permittivity of free space.
In general, for powders that are not artificially charged by a high voltage 
field, the electrical interactive force due to contact (Fe) is much greater than the 
Coulombic image force (Fim).
Pharmaceutical powders are generally organic materials that behave 
as electrical insulators under ambient conditions. Their surfaces can 
acquire electric charge by contact and frictional electrification (often termed 
triboelectrification), mechanical fracture in some materials, corona charging, 
spray drying, induction charging of sprayed liquids, ion and electron beam 
charging, photoelectric charging, thermionic and field emission [Hendricks, 
1973]. These processes contribute greatly to the electric charge on the 
particle surfaces that often remain charged even after separation [Kulvanich 
and Stewart, 1987a]. Tribocharging occurs due to differences in work
k = -n s 0
4 (6)
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functions [Krupp, 1967; Stewart, 1986] between the two dissimilar surfaces. 
Work function (q>, energy potential difference) is equal to the energy given to 
an electron in order for the electron energy to be freed and able to transfer 
from one material to the other [Hendricks, 1973].
All materials, whether conductors or insulators, have electrons 
available at their surfaces which take part in contact charging. This is true 
especially for insulators. In order for an electron to go from one energy level 
to another, the electron has to acquire sufficient energy to bring the electron 
to an excited state higher than its resting or ground state. The transfer of 
electrons between the materials results in a potential difference that 
develops until the potentials of the materials are aligned the corresponding 
Fermi levels. The Fermi level is the energy in a solid at which the average 
number of particles per quantum state is Vz, i.e., one half of the quantum 
states are occupied [Holden, 1992].
1.2.3 Hydrogen bonding (polar groups), surface tension forces,
hydrophobic and hydrophilic interactions.
vdW and electrostatic forces predominate in low humidity 
environments, but at high humidities ( > 65%) surface tensional effects 
become increasingly important. Surface tension and the force of the liquid 
bridge between particle and surfaces are related by:
Fs - 2 Tty rr cos# (7)
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where rr is the radius of the particle, ^is the surface tension and 9 is the 
contact angle.
Hydrogen bond and hydrophobic interactions are particularly relevant 
to interactions in materials containing water. Hydrogen bonds are strongly 
orientation-dependent, water tends to adopt a highly directional tetrahedral 
co-ordination rather than a higher packing density configuration (i.e., close- 
packed van der Waals interactions where the bonds are non-directional). 
Hydrogen bonding is not a phenomenon unique to water; it exists in varying 
degrees between electronegative atoms (e.g., O, N, F, Cl) and hydrogen 
atoms that are covalently bound to similar electronegative atoms 
[Israelachvili, 1992]. The presence of polar groups such as -NH2, -NH, -OH, 
-COOH and -CONH2 confer molecules the capability for hydrogen bonding. 
Hydrogen bonds have the intermolecular distance of the O—H bond in the 
order of 1 .7 A. The distance for H-bonds of the N— H type typically ranges 
between 2.4 and 3.2 A. The bond energy of most hydrogen bonds lies 
between 5-20 kJ mol'1. Their bond energy places hydrogen bonds as 
somewhat stronger than typical van der Waals bonds (-1 kJ mol'1) but 
significantly weaker than covalent or ionic bonds (-500 kJ mol'1). However, 
hydrogen bonding forces are strongly temperature-dependent [Vemulapalli,
1993]. Hydrogen bonds occur both intermolecularly and intramolecularly, 
and can even exist in a non-polar environment [Pixton and Warburton, 1976]. 
They are important for instance in macromolecular and biological assemblies 
such as carbohydrates and proteins [Rizvi and Benado, 1984].
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Hydrophobic interaction describes the unusually strong interaction 
between hydrophobic molecules and surfaces in water or other polar 
chemistries. These interactions are usually stronger than the vdW attraction 
and are associated with rearrangements of H-bond configurations as two 
hydrophobic species come together [Israelachvili, 1992]. Up to date, few 
direct measurements of pure hydrophobic interactions between non-polar 
molecules exist, mainly because they are so insoluble. At present, a 
satisfactory theory of hydrophobic interaction does not yet exist because of 
the inherent problem of making a summation over numerous pair potentials.
The hydrophobic interaction plays a central role in many surface 
phenomena, such as molecular self-assembly, micelle formation, biological 
membrane structure, and in determining the conformations of proteins 
[Kauzman, 1959; Tanford, 1980].
In the case of a solid, unlike that of a liquid, surface tension is difficult to 
determine. There is a rather limited number of methods for obtaining 
experimental surface energy and free energy values for solid materials, and 
many of such methods are peculiar to special solids or situations [Adamson, 
1990]. For example, the particular case of the direct manifestation of surface 
tensional forces in NaCI crystals measured by the work of cleaving the crystal 
with mica [ Adamson, 1990]. There are just a few methods suitable for indirect 
estimation of surface tension like a) calorimetry to determine heats of 
adsorption (small differences exist between coarse and fine crystalline 
material); b) gas adsorption studies (surface area by BET); c) contact angle 
measurements; d) fractal surfaces analysis for the determination of surface 
area (using a specific mathematical geometry) [Meakin, 1988].
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For purposes of studying the dependence of physical properties on 
surface energy, the solid-liquid interfacial tensions can be estimated from 
solubility measurements, nucleation studies and change in lattice parameters 
by compression followed by its dissolution characteristics. Methods for 
estimating surface energy differences at solid-liquid interfaces have focused on 
contact angle measurements and solubility changes [Egawa et a i, 1992].
The interfacial free energy at a solid-vapour interface can be obtained 
by gas adsorption studies [Adamson, 1990]. Adsorption experiments are 
usually conducted at constant temperature and the amount adsorbed is 
represented as a function of the equilibrium gas pressure, followed by a 
thermodynamic treatment, which provides some indication of the energy of 
adsorbate-adsorbent interaction [Hiemenz, 1986]. At solid-solid interfaces, 
adhesive forces exist between powder particles in contact, however, little 
information is available to quantify these interaction forces.
1.3 The interactive behaviour of powders
The interactive behaviour of powders in a formulation is associated 
with the forces acting between particles. The formation of interactive 
powder systems, i.e., drug-drug and drug-excipient interactions, depends 
primarily on the balance between the attractive forces (adhesion and 
cohesion) involved. Adhesive forces in powders develop as a result of the 
contact of particles having dissimilar surfaces and their separation distance 
[Stewart, 1986]. The resulting force depends on the properties of the
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contacting bodies, mainly size and chemical surface properties. Interactive 
forces among particles will be affected by factors such as the 
physicochemical characteristics of the individual components as well as 
environmental and processing conditions [Staniforth, 1993].
1.3.1 Factors affecting particle interaction.
The factors that contribute to particle interaction include: humidity/moisture 
content, morphological characteristics of drug and carrier particles, particle 
size, drug/carrier mass ratio, crystallinity of blend components, the use of 
ternary components, process conditions, such as time and scale of mixing 
[Staniforth e ta i, 1982b; Hickey ef ai, 1994; Peart, 1996; Louey and Stewart, 
1999]. These factors have to be considered fully in order to advance in DPI 
formulation development. The overall performance of a dry powder inhaler, as 
far as device filling, emptying and powder lung penetration is concerned, relies 
on the formulation characteristics and its interactions with the device. The 
formulation characteristics depend on bulk powder properties such as mixing, 
flow/packing, entrainment and separation. In addition, individual particle 
properties including morphology and particle surface effects, electrostatics, and 
surface tension, further modulate powder blend properties. Staniforth [1994] 
summarised the published work on the study of the factors influencing the 
adhesion, cohesion and separation of interacting particles. It is interesting to 
note, the majority of the published studies have focused on investigating 
properties of the earner, namely olactose monohydrate, while little work has
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been devoted to studying the influence of the physicochemical properties of the 
drug.
The evaluation of the surface properties of drug and excipients has 
been largely earned out indirectly by measuring powder characteristics e.g., 
batch uniformity of well characterised materials such as griseofulvin [Zografi 
and Tam, 1976; Hansford et al., 1980]. a-Lactose monohydrate was 
characterised by contact angle measurements [Buckton and Newton, 1986a]; 
and salbutamol sulphate characterised by inverse gas chromatography (IGC) 
[Ticehurst et al,. 1994; Feeley et al., 1998]. Some studies evaluate the degree 
of crystallinity in solids by IGC |Ticehurst et al., 1996] and isothermal 
microcalorimetry [Berlin et al., 1971; Bystrom, 1990; Angberg et al., 1992; 
Sebhatu et al., 1994] and water sorption by microbalance [Hendrisken et al., 
1995, Stubberud et al., 1995]. Similarly, drug surface properties and degree of 
dispersion have been investigated indirectly by assessing drug dissolution 
characteristics [De Villiers et al., 1994; Shah et al., 1994]. Some studies 
addressed interactions in drug-excipient systems (Griseofulvin with 
cyclodextrins in solid binary systems by solubility and dissolution studies [Veiga 
eta!., 1998]) or interactions between gases and solid materials [Bakri, 1997].
1.4 Theoretical considerations of the gas-solid sorption process.
Sorption is the general term applied to the interaction between gas 
molecules (probe vapour) and a solid surface [Adamson 1990]. In any solid, 
the atoms at the surface are subject to out-of-balance forces of attraction
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normal to the surface plane due to the severe distortion of their interatomic 
spacing and charges. The balance of these forces can be partially restored 
by the adsorption of gas molecules [Brunauer, 1943 in Shaw, 1992].
In adsorption, most of the gas molecules remain held at the surface of 
the solid without any intimate mixing between the molecules of the gas 
phase and those of the solid phase. Although gas may enter the cracks or 
fissures of the solid, it is not incorporated into the solid surface itself. The 
process by which bulky gas atoms or molecules penetrate into the structure 
of the solid by a process of diffusion is referred to as absorption. Sorption is 
a rather general term comprising either adsorption or absorption and the 
combination of both. When the gas molecules are freed from the solid into 
the gaseous phase, the phenomenon is known as desorption. In the 
sorption process, the terms of adsorbent and adsorbate correspond to the 
solid and the gas, respectively.
Sorption processes can be classified according to the strength and 
nature of the interaction between the adsorbate molecules and the surface of 
the adsorbent. The term chemisorption refers to adsorption systems in 
which the energy of interaction between the adsorbate and adsorbent is 
large, approaching that of a covalent bond [Adamson, 1990]. Chemical 
sorption involves transfer of electrons between the solid and the gas. Actual 
chemical bonds may be formed at the surface of the adsorbent, and the 
heats of adsorption may be as high as 100 kcal per mole [Purnell, 1962]. 
The term physisorption refers to adsorption systems in which the energy of 
interaction between the adsorbate and adsorbent is relatively small. These 
interactions are based on weak van de Waals interactions, such as
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dispersion interactions, dipole-dipole interactions, and hydrogen bonding. 
Physical sorption results from molecular interaction forces. The formation of 
a physically sorbed layer is similar to the condensation of vapour to form a 
liquid provided that the conditions of temperature and pressure are suitable. 
The heat of physical sorption is of the same order of magnitude as that of 
condensation of the adsorbate (< 1 5  kcal mol'1). The heat of adsorption 
reflects the binding energy between the molecules of a vapour and the 
surface of the adsorbent. Under suitable conditions of temperature and 
pressure, multilayers of physically sorbed molecules are usually formed 
[Brunauer et a/., 1938 in Shaw, 1992]. Physical sorption is reversible in the 
sense that equilibrium is attained, and that upon desorption, the adsorbate is 
recovered unchanged [Adamson, 1990].
The adsorption system in the present study consists of 
pharmaceutical organic drug as the adsorbent and organic probe vapours as 
the adsorbates. The interaction between the drug and organic probes are 
relatively weak; therefore, the system used here is a physisorption system.
1.4.1 Sorption Forces and Energy
With the working conditions of temperature and pressure of 20 to 45 °C 
and pressure of 1 atmosphere (atm), respectively, the sorption of organic 
probes and water vapours by drug compounds is of a physical type. In 
physical sorption, the forces between probe vapour molecules and the 
surface of the adsorbent are usually of van der Waals character [Adamson,
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1990]. The predominant interactions at the surface of particles forming dry 
powder mixes of drug and carrier are of the van der Waals, H-bonding and 
electrostatic types.
The energy associated with electrostatic forces is much greater than 
that of vdW dipolar forces or hydrogen bonds. However, the dominant 
interaction force between particles in organic powders is the vdW force of 
attraction. The vdW forces are noticeable when the interfacial distance 
between particles is 0.2 to 1 nm [Visser, 1989].
The interaction of a gas with a solid is the sum of the individual interactions 
of the gas molecules with the molecules of the solid [Gregg and Sing, 1982]. If 
van der Waals forces alone are effective between the gas molecule and the 
surface of a solid, the potential energy of interaction (sorption energy) is a 
function of the distance between adsorbent and adsorbate molecules [Hill, 
1950]. The curve for the general shape of the potential energy between two 
isolated atoms is the Lennard-Jones potential, or ‘6-12 potential’, expressed by 
[Gregg and Singh, 1982]:
U(r) = -Cr~6 + Br~12 (8)
where XJ{r) is the total potential energy between two atoms, B is an empirical 
constant, C is a dispersion constant and r the distance between the centres of 
the two atoms. In the first term, the inverse sixth power corresponds to the
attraction term. Attraction is due to dispersion forces, van der Waals, and 
conventionally the negative sign implies this contribution, whereas the second 
term indicates repulsive forces arising from the interpenetration of the electron
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clouds of the two atoms. Attraction of the atoms occurs when r > re and repel 
for r <  re, where re is the distance of closest approach. For the total potential 
energy U(r) of sorption of a gas onto the surface of a solid has a minimum at 






Figure 1. Graphical representation of the intermolecular Lennard-Jones 
potential energy. Repulsive and attractive energies and net 
energy as a function of the distance between molecules [Martin, 
1993].
In physical sorption, the energy of interaction between the surface of a 
solid and a gas of different polarity has three components: orientation forces, 
induction forces and dispersion forces.
The potential energy varies irregularly from point to point on a solid 
surface. The points corresponding to the maximum potential energy are 
considered active sites [Hiemenz, 1986]. The surface of a real solid is bound 
to contain various kinds of imperfections like cleavage steps, dislocations,
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defects (Gregg and Singh, 1982; Adamson, 1990). The presence of 
imperfections inevitably produces energetic heterogeneity of the surface and 
sorption takes place on the most energetic (active) sites first.
In the sorption of solvent vapours, the amount of probe solvent sorbed is 
a function of solvent and surface polarities, as well as the number and 
accessibility of polar and non-polar sites on the surface of the drug powder. In 
the case of sorption of polar solvents, the polar groups of the drug organise 
and orient the adsorbate molecules in order to form hydrogen bonds. The 
sorption behaviour of solvent vapours on solid drug surfaces will have different 
interactions depending on the type hydrophilic or hydrophobic groups prevalent 
at the powder’s surface.
In sorption phenomena, solvent molecules attracted by the solid surface 
will remain bound for a time period, a residence time. Sorption residence time 
depends on the binding energy, on the kinetic energy of the solvent molecules 
and on temperature. Dynamic equilibrium in sorption is attained when the 
balance between the adsorbate-adsorbent collision frequency and resident 
time is such that no net gain or loss of adsorbate molecules at the surface 
takes place overtime [De Boer, 1968].
Sorption isotherms where the amount of solvent sorbed (X) is a 
function of solvent vapour pressure (p) and the temperature (T), is given by:
X  = F(p,T) or for an isothermal process: X  = Ft(p )
Brunauer, Emmet and Teller [1940 in Shaw, 1992] considered five 
principal forms of vapour sorption for the experimental isotherms. These five
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types of sorption isotherms are known as BET isotherms and are illustrated 
in Figure 2. Type I corresponds to Langmuir’s monolayer formation. Type 
II is sigmoidal in shape and corresponds to multilayer formation. Type III is 
characterised by heat of adsorption equal to or less than the heat of 
condensation. Type IV and V are considered to reflect capillary 
condensation phenomena in that sorption levels off before the saturation 
pressure is reached.
Figure 2. The five types of BET adsorption isotherms. pQ= 
saturation vapour pressure [Shaw, 1992].
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The procedures for obtaining sorption isotherms or for studying the 
interaction of water with organic materials include thermometric, dew point, 
gravimetric, hygrometric, etc [Gal, 1975; Prixton and Warburton, 1976; Trailer 
and Christian, 1978], and inverse gas chromatography [Coelho et al., 1978; 
Smith et al., 1981]. Inverse gas chromatography (IGC) in the pharmaceutical 
field has been used for the determination of adsorption properties of solvent 
probes on the surface of powders. Ahmed [1989] and Ticehurst et al., 
[1994] have described in detail the use of this technique in the study of 
excipients. The authors analysed the adsorption properties by evaluating the 
surface free energy (7) of the dispersive component.
1.5 Thermodynamic aspects of sorption.
The thermodynamic parameters of the adsorption of gas molecules onto 
a solid can be determined by using IGC and isothermal microcalorimetry. The 
analysis of these parameters provides information about the vdW forces at play 
in the physical adsorption vapour at the solid/gas interface. The forces of 
attraction between adsorbent and adsorbate reflect in turn the surface chemistry 
and charge of the powders.
1.5.1 Free energy of sorption.
The free energy required to transfer a solvent molecule from the vapour 
phase onto a solid surface is a measure of the affinity of the solvent for the
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solid [Bull, 1944]. This is a key thermodynamic parameter for evaluating the 
interaction propensity of a solvent for a solid.
Adsorption of a gas on a solid is a spontaneous process and is 
therefore characterised by a decrease in the free energy of the system, i.e., 
a negative free energy change, the more negative the quantity, the stronger 
the tendency toward sorption. Consequently, the free energy of sorption 
AGS is an indicator of the propensity of sorption. It is related to the enthalpy 
AHS and entropy ASs, of sorption through the Gibbs equation:
AGs=A H s-TAS, (9)
Both AGS and ASs are negative, therefore AHS must also be negative. 
Accordingly, the adsorption process should be exothermic and this is true 
irrespective of the nature of the forces involved [Adamson, 1990]. The 
decrease in the heat content of the system is called the heat of adsorption.
A system is in equilibrium when its entropy is at maximum or its free 
energy at a minimum. In terms of the Gibbs free energy, at constant 
temperature ( I )  and pressure (P), the condition of equilibrium is: (dG)T P = 0
The change in Gibbs free energy with temperature and pressure is 
given by:
dG = -sdT  + vdP + fjdni (10)
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where //, is the chemical potential. The chemical potential is an intensive 
quantity, while G is an extensive property.
The thermodynamic equilibrium between molecules in the gas phase 
and the solid surface is defined by the chemical potential and expressed by:
The chemical potential of the gas depends on pressure and temperature, 
and the chemical potential of the surface molecules depends on temperature. 
From the thermodynamic point of view, isothermal sorption equilibrium is 
reached when the chemical potential of the solvent on the solid is equal to that 
of the solvent vapour above the solid.
the subscripts s and v denote solid (sorbed) and vapour phases respectively, P 
is the partial pressure of solvent vapour at given temperature ( T ); Pa is the 
pressure of the solvent vapour in a saturated atmosphere at 7, R is the gas 
constant.
If the vapour is considered to behave ideally, and if Raoult’s law is 
introduced for the solvent probe P  = P ° x\, where x\ is the (mole fraction)
dju(gas) = dfi(surface) (12)
fi° s — fj.0 v + ie rin (13)
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concentration of the probe vapour, the chemical potential can be written in the 
form:
^il = ^ i° + R T ln x 1 (14)
At equilibrium, the Gibbs free energy (AG/) at any temperature can be 
further calculated by taking into account the relationship between the 
equilibrium constant and the free energy change:
&G° = -R T h i^ -  (15)
or
AG/ = -R T \n K eq (15a)
where x is expressed in mole fraction, and is the equilibrium constant. 
Thus, sorption is accompanied by a decrease in the free energy of the 
system, the more negative AGs the stronger the tendency towards sorption, 
when the system is in equilibrium AGs is zero (Noggle, 1985).
From a thermodynamic or statistical mechanics point of view, the 
internal energy and entropy of a molecule should be different in the adsorbed 
state from that in the gaseous state [Vemulapalli, 1993]. It is clear that the 
adsorbed molecule may lose part or all of its freedom to rotate. The average 
molar energy for the system Em can be written:
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(16)
The free energy of sorption is related to the partition function Q that relates the 
probability of finding a molecule at some particular point on the surface 
according to the Boltzmann principle [Adamson, 1990]. From the definition of 
Helmholtz free energy:
where Q could be essentially Qmt for the evaluation of rotational energy 
contribution to the energy and entropy change occurring during the adsorption 
of gas molecules on surfaces.
1.5.2 Enthalpy and Entropy of sorption.
Heat is given off upon the sorption of vapour on the solid, i.e., sorption is 
an exothermic process. Upon desorption, heat is absorbed by the system, i.e., 
it is an endothermic process. The enthalpy of adsorption (AHs) at constant 
surface coverage is called isosteric enthalpy, which is the quantity of heat
AF = E m-TS (17)
where AF is the Helmholtz free energy, then:
AF =-R T \n Q (18)
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released or absorbed during the sorption process. The heat of sorption is a 
measure of the interaction between the vapour and the solid. Rearranging 
equation (13):
AG°s — f i ° s  - p K (19)
r  p \
(19a)
R Inr P ''
\  o y T T
(20)
R In - a  g : (20a)
AG / is the standard free energy of change for the sorption of one mole of 
the vapour. Where P  is the partial pressure of solvent vapour at given 
temperature (T ); PQ is the pressure of the solvent vapour in a saturated 
atmosphere at absolute temperature r, and R is the gas constant. For the 
derivative since PQ is a constant, dQnP0)/d(l/T) gives the Clausius-Clapeyron 
equation:
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Even though enthalpy is a function of temperature, it can be treated as 
a constant over a small temperature range (for example, the enthalpy of 
vaporisation of water changes only by 1% for a 10°C change in temperature). 
The value of the isosteric heat of sorption is usually obtained from the 
Clausius-Clapeyron equation using vapour pressure of the solvent at a 
minimum of two temperatures: more temperatures will give a better estimate 
[Labuza et al., 1985]. The Clausius-Clapeyron equation is derived by 
considering two different equilibrium states, at slightly separated 
temperatures and pressures [Noggle, 1985]. Enthalpy is a state function, a 
differential molar quantity that varies with the amount sorbed. The Clausius- 




where C is the integration constant. Thus, the enthalpy of sorption can be 
obtained by plotting InP vs. 1/7 under isosteric conditions, which results in a 
straight line with negative slope equal to -A/&R. The enthalpy change is a 
measure of the energy changes occurring upon sorption of solvent molecules 
onto powder surfaces. The enthalpy changes can be related to the binding or 
repulsive forces of the system. Negative values denote the existence of 
binding whereas positive values denote repulsion [Apostolopoulos and Gilbert, 
1990]. In the case of sorption, negative values denote sorption whereas 
positive values denote desorption.
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(25)
known as the van’t Hoff equation. This may be integrated, assuming AHS to 
be constant over the temperature range considered.
The sorption process involves the loss of degrees of freedom for the 
adsorbate molecules when passing from the free gas phase to the adsorbed 
layer, hence a decrease of entropy occurs. The entropy of adsorption can 
be interpreted in solid surface behaviour in the same manner as it is 
interpreted in solution thermodynamics. For instance, the degree of
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‘disorder’ of an organic surface is related to the number of possible 
configurations which that surface can have under specified conditions [Rizvi 
and Benado, 1984]. Namely to the number of different states with the same 
average internal energy the system can adopt. In sorption of water, entropy 
decreases from localisation of water at specific randomly distributed ‘active 
sites’ of high AHSt while an increase in entropy results from solubilisation and 
swelling [Bryan, 1980].
Once AGS and AHS are obtained by means of the Clausius-Clapeyron 
and van’t Hoff equations, respectively, the entropy of sorption can be 
calculated by rearranging equation (9):
Entropy changes can be used to characterise the degree of ‘order or 
disorder* existing in the system and to the interpretation of processes like 
crystallisation, dissolution, and swelling [Iglesias et a/., 1976]. Negative ASs 
values denote a change toward more ordered systems whereas positive ASs 
values identify more random systems.
Bryan [1980] reported that water sorption on proteins consists of two 
entropic contributions: positive ASs value for the incipient solution formation and 
negative ASs for the localisation of water molecules. Similarly, Betthelheim et 
al., [1970] working with polymer-water systems reported that the entropy is 
positive for the water molecules but could be either negative or positive for the 
polymer, depending on the particular polymer. Polymer matrix swelling due to
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water molecules resulted in a positive entropy change for polymers undergoing 
such a conformational change.
1.6 Thermodynamic approach to surface energy for the 
evaluation of particle interactions.
Surface energy properties can be weighed by thermodynamic 
parameters. Thermodynamic properties have been used to understand the 
behaviour of liquids, e.g., water at the surface and in the interior of solid 
compounds. For solids, thermodynamic functions can be obtained to provide 
theoretical interpretations to the physical phenomena occurring in powder 
surfaces.
The surface tension (y surface free energy) of solids are invariably more 
difficult if not impossible to measure than those of liquids. The surface of a 
solid is very seldom homogeneous as that of liquid interfaces. Several 
investigators [Zografi and Tam, 1976; Kawashima et al., 1981] based their 
work on measurements of contact angles on compressed solids to study 
surface energetics. Buckton and Newton [1986b] studied the effect of particle 
size on wetting of pharmaceutical powders using contact angle measurements.
The contact angle technique has been widely used although its 
application to powders in the pharmaceutical area has decreased due to the 
problem associated with compressing the powder in order to make the 
measurement, and the resulting uncertainty about the faces making the 
interface at the time of measurement. For instance, crystals may show
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preferred orientation planes during compression due to the tendency of the 
crystals to orient themselves parallel to the upper flat punch face [Chan and 
Doelker, 1985].
There are alternative or complementary techniques to contact angle 
measurements for the examination of thermodynamic parameters. The most 
recent techniques for the study of water sorption on solid pharmaceutical 
systems are gravimetric or microbalance, inverse gas chromatography and 
isothermal microcalorimetry. Sorption isotherms can be obtained by varying 
the relative humidity surrounding the powder sample, isotherms are useful 
especially for studying the surface integrity of powders in terms of 
crystallinity/amorphous content for stability purposes.
The vacuum microbalance was used by Otsuka et al. [1988] and Saleki- 
Gehardt et al. [1994] to detect small changes in surface energetics of materials 
including ce-lactose monohydrate. They observed that the face of a crystal has 
a greater tendency to wet than has the bulk powder, due to the differences in 
energetics of crystal defects and edges compared to the energetics of flat 
surfaces.
Inverse gas chromatography (IGC) is a technique that was first used in 
the field of Food science [Gilbert, 1984], shortly after the technique found wide 
use in Soil sciences [Rhue and Rao, 1990]. IGC probe analysis has been 
widely used to study the sorption of water and volatile organic chemicals on 
materials such as soil [Pennell et al., 1992]. In Food science, Apostopoulus 
and Gilbert [1990] determined moisture sorption of a series of coffee 
components, and Lin [1993] studied the sorption properties of com meal 
extrudates. The thermodynamic functions obtained by IGC have been
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successfully applied to investigate the structure changes in biopolymers 
[Carrillo et al.,1988] and to predict biopolymers mucoadhesion and 
biocompatibility [Esposito et al., 1994]. In the pharmaceutical field, IGC has 
been used for drugs and excipients [Ahmed, 1989; York, 1994].
Microcalorimetry has a number of applications in physical pharmacy. 
Bakri [1993] designed an isothermal microcalorimeter flow cell for the Thermal 
Activity Monitoring (TAM). Bakri [1988a, b, 1997] has earned out extensive 
work using TAM for the study of surface thermodynamic properties of powders 
relevant to pharmaceutical systems. Sheridan et al., [1993] used a-lactose 
monohydrate for the microcalorimetric determination of the heat adsorption of 
water.
1.6.1 Inverse Gas Chromatography (IGC).
In the pharmaceutical field, Ahmed [1989] used IGC for the determination 
of the solubility parameter of sodium starch glycolate (Explotab™, Penwest) 
with other powders in complex quinary mixtures and Ticehurst et al. [1994] 
studied the surface properties of salbutamol sulphate.
IGC is a high-resolution technique frequently used in pharmaceutical 
research for investigating the thermodynamic properties of powdered 
materials. IGC involves packing the powder of interest into a standard glass 
GC column and individually injecting small amounts of solvents of varying 
polarity used as probes (e.g., non-polar alkanes and polar volatile organic 
solvents). The selection of different organic probes is based on the molecular 
reactivity [Gilbert, 1984].
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The different column retention of a given probe reflects the difference in 
surface energetics between the solid materials used for packing the column. 
From the retention data, the obtained capacity factors are in turn used to 
estimate thermodynamic parameters such as heats of sorption, Gibbs free 
energy, entropy and enthalpy of Sorption.
Examination of the solid state properties (structural and 
thermodynamic) by IGC, allows the estimation of other solid properties like 
dissolution, flow and/or compaction [Esposito etal., 1994].
Studies utilising IGC for pharmaceutical systems [Ticehurst et a/., 1994, 
1996; Huu-Phouc et al., 1986, 1987] demonstrated that this technique is 
suitable for surface analysis of powders before and after a processing 
operation. Several investigators have used IGC to measure and compare the 
solubility parameters of test materials before and after subjecting the materials 
to a given process. Ahmed [1989] determined the solubility parameters of 
sodium starch glycolate (Explotab) to calculate the interaction parameter (<p) 
and relative intensities of the cohesive and adhesive interactions in ternary and 
quinary systems. The author concluded that the relative intensities of 
interactions rather than the values themselves appeared to predict particle 
interaction behaviour in a given powder system. Egawa et al., [1992] showed 
that the solubility parameters increased after cefalexin powder was milled or 
lyophilised, indicating that the energy of cohesive interactions between 
molecules had increased. Milling was proven to be a high-energy mechanical 
treatment that increases cohesive energy of the materials as measured by 
IGC. Ticehurst et al., [1994,1996]; York et al., [1998] and Feeley et al., [1998] 
studied the effect of communition on the solubility parameters of several
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pharmaceutical powders including aspirin, carbamazepine, o-lactose 
monohydrate, d-l propranolol hydrochloride and salbutamol. It was determined 
that the solubility parameters of aspirin and carbamazepine were not 
significantly affected by milling whereas those of cs-lactose monohydrate, d-l 
propranolol hydrochloride and salbutamol were affected.
1.6.2 Isothermal Microcalorimetry by Thermal Activity Monitor 
(TAM).
Microcalorimetry under isothermal conditions using TAM is well 
established for compatibility and stability studies during drug development. 
[Bakri, 1993 and 1997]. The recorded heat flux (P) can be related to the 
reaction rate and reaction enthalpy of the process under study [Bakri et al., 
1988a, 1988b and Bakri, 1990]. The sample is usually loaded into a sealed 
ampoule and is then placed in the measuring position of the TAM. This 
closed system does not allow any control or change of the environmental 
factors such as water or solvent vapour pressure within the sample during 
the measurement. It is important to be able to cover the entire range, 0%- 
100%, of relative humidity (RH), or vapour pressure change at ambient 
temperature when studying the thermodynamics and kinetics of the 
sample/vapour interaction. For this purpose, a gas pressure controller 
device was developed to allow very accurate control of solvent vapour 
pressure (e.g., humidity) of a continuously flowing gas phase to which the 
sample is exposed [Bakri, 1992]. Bakri [1997] studied powder surface 
energy using sorption isotherms determined by TAM during vapour induced
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phase transitions, the study explored the effect of water activity on 
amorphous powders.
Microcalorimetry is a technique where the heat of adsorption of water 
onto the surface of powder is measured. This method provides a direct 
measurement of energy changes in a process by monitoring the heat change 
in an isothermal system. Two different experimental set-ups can be used in 
microcalorimetry, the closed ampoule and the open flow systems. The closed 
ampoule system is often used to measure heat of mixing. The flow cell 
configuration is used to measure the heat of adsorption of solvent vapours 
flowing through powder samples in the instrument’s cell. The technique 
contains sample and reference cells held at constant temperature by a large 
heat sink. The technique has the sensitivity to measure very small heat 
changes of the order of pJ s'1. Rowe et al. [1993] determined the heats of 
adsorption of water on different grades of microcrystalline cellulose. Landin et 
al., [1993] investigated how heats of adsorption correlate with the amorphous 
content of the adsorbent. Microcalorimetry has also been used to study the 
amorphous content of a-lactose monohydrate following processing, by 
conducting heat of crystallisation measurements that enabled the 
characterisation of amorphous content down to 1% [Briggner et al., 1994, 
Sebbatu et al., 1994]. This technique allows the presence of surface 
amorphous material to be detected which is not possible with other techniques 
like X-ray diffraction (XRD).
Atomic force microscopy (AFM) and molecular modelling are techniques 
that have been used in pharmaceutical systems as complement to IGC [York, 
1998], and TAM [Carvajal and Staniforth, 1998]. The combined use of
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instrumental techniques allows a better understanding of the physical 
properties of powders. Only a few studies using AFM [Louey et al., 1999] or 
molecular modelling in combination with other techniques have been reported 
to date because of the high degree of experimental care required, especially 
with AFM, and also due to the elusiveness of reliable computational interaction 
parameters required with these techniques.
1.7 Objective.
This study focuses on the impact that the physicochemical properties 
of a drug have on the drug’s bulk properties, specifically in terms of the 
drug’s behaviour as a powder and its interactions with other powders. The 
importance that powder properties and powder interactions have in the 
pharmaceutical industry cannot be overemphasised. And this study explores 
the extent to which the physicochemical properties of a drug, particularly its 
surface properties, manifest themselves at a macroscopic level in the bulk 
drug destined for pharmaceutical manufacturing. The experimental design 
for an investigation such as the present one requires the surface properties 
of the drug as one of the control variables. The observer can then fix the 
type of surface and determine how different sets of surface properties 
respond to the same perturbation. To this effect, the investigation reported 
here used as test materials two crystal polymorphs of the same drug. The 
choice of crystal polymorphs as test materials for this study offers a unique 
lens through which, it is hoped, some molecular attributes of the crystal
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surface can be viewed in a common frame with the bulk properties of the 
corresponding powder.
Crystal polymorphs are different materials with the same chemical 
composition. Differences in physicochemical properties between polymorphs 
stem from the different configuration and packing arrangements of the same 
molecular entity. A critically important point is that the above statement 
applies to all physicochemical differences between polymorphs, including 
their reactive and interactive properties. The basic hypothesis of the present 
study was that if two polymorphs of the same drug exhibit, as powders, 
measurable differences in their cohesive/adhesive interactions, the two 
materials should exhibit corresponding physicochemical differences at the 
microscopic level of their surfaces’ molecules. By studying the interactions 
of the two types of surfaces with a common molecular probe, the observed 
differences in surface properties of the two materials can be linked to the 
macroscopic cohesive/adhesive behaviour of the corresponding bulk 
powders.
The investigational drug Ro 24-5913, a LTD4 antagonist, was chosen 
for the present study. The chosen drug meets two criteria critical for 
purposes of the present study. First, the drug is intended for respiratory 
delivery, so the drug choice will produce results that are reflective of, and 
consequently of immediate relevance to, a true clinical trials situation. 
Second, the selected drug exists as two well characterised crystal 
polymorphs, making a material suitable for testing the above stated 
hypothesis.
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The idealised conception of the experimental design for this study has 
the pharmaceutical processing scientist confronted with two choices, A and 
B. The choices A and B are lots of bulk drug substance made of polymorph 
A and B, respectively. The two lots of drug substance are equally suited for 
pharmaceutical manufacturing in terms of critical processing properties such 
as particle size distribution and powder bulk density. In this scenario, the 
choice of polymorph does not affect product shelf-life, in vivo activity nor 
patent protection. The processing scientist has to make her choice based 
on the differences that the two materials exhibit during pharmaceutical 
manufacturing, and the consequent differences in final product performance 
the choice of polymorph brings.
1.8 Drug polymorphism and polymorphic drug behaviour.
Many organic molecules are known to crystallise into several 
modifications known as polymorphs. Polymorphism is the ability of any
compound to crystallise as more than one distinct thermodynamic phase, i.e., it 
exhibits more than one three-dimensional molecular packing and orientation in 
its crystal lattice. Crystal polymorphism is an extremely common occurrence 
among organic molecules, particularly drugs. Polymorphs exhibit among 
themselves differences in crystal energy contents associated with different 
molecular structures. The typical free energy differences between polymorphs 
are small (lattice energy differences of a few tenths of kcal mol"1) [Burger and 
Ramberger, 1979].
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The different behaviour of organic polymorphs is of fundamental 
importance to some industries, particularly the pharmaceutical, painting 
pigments, explosives, agrochemical and photography industries [Leusen,
1994]. It is well established that crystal polymorphs have considerable effects 
certain physicochemical properties such as solubility and dissolution rate, such 
effects in turn reflect differences in the free energy at the polymorphs’ core and 
at their surfaces, respectively. In the solid state, polymorphic drugs affect 
products during formulation development and on-stream processing [Chan and 
Doelker, 1985; Brittain, 1994] with downstream effects on bioavailability and 
therapeutic efficacy. Polymorphism influences the powder properties of the 
drug such as vapour pressure, apparent solubility, density, surface tension, 
hygroscopicity and rates of reaction [Fairbrother and Grant, 1978; Marshall and 
York, 1989; Giron, 1990].
Polymorphic drugs present variations in surface free energy, affecting 
particle and bulk properties of the powdered solid, thus affecting interactions 
with carrier’s and overall performance in a formulation. Changes in one 
physical attribute of the active, such as particle size or crystal habit, can have 
important consequences pharmaceutical processing parameters like 
dissolution, flow and/or compression, as well as on dosage form performance 
(efficiency of drug delivery and bioavailability).
In dry powder inhaler formulation, particle powder properties are crucial 
for efficient drug delivery into the lower airways of the lung. Given the critical 
requisite for delivering the drug’s fine particles from drug-cs-lactose 
monohydrate powder blends with DPIs, analytical methods are necessary for 
quantifying the interparticle forces during powder mixing, deaggregation and
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fluidisation processes in dry powder formulations. Examination of powder 
adhesion, surface charge and thermodynamic properties are likely to aid in the 
optimisation of DPI formulations.
The use of thermodynamic parameters as practical indicators for the 
detection of differences in the surface energies of different materials provides 
an opportunity to explore how intermolecular interactions ultimately manifest 
themselves at the macroscopic level of the bulk powder.
York [1994], Hancock et al. [1997] and Feeley et al. [1998] have 
examined the surface energy properties of several batches of powdered raw 
materials used in pharmaceutical manufacturing. The authors showed that 
subtle differences in the powder properties among batches could be detected 
using inverse gas chromatography (IGC). Bakri [1997] used a novel 
calorimetric approach to study the interactions between powdered materials 
and water vapour.
Polymorphism brings about changes in several physicochemical and 
physico-mechanical properties of organic compounds. As a result, other 
factors related to the functionality and/or processability of pharmaceutical 
products can be affected.
The behaviour of powders, in terms their mixing and the resulting 
physical stability of their blends, dispersion and deposition properties, may be 
explained in terms of the surface energetics responsible for the interaction of 
the drug with the carrier excipient. Linden et al. [1994] pointed out that the 
interaction energy should be "controlled" by exploiting interfacial properties of 
the powders in order to enhance powder properties.
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1.9 Physicochemical properties of the two polymorphs of 
Ro 24-5913.
The drug Ro 24-5913 was specifically selected in the present study 
because of its therapeutic potential for pulmonary delivery and because it 
exhibited two distinct polymorphic forms. This type of system was chosen in 
order to investigate the interactive properties of two different surfaces of the 
same chemical composition.
This pharmaceutical new chemical entity Ro 24-5913 {(E)-4-[[3-[2-(4- 
Cyclobutyl-2-thiazolyl) ethenyl] phenyl] = amino]-2,2-diethyl-4-oxobutanoic 
acid}, is a leukotriene D4 antagonist. It is somewhat sensitive to light and very 
hydrophobic, practically insoluble in water (equilibrium solubility < 2 pg/ml) and 
buffer at physiological pH. The two different polymorphs of Ro 24-5913, A 
and B, can inter-convert A to B via solvent-mediated transformation [Kulkarni 
and Robinson, 1994]. The chemical structure and some physicochemical 
properties of this compound are given in Figure 3.
Molecular weight 412.6
Aqueous Solubility < 2 pg/ml
Log P o/w 4.14
OH
Figure 3 Chemical structure of Ro 24-5913 and physicochemical properties.
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Polymorph B is the thermodynamically stable crystal modification. 
However, the two polymorphs are sufficiently stable as to remain without 
change for indefinite periods of time under ambient conditions. The two 
polymorphs are also stable under processing conditions such as milling. The 
two crystal forms of the drug used in this study can be clearly distinguished by 
different techniques.
The single crystal X-ray diffraction structures of the two crystal 
modifications have been solved by Blount et al., [1993]. The unit cell 
parameters of for both phases are summarised in Table 1. Figure 4 shows the 
graphical representations of the data in Table 1. The two crystal phases are 
monoclinic, but they have evident differences in molecular conformation and 
packing, clearly shown in Table 1 and Figure 4.
Table 1 Unit cell parameters for polymorphs A and B of Ro 24-5913 
[Blount e ta i,  1993].
Crystal
Form







A 4 18.018 6.916 18.182 92.15 2264 566 P21/a








Differences between polymorphs A and B. Unit cells are presented
in their corresponding spatial representation [after Blount et al., 1993].
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Intrinsic dissolution is a test frequently performed when studying 
crystal polymorphs. This parameter corresponds to the dissolution rate at 
constant surface area. Therefore, differences in intrinsic dissolution between 
polymorphs provide the first quantitative measure of the differences between 
the polymorphs’ surfaces. Figure 5 shows the different intrinsic dissolution 
of polymorphs A and B [Phuapradit et al., 1993]. The slower dissolution of 
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Figure 5 Intrinsic Dissolution profiles of Ro 24-5913 polymorphic forms 
[Phuapradit et al., 1993].
The choice of polymorph for tablet manufacturing has a measurable 
influence in the dissolution properties of the dosage form. Figure 6 shows 
that the extent of dissolution of Ro 24-5913 tablets after 45 minutes was
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In-vitro dissolution profile of polymorphs A and B of Ro 24- 
5913 in a suspension and a tablet [Phuapradit etal., 1993].
The effect of polymorphism on dissolution is one of the most widely 
known and best documented aspects of polymorphism in pharmaceuticals. 
But polymorphism has other important effects, especially during 
pharmaceutical processing. Polymorphs often have significantly different 
mechanical properties, making it necessary to use different to attain a similar 
end point during manufacturing. Figure 7 shows the difference in 














Fiaure 7 ,ntrins'c compaction force profiles of polymorphic polymorphs 
A and B of Ro 24-5913 [Phuapradit et al., 1993].
Table 2 provides a summary of comparative information on some of 
the physicochemical properties of polymorphs A and B. Form B exhibits 
greater solubility and intrinsic dissolution, consistent with form B being the 
thermodynamically stable form. Form B also exhibits the higher absolute 
density, a frequent occurrence in the case of thermodynamically stable 
polymorphs. The information of Tables 1 and 2, together with Figures 4 
through 7 clearly shows that polymorphs A and B are two different materials. 
The two crystal forms have different molecular arrangements (Table 1 and 
Figure 4), as well as different physicochemical (Figures 5 and 6) and 
different physicomechanical (Figure 7) properties. The present study
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investigates how the physicochemical differences between polymorphs A 
and B are manifested at the surface of the crystals’ particles, and how such 
differences relate in turn to the interactive behaviour of the corresponding 
bulk powders.





Crystal Habit unmicronised needle-like unmicronised equadrant-
like
(See SEMs) micronised elongated micronised rounded
Bulk Density g ml' 1 unmicronised 0.155 unmicronised 0.384
micronised 0.170 micronised 0.168
Absolute Density1 g ml' 1 
(unmicronised form)
1.157 1.239
Absolute Density1 g ml'1 
(micronised form)
1.260 1.290
Melting Point °C 
(Hot stage microscopy)
162-167°C 162-172°C
AHf J g'1 (unmicronised) 254.2 275.8
AHf J g'1 (micronised) 275.0 300.0
Water Solubility2 pg ml*1 1.23 0 .8 6
Intrinsic Dissolution3 
mg cm'2 min' 1 (Fig. 5)
0.0090 0.0062
In-vitro Dissolution3 % 
at 45 min (Fig. 6 ).
96 85
Compaction4 Fig 7
1 Gas Pycnometry (Porous Material Inc.).
2 Equilibrium solubility at 25 °C determination by HPLC (Sethachutkul et al., 1990). 
344 Phuapradit et al., 1993.
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2. MATERIALS, METHODS AND PHYSICAL
CHARACTERISATION
Dry powder formulations were prepared as binary blends consisting of 
of-lactose monohydrate as the carrier and polymorph A or B of the drug. The 
drug substance, irrespective of polymorph, was milled in order to bring its 
particle size to a range suitable for processing and use in a DPI formulation. In 
addition, for purposes of the present study, the particle size distribution of the 
two crystal forms of the drug substance had to be made the same in order to 
eliminate, as much as possible, the effect of particle size differences on the 
interactive properties of the powders.
All organic solvents and reagents used for HPLC analysis were UV 
grade; water was freshly distilled and the gases for IGC and TAM were of high 
(chromatography grade) purity.
2.1 Characterisation of Carrier a-Lactose Monohydrate
^-Lactose monohydrate (Sheffield Products, Plainfield, NJ, USA) was 
sieved in order to obtain a size fraction between 45 - 106 pm (including fines, 
i.e. size < 45 pm), using a vibratory sieve shaker (Model Analysette 3, type 
Fritsch GmbH, Manufacturers Inc., Germany) operated at an amplitude setting 
of 4 for 2 0  minutes.
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2.1.1 Particle Size Analysis
Sieve analysis. In order to verify the particle size range of o-lactose 
monohydrate obtained, sieving analysis was carried out using an ATM sonic 
sifter (ATM Corporation, Milwaukee, Wl, USA) at 7 sift amplitude for one 
minute. The sieve apertures used were 45, 53, 75, 90, 106 and 125 pm. 
About 2 g. of powder were used for each test. After the sieving test, the 
powder from each stage (sieve fraction) was carefully collected and weighed 
on an analytical balance (Mettler PM480 DeltaRange, Mettler Instruments 
Group, NJ, USA). The sieving analysis was done in triplicate.
Laser Diffraction Analysis. The particle size distribution of the powdered 
material was measured by laser light diffraction analysis with a Mastersizer X 
(Malvern Instruments Ltd., Malvern, UK). The technique involves the 
measurement of the angle of diffraction of the light scattered by the particles 
traversing a laser beam. The angle of diffraction, which is a function of the 
particle size, allows the calculation of the particle size distribution. A 20 ml 
volume stirring cell was chosen as the sample presentation unit, circulating at 
medium speed (1800 -  2200 RPM). a-Lactose monohydrate was dispersed in 
2-propanol (Fisher Scientific), the sample was sonicated for 5 minutes in order 
to disperse agglomerates. The suspension was then added dropwise until an 
obscuration of 10-30% was attained in the instrument. Once the obscuration 
reading had stabilised for approximately 1 min., the particle size measurement 
was carried out in triplicate using a 100 mm lens. Particle distribution by
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volume, using Fraunhofer analysis was obtained and reported throughout this 
work.
The particle size distribution of the sieved olactose monohydrate is 
shown in Figure 8 . The 10th (dvio), 50th (dvso) and 90th (dv90) percentiles of the 
sample size population correspond to 35.4 pm, 72.2 pm and 114 pm for dv^, 
dvso and dvgo, respectively, with a mean diameter of 78 pm. The surface area 
of o-lactose monohydrate, measured by the BET method using a gas 
adsorption/desorption apparatus (PMI, Porous Materials Inc. Automated BET 
Sorptometer) was 0.70 m2 g'1.
Lord [1993] reported that a lactose sieve fraction in the range from 90 to 
125 pm produced reproducible fluidisation, entrainment and removal of powder 
from the Rotahaler™ DPI device. In the present study, the use of a sieve 
fraction of a-lactose monohydrate in the range of 45 -  106 pm resulted in good 
powder properties in terms of fluidisation, entrainment and removal of powder 
with both the Rotahaler™ and the Dryhaler™ DPI devices.
56
100 -











|  20 - 
O
04;
0 20 40 60 80 100 120 140 160 180 2
Particle Size (urn)
Figure 8 Particle size distribution of sieved a-lactose monohydrate (sieve 
fraction 45-106 pm).
The mechanically sieved a-lactose monohydrate contained ‘fines’ 
(particles < 45 pm). Fines were determined by removing them with an air jet 
sieving (Alpine air jet) and found to be present at the level of about 12% by 
weight. The presence of fines has been shown to improve DPI performance 
[Lord 1993; Ahmed 1994]. Based on these practical and functional reasons, 
it was decided not to remove the fines from the sieved fraction used in the 
present study.
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2.1.2 Scanning Electron Microscopy (SEM)
The particle characteristics of olactose monohydrate were examined 
using scanning electron microscopy (JEOL 6310, Japan Electron Optics, 
Ltd., Tokyo, Japan). For the sample preparation, a-lactose monohydrate 
powder was carefully sprinkled on double adhesive carbon fixers mounted on 
aluminium planchettes. A thin conductive layer of gold was sprayed on the 
sample surface using a sputter coater (Model S150B, Edwards High 
Vacuum, Sussex, U.K.).
Figure 9 shows the SEM for a-lactose monohydrate crystals with their 
typical ‘tomahawk’ shape. Lactose fines are also observable in the picture.
Figure 9 SEM for a-lactose monohydrate, size 45-106 pm (including fines).
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2.2 Characterisation of Bulk Drug Substance
2.2.1 Drug micronisation technique
All formulation work was carried out using micronised drug in order to 
reduce the particle size to the desired range of less than 6  pm, for inhalation 
use. For the micronisation process, the bulk drug was first screened through 
6  and 12 mesh sieves. The screened material was then placed in the mill’s 
feeder, and passed through a fluid energy mill (4” Sturtevant Microniser) where 
the micronisation took place. The conditions used for the operation of the mill 
were: feeder # 250 (1.5") at flow rate of 17-20 g min'1, air volume of 
1.42 m3 min'1, injection jet (feed) pressure 45.5 Kg and a grinding pressure of
40.9 Kg. In the air micronising reduction mill, grinding is achieved by 
continuously projecting the drug particles in high speed air jets against a rapidly 
circulating stream of the still unmilled particles. The velocity of the particles in 
the jet is of the order of 300 m s'1, thus producing the high-energy impact 
responsible for particle size reduction.
2.2.2 Methods for solid state characterisation of Ro 24-5913
Polymorphism can have a significant impact on the bioavailability of 
the drug and on the in vivo performance of a drug product. One aspect of 
crystal polymorphism that generates much interest in pharmaceuticals is 
precisely that of its effect in bioavailabilty. The focus of the present study, as 
stated in Chapter 1, is rather to use the phenomenon of polymorphism as a
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means to have one chemical entity, namely the active ingredient, in two 
distinct surface configurations. The drug used in the present study was 
subjected to analysis by a variety of techniques commonly used in the 
characterisation of solids state materials. The series of analyses described 
below provide the baseline differentiation between the two polymorphs used, 
and most importantly, point toward the analytical techniques of choice for 
purposes of comparing the materials’ surfaces and the corresponding 
powders’ interactive properties.
2.2.2.1 X-Ray Powder Diffraction (XRD)
Powder XRD measurements were conducted on a Scintag XDS 2000 
X-ray diffractometer, equipped with a Copper X-ray source and a Peltier- 
cooled solid state detector.
Sample Preparation. The samples were run using a zero background 
plate made out of quartz. The zero background plate was covered with a 
thin layer of petrolatum to hold the powder sample and then placed on a 
stainless steel analysis cup. The sample powder was then sprinkled on top 
of the plate. The plate was gently tilted in order to let the powder flow 
downward, a portion of the powder would stick to the plate, while the excess 
powder would fall off onto a sheet of weighing paper. In this way the powder 
particles stick to the plate in a random manner; at least, no orientation of the 
particles is forced by the operator. The excess powder was reapplied in the
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same fashion in order to get a uniform and complete coverage of drug 
particles on the plate.
Operating Conditions. On each day powder XRD experiments were 
conducted, the instalment's alignment was verified prior to running the 
samples. A Curundum standard shaped plate (NIST SRM 1976 Cuoindum 
Plate Standard) was placed on the sample holder and the standard 
diffraction pattern between the 2-0. range of 34.8° and 35.5°, changing the 
2-0 angle at steps of 0.02° and 2.5 sec. of duration, was obtained.
Sample Analysis. Samples were run under the same conditions as 
the Curundum standard with the exception of the 2-0  angle, which covered 
the range of 1 ° to 40° for the samples. The detector scatter slit had a width 
of 0.3 mm for the samples. A change of the detector slit from 0.5 to 0.3 mm 
resulted in a decrease in the peak intensities measured, but it allowed a 
better resolution capability between peaks.
Results. Samples of micronised polymorphs exhibited the same powder 
XRD patterns as unmicronised material (not shown), indicating that no solid- 
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Figure 10 Powder XRD patterns for micronised Ro 24-5913 polymorphs A 
and B.
2.2.2.2 FT-IR and FT-Raman spectra
FT-IR and FT-Raman spectra are also widely used techniques to 
differentiate polymorphs. The FT-Raman procedure consisted of placing 
powder on a sample holder in the Raman accessory of Bio-Rad Digilab FTS- 
60A FT-Raman spectrophotometer. FT-Raman spectra were obtained 
under the following conditions: Excitation laser type, Nd-YAG near-IR laser 
operating at 1.064 pm or 9395 wavenumbers; the laser power at the sample 
was 710 mW, with a typical scan time of two minutes. The instrument was
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equipped with a liquid nitrogen-cooled Germanium detector. The resolution 
was 8 cm'1 at a typical range of 3500-200 cm'1.
The bulk drug substance was analysed by FT-IR and FT-Raman in 
order to determine if such spectroscopic techniques can differentiate the two 
polymorphs. The IR and Raman spectra are presented in Figures 11 and 12, 
respectively. The IR analyses were run at with a resolution of 4 cm'1 using 
twenty co-added interferograms over the frequency range 4000-400 cm’1 
[Lanyi, 1993]. The FT-IR results indicated that polymorph A and polymorph B 
are distinguishable but complicated, namely, that their spectral differences are 
not readily discernible. In other words, the IR patterns are so closed to each 
other that differences between the two polymorphs could be missed. Although 
these results do not necessarily preclude the ability of FT-IR as a technique to 
differentiate between the two polymorphs, the results indicate that FT-IR is not 
one of the most suitable techniques for purposes of the present study.
The obtained FT-Raman spectra are much simpler and readily useful for 
identification of the two polymorphs. The analytical peaks chosen were the 
two at 1626 and 1608 ±2 cm'1 delta shift. The ratio used can be defined as 
/ i626^1608 where 7V is the peak height intensity at the frequency v. These two 
peaks were chosen because they correspond to peaks present in the spectrum 
of polymorph A but absent in the spectrum of polymorph B. The ratios of 
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Figure 12 Raman patterns for Ro 24-5913 Polymorphs A and B.
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2.2.2.3 Microscopic Analysis.
Three microscopy techniques were used for the analysis of the two 
polymorphs of the drug substance. The techniques used were optical 
microscopy, Scanning Electron Microscopy (SEM) and atomic force 
microscopy (AFM). Drug particle and surface characteristics (crystal habit 
and texture) were examined using scanning SEM and AFM, respectively. It 
is worth mentioning at this point that the powder blends of the formulations 
were also examined by SEM.
2.2.2.3.1 Methods
Optical Microscopy. The unmicronised samples were suspended in 
USP grade mineral oil and observed under the microscope (Leitz Aristomet, 
Leitz Wetzlar, Germany) at 500X magnification.
SEM. A sample of drug powder or powder blend with a-lactose 
monohydrate was sprinkled on to double adhesive carbon fixers mounted on 
aluminium planchetttes. In some instances, the pure drug was suspended 
in an organic solvent such as cyclohexane in order to obtain an acceptable 
dispersion of individual particles. With this treatment, the electrostatic 
charging of the particles was reduced, thus facilitating sample preparation for 
SEM analysis. Following the same technique for sample examination as 
that described above for the SEM analysis of a-lactose monohydrate, a thin 
conductive layer of gold was sprayed on the sample surface using a sputter
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coater. The prepared samples were then examined using the JEOL 6310 
SEM instrument.
AFM. Powder particles were mounted on smooth sheets of mica. 
The powdered samples were prepared using Tempfix™ (Agar Scientific LTD, 
U.K.), which was melted at a temperature of 120°C on top of a steel thin disk 
plate and allowed to cool before the sample powder was sprinkled on it. In 
order to avoid agglomerates, the coated steel plate was scantly sprinkled 
with the powder sample, either cu-lactose monohydrate or drug. The steel 
plate was then re-warmed on a hot plate to a temperature of 50°C, at which 
the resin becomes very adhesive for about 20 minutes. After cooling to room 
temperature, the resin sets quickly trapping some particles and the excess 
powder was blown off. The surface of the cu-lactose monohydrate and drug 
particles were examined using atomic force microscope (MultiMode SPM 
and Nanoscope III control system, Digital Instruments, Santa Barbara, CA, 
USA) operating in tapping mode, with a silicon V-shaped cantilever at a 
frequency of 2-5 Hz. A 125-pm x-y scanner was used. More than 20 
individual measurements were performed at randomised sites for each 
sample.
2.2.2.3.2 Results
Optical Microscopy. Figure 13 shows the microscope images for
unmicronised polymorphs A and B. The two micrographs shown in the figure
were obtained at the same magnification. The morphological differences
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between polymorph A and polymorph B are clearly distinguishable on the 
photographs. Unmicronised Ro 24-5913 drug polymorph A exhibits needle­
like crystals, whereas polymorph B exhibits rod-like crystals. In addition, the 
differences in size of the two polymorph drug crystals are readily noticeable.
SEM. After micronisation, polymorph A looks elongated and B looks 
rounded (Figure 14). The photographs of the material showed that projected 
particle size obtained after milling was less than 5 pm.
AFM. The AFM images obtained here can only be used in a 
qualitative manner in the assessment the surface of the micronised (3 -  5 
pm) drug particles. This is so because the AFM analysis of the micronised 
drug presented a series of problems. Similar difficulties were reported by 
Robertson [1997], who reported the difficulties encountered trying to obtain 
good AFM representations of surface morphology when working with 
particles smaller than 10 pm. The problems associated with the AFM 
analysis of micronised materials have to do with the risk of tip contamination 
with minute particles. The AFM analysis in the present study was mostly 
restricted to flat exposed areas of the crystal, where the cantilever was able 
to scan freely without being impeded to move by tapping as the tip 
approached the crystal surface.
The AFM examination of drug surfaces indicated that the surface of 
polymorph A is smooth and somewhat flat (Figure 15). In contrast, surface 
of polymorph B presents more asperities and clefts, evident as ‘hills’ and 






Fiaure 13 Microscope images of unmicronised drug polymorphs
A (top) and B (bottom). Notice that the two images are 
taken at the same magnification.
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Scanning electron photomicrographs of micronised drug 
top: polymorph A , bottom: polymorph B.
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Figure 15 AFM images of drug micronised polymorph A (n>20, individual 
measurements were performed at randomised sites for each 
sample).
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Figure 16 AFM images of drug micronised polymorph B (n>20, individual 
measurements were performed at randomised sites for each 
sample).
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2.2.2.4 Particle size analysis and surface area.
Particle size analysis of the drug was performed using a Malvern 
Mastesizer X laser light diffraction instrument, in the same manner as 
described above for <*-lactose monohydrate. However, the sample 
preparation for the drug was slightly different from that of cs-lactose 
monohydrate. It is noteworthy to mention at this point that the instrument 
was checked for reliability with monodisperse polystyrene beads of different 
sizes, traceable by the NIST (National Institute of Standards and 
Technology). In addition, to ensure reproducibility and validation of the 
method two experimental practices were carried out: a) possible formation of 
undesired agglomerates or aggregates in the dispersed particle phase were 
looked for using a light microscope; b) obscuration was monitored with time, 
as no change was necessary. The drug was dispersed in hexane (Fisher 
Scientific), and sonicated for one minute to disperse agglomerates. The 
hexane-drug suspension was then added dropwise until an obscuration of 
20-30% was obtained. The 45 mm lens was chosen for the detection of 
particles in the range of 0.1 -  80 pm. Three runs were conducted for each 
drug sample. Fraunhofer analysis was used for the calculation of the 
particle size data, and the frequency distribution by volume.
A gas adsorption/desorption apparatus (PMI, Porous Materials Inc. 
Automated BET Sorptometer) was used for the determination of the surface 
area of both polymorphs of the drug by the BET method. About 2 g of 
sample was placed into the glass loop then this loop was submerged into 
liquid nitrogen. Vacuum was applied to the sample for about 24 hrs. prior to
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the measurement. Depending on the magnitude of the sample’s surface 
area, either nitrogen or krypton can be used as penetrating gas. Nitrogen is 
generally used for measuring large surface areas, whereas krypton is used 
for measuring smaller surface areas. Both gases were used for the 
determination of the micronised drug surface area.
As discussed in Chapter 1, the experimental design of the present 
study requires that the particle size distributions of the two polymorphic 
materials of Ro 24-5913 to be as close as possible to each other. Table 3 
shows the particle size distributions of micronised Ro 24-5913, polymorphs A 
and B. A comparison of the particle size distributions for both polymorphs 
are shown in Figure 17. Results of surface area analysis are also presented 
in Table 3.
Table 3 Particle size3 distributions and surface areab for micronised
Ro 24-5913, polymorphs A and B.
Ro 24-5913 Lot No. Surface
Area
_2 _-1 m g
Particle Size Distribution (pm)
dVgo dvso dvio
Polymorph A DS 21687-44 8.18 5.8 2.4 0.9
Polymorph B 3P-4223 7.38 4.7 2.2 0.8
a Particle size distribution by Malvern Mastersizer X Laser Diffraction. 
b Surface area by BET.
The particle size of the drug for both polymorphs was reduced in the 
present study in order to make the materials suitable for processing. Size 
reduction also results in an increase of both surface forces and surface free 
energy [Staniforth 1982b], which promote inter-particle interactions.
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The particle size of or-lactose monohydrate, as previously mentioned, 
was kept in the range of 45-106 pm (including fines) for use as carrier with 
similarly-sized micronised drug of two polymorphs. Thus, any change in the 
performance of the powder system could be considered to be primarily the 
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Figure 17 Particle size distribution for both polymorphs of the 
micronised drug (n=3).
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The micronised powders of polymorphs A and B showed to have very 
similar particle size distributions, as shown in Figure 17.
2.2.2.5 Thermal analysis -  Differential Scanning Calorimetry (DSC) 
and Heat capacity.
The DSC technique is commonly used to differentiate and to study the 
thermodynamic relationship between polymorphs. Samples of both 
polymorphs of Ro 24-5913 were analysed using DSC. A sample of about 2 
- 3 mg was placed into an aluminium pan and hermetically sealed. The 
sample was placed in the DSC apparatus (DSC-7 Perkin Elmer, Connecticut, 
USA). Two different heating rates were used, 5 and 10°C min'1. Table 4 
shows the DSC data obtained.












Indium (Calibration) 1 0 .0 7.350 28.6 156.5
Ro 24-5913 Polymorph A 
unmicronised 5.0 2.740 254.2 172.7
micronised 5.0 3.124 275.0 172.1
1 0 .0 2.792 279.7 174.3
Ro 24-5913 Polymorph B 
unmicronised 5.0 3.665 275.8 173.6
micronised 5.0 3.080 300.1 171.9
1 0 .0 3.237 282.4 174.7
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The DSC was used to determine the onset temperatures of the 
endothermic melting event and the heats of fusion of both polymorphs. 
Typical DSC thermograms for Ro 24-5913 are shown in Figure 18. These 
thermograms remained similar at the two heating rates used. Variations in 
DSC thermograms produced by changing heating rates are indicative of non- 
thermodynamic (i.e., kinetic) events accompanying the event under study. 
Such kinetic events are in turn the manifestation of imperfections in the 
crystal phase due to impurities for example, or brought about by external 
factors such as the mechanical stress exerted on the on the crystal during 
milling. The DSC thermograms in Figure 18 show that the indications of 
changes to the crystallinity of the micronised drug were not observable by 
DSC.
Heat Capacity is another thermodynamic quantity that can be readily 
measured by DSC. Heat capacity corresponds to the second derivative of 
free energy with respect to temperature, thus making it a more sensitive 
parameter in differentiating solid phases, particularly of the same material. 
Polymorph B has lower heat capacity than polymorph A (Figure 19). Heat 
capacity is perhaps the one thermal property that depends entirely on how 
the molecules are assembled, i.e., it depends on an ensemble of molecules, 
on how they pack together, and on how far and how fast the molecules can 
move from their equilibrium positions while still maintaining the crystal phase. 
Other thermal properties depend on the chemistry of individual molecules, or 
on groups of molecules, but at the precise point where the thermodynamic 
phase they form is being disrupted (i.e., on how the molecular ensemble is 
disassembled).
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Table 5 and Figure 19 represent the average values of two runs for 
each polymorph. Two runs were sufficient for reliability in the results, since 
the instrument is checked daily for calibration prior to use with a sample. 
Table 5 gives the heat capacity measurements for the two polymorphs of 
Ro 24-5913 . Figure 19 shows that the heat capacity of polymorph A was 
higher than that of polymorph B for the entire temperature range studied. 
This result is consistent with polymorph A being the less thermodynamically 
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Figure 18 DSC thermogram for Ro 24-5913 polymorphs.
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Table 5 Heat Capacity for Ro 24-5913 polymorphs A and B
Note: Universal Gas Constant, R = 8.31 J mol’1 °K'1 
Ro 24-5913 M.W. = 412.55 g mol'1 Temp. °K = 273 + °C
Temperature
°C
Polymorph A Polymorph B 
Average (n=2)
J g*1 -C’1
Polymorph A Polymorph B 
Cp Relative to R 
Dimensionless
30 1.2993 1.2815 0.2129 0.2319
40 1.3351 1.3292 0.2118 0.2405
50 1.3787 1.3517 0.2119 0.2446
60 1.4228 1.3924 0.2121 0.2519
70 1.4617 1.4284 0.2116 0.2584
80 1.4976 1.4651 0.2106 0.2650
90 1.5416 1.4995 0.2108 0.2711
100 1.5843 1.5428 0.2109 0.2789
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Figure 19. Graphical representation of heat capacity for both drug 
polymorphs.
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2.2.2.6 Water vapour sorption
The two polymorphs of the experimental drug In the present study 
have shown differences in their physical characterisation by a number of the 
techniques reported above. Vapour sorption is also a technique often used 
to characterise polymorphs. Water uptake by a powder may have different 
effects on the powder’s interactive properties, for example, increasing 
agglomeration via surface tension forces, and reducing electrostatic charges. 
These effects may depend on how the amount of water sorbed alters the 
functionality of the drug in systems such as DPI formulations.
Samples of both polymorphs were placed in a microbalance water 
vapour adsorption/desorption apparatus (VTI Corporation, Hialeah, FL, 
USA). Two different instrumental variants are available for the 
determination of sorption isotherms: a vacuum system and a flow system. 
The vacuum system uses pressure to control the relative humidity, the 
pressure is varied from a zero-point value to the saturation pressure of water 
at the temperature of interest. In the vacuum system, the atmosphere 
surrounding the sample consists exclusively of water vapour, and samples 
have to be dried prior to the analysis. The flow system uses wet/dry gas and 
uses the dew point feedback mechanism to control the relative humidity. In 
the flow system, the sample is always under 1 atm. of pressure in an 
environment made of a mixture of nitrogen and water vapour. Samples do 
not have to be dried prior to starting an analysis with the flow system. The 
vacuum and flow systems are equivalent in principle, although in practice 
they are rather complementary. The vacuum system is very valuable in the
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study of the properties and qualities of the material, e.g., during chemical 
synthesis optimisation, whereas the flow system is very useful for studying 
the behaviour of powder materials under conditions pertinent to 
pharmaceutical processing.
The amount of sample used for an analysis depends on the sample’s 
tendency to pick up water. If the sample is highly hygroscopic, about 2-5 mg 
are sufficient for the test, but if the sample is non hygroscopic, a larger mass 
is needed, about 25 mg or more. For this study, water sorption isotherms 
for both polymorphs were earned out using the flow system and a sample 
size of about 50 mg.
2.3 Preparation of drug Lactose blends
2.3.1 Blending technique.
Mixing of powders is one of the most important unit operations during 
production of pharmaceutical dosage forms, whether solids for oral delivery or 
powders for inhalation. ce-Lactose monohydrate is the most widely used 
carrier in DPI formulations, and was chosen for the formulations of the 
present study. Homogeneous binary powder blends of drug and cu-lactose 
monohydrate were prepared. The blends contained different concentrations 
of micronised Ro 24-5913, either as polymorph A or B. ^-Lactose 
monohydrate (Sheffield Products, Plainfield, NJ, U.S.A.), sieved fraction of 
45-106 pm (including fines), was used as the carrier. The powder blend
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formulations prepared had drug loads of 1, 5, 25, 50 % w/w. The powders 
were mixed in a glass container using a Turbula mixer (Willy A. Bachofen 
Maschinenfabrik, Switzerland) for 15 minutes using a 100 g batch size. A 
mixing time between 1 0  and 2 0  minutes is usually sufficient to obtain powder 
mixes with homogeneous characteristics. A shorter mixing time might result 
in an inhomogeneous system and longer times may cause segregation 
[Ahmed 2000]. After mixing, samples were removed and assayed for drug 
homogeneity by HPLC.
2.3.2 Content uniformity studies.
Homogeneity of the powder blends was assessed for each 
polymorph/lactose mixture by randomly withdrawing with a spatula, 1 0  
samples, each weighing 2 0  ± 1 .0  mg, from different parts of the powder 
blend. The powder samples were placed individually in 10 ml amber 
volumetric flasks. The diluent system used throughout the analysis 
consisted of a solvent mixture of acetonitrile:water:tetrahydrofuran at a ratio 
of 50:30:20. Diluent was added to each flask containing the powder sample, 
and the resulting mixture was then sonicated for 10 min. After sonication, 
the volumetric flasks were filled to volume with the diluent and thoroughly 
mixed. The resulting solutions were filtered through a Miliex HV 0.45 pm 
filter. All work was conducted under subdued light and using low-actinic 
glassware. Samples were assayed by HPLC, using the method of reported 
by Aggarwal et al., [1993].
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2.3.3 HPLC analysis.
The HPLC method used is outlined in Table 6 . Linearity of the HPLC 
method was confirmed by preparing standards of Ro 24-5913 at different 
concentrations for both polymorphs within the range of concentrations used.
Table 6  HPLC Method for Ro 24-5913:
Instrument Waters HPLC
Pump Model 600E Multisovent Delivery System
Injector WISP Model 712
Column Nova-Pak Ci8, 15 cm x 3.9 mm i.d., 4 mm
Mobile Phase Buffer pH 5.5:Acetonitrile:Tetrahydrofuran (52:43:5)
Flow Rate 1 .0  ml min-1
Detector/Setting Applied Biosciences/240 nm.
Injection Volume 25 ul
Approx. Ro 24-5913 
Retn. Time
4.8 min
Approx. Run Time 1 0 .0  min
Calibration curves with each polymorph of Ro 24-5913 (Figure 20) 
were prepared to verify concentration range linearity and performance of the 
HPLC instrument. A series of standard solutions were prepared from stock 
solution of 1 mg ml' 1 to cover the concentration range of 1 -  250 pg ml'1. 
This concentration range was sufficient to encompass the concentrations of 
all unknown samples analysed. Each standard solution for the calibration 
curve was injected in duplicate.
For each analysis session, fresh standard solutions were prepared in 
duplicate, each from separate weighs, at high and low concentrations within 
the range of linearity for both polymorphs. For the determination of the 
concentration of Ro 24-5913 in the samples, standard solutions were
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injected along with the samples to be tested before and after the unknown 
samples. Standards were injected five times and unknown samples twice. 





the concentration of drug Ro 24-5913 in the sample was determined using the 
mean response factor and the peak area of the unknown sample.
Tables 7 and Figure 20 show the linear regression obtained for the 
calibration curves for Ro 24-5913 polymorph A and B, respectively. 
Calibration plots were linear over the range 1-250 pg ml"1, and passed 
through the origin.
Table 7 Linear regression data for HPLC analysis of Ro 24-5913 
polymorphs A and B.
Ro 24-5913 Slope (counts)* Intercept (counts)* R*
Polymorph A 29241 3636 0.9999
Polymorph B 30363 16120 0.9997
A typical chromatogram for Ro 24-5913 is shown in Figure 21 (data 
information obtained from PE Nelson Access Chrom Integration Package 
validated and used at Roche).
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Calibration Curve Ro 24-5913 Form A
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Figure 21 HPLC Chromatogram of Ro 24-5913.
2.3.4 Content uniformity testing.
The average values of content uniformity for Ro 24-5913/a-lactose 
monohydrate blends are shown below in Table 8. The coefficient of 
variation was found to range from 3 to 5.7% indicating acceptable 
homogeneity of the powder blends. The range value for content uniformity
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of the active ingredient is within the acceptable criterion given for dry powder 
inhalers to ensure uniformity of dosage units [U.S. Pharmacopeia XXIII, 
1995].
Table 8  Content uniformity analysis for different Ro 24-5913 
formulations. Mean and standard deviation for n= 10.
Polymorph A











































2.4 Characterisation of Powder Blends.
2.4.1 Infrared and Raman Spectroscopy
These techniques involve examination of the twisting, bending, 
rotating and vibrational motions of the atoms in the molecule. IR detects a 
change in the dipole moment whereas Raman detects changes in the 
polarisability of the molecule during vibration. Raman spectroscopy can 
provide important information that is often not available from IR. When an 
incident beam of laser light hits upon the sample, some of the light may be 
absorbed, but much of it will be scattered by the material. The spectrum of
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a compound is essentially the superposition of absorption bands of the 
specific functional groups of pure materials. In the case of mixtures, the lack 
of absorption in specific frequency regions can be correlated with restrictions 
on specific vibrational modes in the molecule. The loss or shift of vibrational 
modes in a molecule is, in turn, indicative of an intermolecular interaction 
involving the corresponding functional group. Consequently, when 
comparing the IR or Raman spectrum of a pure material with that of a blend, 
it is possible, at least in principle, to gather information about the type of 
interactions taking place between the materials in the blend. Hindrance in 
the powder blend to a particular molecular vibration would be indication the 
interaction between the drug and olactose monohydrate, for example.
The Raman spectra for the neat polymorphs A and B are shown in 
Figures 22 and 24, respectively. For comparison, each of these two figures 
also shows the Raman spectra of neat a-lactose monohydrate. Figures 23 
and 25 show the Raman spectra obtained from the 5% drug-lactose mix for 
polymorphs A and B, respectively. Figures 23 and 25 show the blends’ spectra 
originally obtained, as well as those resulting after subtracting the spectrum of 
oHactose monohydrate.
It was found that the lower limit of detection by Raman of Ro 24-5913 
polymorph A is of the order of 1%. The band at 1626 cm' 1 is clearly not due 
to a-lactose monohydrate, but to polymorph A. At higher concentrations, 
more details of the spectrum become apparent. On the other hand, 
polymorph B is a very strong Raman scattering material. This substance is 
detectable even at 0.5% w/w.
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Functional groups manifest themselves at different frequency regions 
of the FT-IR or FT-Raman spectrum. The OH and NH groups, which are 
likely to form hydrogen bonds, are noticeable a wavenumber values greater 
than 3000 cm-1. Functional groups containing aromatic CH groups are in 
the region below than 3000 cm"1. Double bonds such as C=C, C =0  and 
C=N are located in the region below 1600 cm"1.
The top spectra in Figures 22 and 24 correspond to drug form A and 
drug form B respectively. Both showed a peak close to 3000 cm"1, which is 
typical for aromatic CH groups. This peak disappeared after mixing either of 
the drug polymorphs with a-lactose monohydrate and subtracting the 
a-lactose monohydrate pattern from the drug (Figures 23 and 25 bottom 
spectra). These results can be interpreted as an indication of van der 
Waals interactions between the drug and a-lactose monohydrate. No 
evidence of hydrogen bonding between the drug and cu-lactose monohydrate 
was detected, and the rest of the drug spectrum after subtracting olactose 
monohydrate was identical to that of the pure component.
The IR technique did not reveal the spectral changes observed by 
Raman when comparing neat materials and powder blends. Even though the 
drug and a-lactose monohydrate both possess dipoles and hydrogen 
bonding groups (prerequisites for Raman and IR detection), interactions 
between the drug and a-lactose monohydrate in the binary powder blends 
used in this experiment were not detected by IR.
The interactions taking place at the surface of dry powders for 
inhalation are mainly due to van der Waals forces and electrostatic
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interactions [Visser 1989]. The Raman spectra in Figures 23 and 25 show 
interactions involving the aromatic moieties of the drug. Since the carrier 
lacks aromatic groups, the drug-carrier interactions detected by Raman are 
of the van der Waals type, specifically dispersion interactions involving a 
dipole and an induced dipole.
The interactions in the powder blends may be too weak to produce a 
change in a permanent dipole or functional group in the molecule, capable of 
producing a noticeable shift in the IR spectra. These results do not 
necessarily mean that the IR spectra are devoid of any information regarding 
hydrogen bonding or other dipole interactions between the drug and the 
earner. It is possible that a more in depth analysis of the IR spectra will 
reveal not readily observable drug-carrier interactions. However, the 
purpose of the present study is not to investigate whether IR, or any other 
technique whose measurements produce practically imperceptible 
differences between polymorphs A and B, can be made to differentiate 
between them. The variety of instrumental characterisation techniques 
explored in this study was included with the purpose of identifying those 
techniques that most clearly and readily differentiate between polymorphs A 
and B, in terms of their interactive behaviour as powders.
2.4.2 SEMs of the drug blends
Characterisation of powder formulation blends of drug-lactose at 
different drug concentrations was conducted by scanning electron 
microscopy. SEM photographs showed how micronised drug particles
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physically adhere on coarse olactose monohydrate. SEM could also show, 
in a rough manner, the drug load necessary to cover a-lactose monohydrate 
particles in a “monolayer”.
SEM photographs of 1, 5 and 25% w/w drug polymorphs A and B in 
of-lactose monohydrate blends are presented in Figures 26, 27 and 28 
respectively.
The photomicrographs clearly show that a drug load of 1% is not 
sufficient to completely cover the crystals of ce-lactose monohydrate, whereas 
photomicrographs of 25% drug load shows an “overload”. Among the different 
drug concentrations used in this study, the 5% w/w drug load seems to be the 
closer percentage needed for covering the of-lactose monohydrate in a 
“monolayer”. A more detailed discussion in regards to the degree of drug 
























Raman s h i f t  lcm -1)
Van Arnun 21503-1C3-A tneme 3590 
AES-0 SCANS’ 04




















Haman s n i f t  (cm-11 
920149 C .a r/a jd ! La rlose  (nC). Ir.emc 4600 
TYPE'RA
CREAffD-Mon Ju l 18 12. 09 06 1994 SCANS-64
OPER-ML
RLP0HER-720«m
Figure 22 Raman spectrum for pure Ro 24-5913 polymorph A (top) and 
cr-lactose monohydrate (bottom).
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Figure 23 Raman spectrum for the mix 5% of drug polymorph A in-a- 
lactose monohydrate (top); and the spectrum of the 5% drug 
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Raman spectrum for the mix 5% of drug polymorph B in a- 
lactose monohydrate (top); and the spectrum of the 5% drug 
polymorph B, with a-lactose monohydrate subtracted out.
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Figure 26 1% micronised polymorphs A (top) and B (bottom) in a-lactose
monohydrate (45-106 pm).
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Figure 27 5% micronised polymorphs A (top) and B (bottom) in ^lactose
monohydrate (45-106 pm).
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Figure 28 25% micronised polymorphs A (top) and B (bottom) in a-lactose
monohydrate (45-106pm).
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3. STUDY OF PARTICLE INTERACTIONS:
ADHESION AND ELECTROSTATIC FORCES.
3.1 Adhesion Force Measurements
The forces of adhesion of solid particles onto surfaces have been 
measured in a number of reported studies, using variations of a centrifuge 
method. The results of such studies have been reported by Donald [1969], 
Staniforth [1981a and 1982b], Laycock and Staniforth [1984], Booth and 
Newton [1987], Kulvanich and Stewart [1987c], All reported methods are 
variations of a technique originally devised by Krupp [1967], which consists on 
placing a powder sample in a modified centrifuge tube. The adhesive forces 
are indirectly measured by overcoming them through the application of a 
known centrifugal force that causes the detachment of adherent powders from 
substrate surface.
Kulvanich and Stewart [1987c] developed a compartmental centrifuge 
cell that effectively separated small particles from large ones. The 
centrifuge method assesses the extent of particle detachment by assaying 
the total amount of material detached, the centrifuge method provides no 
information on the number or the size of the particles detached from the 
carrier. The centrifuge method is nevertheless capable of reflecting 
differences in processing conditions used in the manufacture of DPI’s. In 
order to apply forces of magnitude similar to those undergone by powders 
during aerosolisation in DPI formulations, Lord [1993] reported modified 
conditions of centrifugation. Blends made from different combinations of
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powder materials have been used in investigations intended to characterise 
and differentiate between mixes of unstable or weakly bound, and stable or 
strongly bound particles. Staniforth et al. [1981a] found that using a spin rate 
of 4000 rev min' 1 (RPM), a ‘break’ point existed between relative stable and 
unstable adhesive mixes. Similarly, Lord and Staniforth [1996] later reported 
that the ‘break’ point occurred at a relative centrifugal force of 2 0 0 0  g  using a
maximum centrifuge velocity of 4000 RPM.
In the present study, the centrifuge method was used to carry out 
adhesion force measurements. Powder blends were subjected to spin rates 
of 1000, 3000 and a maximum of 5000 RPM (3000 g). The extent of drug
detachment from drug-lactose blends was investigated under the above 
centrifugation conditions, using also different drug load concentrations. The 
results are expressed as percentages of drug removed from the carrier.
3.1.1 Materials and Methods
Centrifugation studies were carried out on the binary powder blends of 
the drug (Ro 24-5913) and a-lactose monohydrate. The drug load 
concentrations used were 1, 5, 25 and 50% (w/w), for each of the two crystal 
forms of the drug. The centrifugation technique used was the same as that 
described by Lord [1993]. Figure 29 shows a diagram of the centrifuge cell 
used in the adhesion studies. The centrifuge cell consists of a sample and 
collection compartments separated by a 45 pm mesh screen. The size of the 
screen mesh was chosen based on the lactose size range of 45-106 pm . The
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purpose of the mesh was to trap the large o-lactose monohydrate particles in 
the sample compartment of the cell, while allowing the small drug particles to 
pass to the collection compartment of the cell. In this way, the assay of the 
drug in the collection compartment is a measure of the amount of drug 
detached from the carrier.
It is pertinent at this point to discuss the effect of o-lactose 
monohydrate fines in these experiments. As discussed in Chapter 2, the 
a-lactose monohydrate carrier used in this study contained a fraction fines, 
i.e., particles smaller than 45 pm. The presence of fines was an intentional 
attribute of the carrier, included for purposes of product performance. One 
consequence of having a-lactose monohydrate fines in the blends is that the 
amount of drug assayed in the collection compartment of the cell is a 
composite quantity. The assay of drug in the collection compartment after 
centrifugation is the combined measurement of drug coming from two 
sources. One is the drug coming as particles detached from the carrier. The 
other is the drug still attached to, and carried over by, the a-lactose 
monohydrate fines that passed into the collection compartment. The amount 
of carrier fines is exactly the same in all powder blends irrespective of the 
drug polymorph used; the same cu-lactose monohydrate material was mixed 
with both polymorphs. One cannot overemphasise that the present work is in 
essence a comparative study of the effects that the choice crystal form of the 
drug (namely, polymorph A or B) has on a set of otherwise invariant 
conditions, and the reader is referred to Section 1.7 of this report. 
Throughout this work, any individual measurement is a necessary means to
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an end, namely, a comparison. In the context of the present investigation, a 
result is the comparison between polymorphs A and B, and an individual 
measurement can be considered as half the minimum information needed for 
a comparison. Therefore, given the spin rate and drug load of centrifuge 
experiments described here, the differences observed in the extent of drug 
detachment between blends of polymorphs A and B (as measured by the 
composite drug assay in the cell’s collection compartment), are attributable to 
the choice of polymorph used to present the drug.
Figure 29. Schematic of the centrifuge cell [Lord 1993].
A double-sided adhesive carbon conductive stub (12 mm) was attached 
to the sample compartment. An aliquot of powder blend was placed on the 
carbon stub. The loaded sample compartment was assembled in a centrifuge 
cell without the mesh screen. The cell was placed on a jolting volumeter 









where two taps were sufficient to remove the excess of powder in a 
reproducible manner. The screen mesh was then placed in position and the 
sample was centrifuged at 1000,3000 or 5000 RPM for 1 minute.
Samples from the donor compartment, the collection compartment 
and the mesh were analysed by HPLC. The content of drug still adhered to 
or detached from lactose was analysed by HPLC (as described in Chapter 
2), by ultraviolet (UV) or by fluorescence spectrophotometry. UV Absorption 
spectrophotometry was used to analyse the amount of drug retained on the 
carrier at the 5, 25, and 50% w/w levels of drug concentration. Fluorescence 
was used in the case of 1 % w/w drug.
Ultraviolet (UV) and Fluorescence Analyses: Standard curves of each 
polymorph, A and B, were prepared. A stock solution of 1 pg/ml of the drug 
was prepared in 1 0 0 % methanol, aliquots were withdrawn from the stock 
solution and further diluted in a mixture of methanol: water (50:50). The 
drug-lactose samples were dissolved in this solvent mixture directly. The 
standard concentrations used were 0 (blank), 50, 100, 250, 500, 750 ng/ml. 
A Hewlett Packard photodiode ,array spectrophotometer model 8452A 
UV/VIS (Hewlett Packard Co., Paramus, NJ) and 1-cm quartz cuvettes were 
used for the analyses. Each determination was carried out using a 
wavelength scan, and readings of absorbance at two different wavelengths, 
238 and 336 nm, were taken to construct the standard curve. The standard 
curve obtained was linear for the range of concentration chosen, and the 
concentrations of the unknown samples all fell within the range of the 
linearity of the curve. Fluorescence spectrometry was used to measure 
drug concentrations in cases where the drug content was low, as in the case
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of blends with 1 % w/w drug load. A standard curve was prepared using 
solutions with drug concentrations ranging from 5 ng/ml to 250 ng/ml. The 
emission intensity of the solutions was measured in a Shimadzu RF-551 
spectrofluorometer (Shimadzu Corporation, Kyoto, Japan), using 1 cm. 
quartz cells and wavelengths of 340 nm and 405 nm for excitation and 
emission, respectively.
The amounts of drug present after centrifugation in the cell’s sample 
and collection compartments, as well as the mesh were determined by 
chemical assay as described above. The assay values were then used to 
account for mass balance. Table 9 summarises the drug mass balance of for 
drug detachment at different drug concentrations (1, 5, 25 and 50% w/w of 
drug in a-lactose monohydrate) by centrifugation at 5000 RPM (3000 g) for 1 
min. The highest spin rate was chosen for purposes of confirming that mass 
balance is maintained through these experiments. It should be noted that 5000 
RPM was the only spin rate for which detachment was observed at all drug 
concentrations.
Table 9 Summary of the drug detached from lactose using the centrifuge 
technique -  Data represent the mean and standard deviation (n = 4).
Percenltage of drug content found
Powder Blend Removed Adhered Mesh
% w/w Drug Mean s.d. Mean s.d. Mean s.d.
Polymorph
1% A 1.91 0.48 98.09 2.56 1.43 0.75
1% B 4.88 1.03 95.12 1.33 3.66 2.36
5% A 14.87 2.69 78.89 3.79 6.24 2.04
5% B 18.40 0.42 77.49 5.56 4.11 1.41
25% A 17.48 0.52 72.78 4.18 9.74 3.24
25% B 21.41 1.29 73.54 2.97 5.05 0.84
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The data in Table 9 show that the methodology used for analysis of the 
centrifuged samples provides quantification of the amount of drug in the 
different sections of the centrifuge ceil used in this study.
3.1.2 Results and Discussion
The forces of separation measured using the centrifuge method can be 
considered as a measure of the drug-carrier adhesion forces overcome during 
centrifugation at that particular spin rate. Each spin rate results in a different 
detachment force applied to the drug-lactose-blend. The spin rate can 
therefore be viewed as a force probe applied to determine the amount of drug 
with the corresponding attachment force in the blend.
The force of adhesion between a fine adherent particle and a earner 
substrate surface resisting removal by spinning in the centrifuge until it finally 
detaches, can be calculated from Newton’s second law of gravity:
where F  is the force acting on the particle, m is the mass of the particle, a is 
the centrifugal acceleration and g  is the acceleration due to gravity. The 
centrifugal acceleration (a) can be calculated from:
F = m ( a + g ) (28)
a-co21 (29)
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where &  is the angular velocity and /  is the distance between the centre of the 
particle and the axis of rotation:
n (30)
30 S.
Su is the centrifugal speed in rev min"1 (RPM).
For at21 » g ,  the following approximation applies:
=ma>21 (31)
where i^et is the detachment force from the carrier applied to the drug particle.
The force acting on the particle during centrifugation is related to the particle 
mass, the angular velocity and the distance between the centre of the particle 
and the axis of rotation. For spherical particles, the detachment force from 
equation 28 can be rewritten in terms of the material’s density and the particle
where d  is the diameter of the drug particle and p  is the particle density. 




R.C.F. = — (33)
where Fg= mg, and g  = 980 cm sec-2
Table 10 gives the relative centrifugal forces applied in this 
experiment for the different spin rates and the calculated force of separation 
for the 50-percentile-diameter size of 2.4 and 2.2 pm for polymorph A and B, 
respectively (equations 25-30).
Table 10 Relative centrifugal force. Centrifuge distance between the 
centre of the particle and the axis of rotation /  = 1 0 .8  cm.
centrifuge spin rate © ©2/ R.C.F. Fdet
RPM rad-sec' 1 cm-sec'2 g Dynes-particle’1
0 A B
0 0 .0 0 0 1 .0 0 0 0 .0 0  0 .0 0
1 0 0 0 104.72 118436 120.853 1.08 0.85
3000 314.16 1065922 1087.676 9.72 7.67
5000 523.60 2960895 3021.322 27.00 21.30
In cases where a system is composed of monosize adherent particles, 
the adhesion and detachment forces are the same but with opposite sign 
[Krupp, 1967; Zimon, 1982]. Thus, the detachment force of all particles 
leaving the substrate can be calculated by multiplying particle mass and the 
R.C.F (equation 33). However, the calculation of the detachment force of the 
two systems in the present (real situation) study is more complicated because
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the particle size is not a single value, but a distribution. Each polymorph of the 
drug has a particle size distribution that is difficult to define without resorting to 
assumptions regarding particle geometry. Consequently, particle masses in 
systems consisting of distributions of irregularly shaped particles are always 
indirect estimates. For any particle shape, an increase in size is projected as 
a square power in surface area and a cubic power in its volume, hence its 
mass. Since the surface area, which provides the particle’s “anchor” for 
attachment onto the earner, increases more slowly than the mass as the 
particle size increases, it follows that the coarser particles will be removed with 
greater ease than the fine adherents at a given detachment force. The 
estimation of the true adhesive (or detachment) force between drug particles 
and carrier is not entirely possible because particles’ masses are not exactly 
known, and available methods for particle size measurement assume spherical 
particle shape, thus giving always underestimates for particle surface area.
The magnitude of the error involved by the assumption of spherical 
geometry can be assessed by comparing the specific surface area calculated 
from the particle size distribution and absolute density data, with the specific 
surface area measured directly by BET isotherm. Figure 17 (Chapter 2) shows 
the raw particle size distribution for polymorphs A and B of the drug, 
determined by laser diffraction. The ordinate represents the frequency P  (in 
percent volume), for each particle size, (diameter) D, of the corresponding 
(assumed) spherical particles. Consider a volume V of the material under
PV
investigation, for each particle diameter, A , there is a volume occupied by 
particles of that size. Thus there are
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PtV (34)
particles of diameter A  in a volume element . It follows that the particles 
in each fraction of the sample have a collective surface area of
where p  is the absolute density of the material determined by gas pycnometry.
Equation 36 gives estimates of specific surface area of 2.81 m2 g' 1 and 
3.11 m2-g'\ for polymorph A and B, respectively. In contrast, the 
experimentally determined specific surface areas for polymorph A and B are 
8.18 m2 g' 1 and 7.38 m2 g"1, respectively. The discrepancy in surface area 
calculated from particle size data and measured by BET isotherm is a clear 
indication of the complexities that the irregular geometries of powders bring into
(35)
The specific surface area, As, is thus given by:
(36)
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their study. There are two major sources of discrepancy between the 
calculated and measured specific surface areas. The laser diffraction analysis 
of particle size underestimates surface area by assuming spherical shape. In 
addition, the yardstick scales between laser diffraction and BET isotherms are 
totally different. Reliable laser diffraction analysis is applicable at scales 
approaching 1 pm or greater (nanometer-sized particles are more reliably 
measured by dynamic light scattering). In contrast, BET measurements are 
made at the scale of the Helium atom. Consequently, while BET surface area 
measurements encompass particle shape, rugosity and porosity at the atomic 
scale, laser diffraction measurements represent spherical particles with smooth 
surface at the near-micron scale.
It is pertinent at this point to digress on what is meant by a smooth 
surface in laser diffraction, and the difference between the yardstick scales of 
laser diffraction and BET pycnometry. The definition of a smooth surface is 
actually quite objective, and is dependent on the wavelength of the light used 
for inspection. A surface of optical flat grade is smooth to a scale of X/20, 
where X is the wavelength of the incident light. The laser diffraction 
measurements reported here use a beam of red light, placing X in the order of 
800 nm. This means that any irregularities such as bumps, kinks, fissures and 
the like, with dimensions in the order of 40 nm (the yardstick for diffraction) or 
less, will have no discernible effect on the diffraction pattern of the particle. 
However, the 40 nm scale is sufficiently large to fit a few hundred of the Helium 
atoms used in BET pycnometry. Depending on the scale, particle topology 
characteristics clearly reflected in BET measurements can be undiscemible in 
the corresponding light diffraction pattern. The tendency of diffraction
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measurements leading to underestimates of surface area is accentuated by the 
fact the mathematical treatment of diffraction data restricts particle geometry to 
that of spheres, thus to the minimum surface area.
The surface area of interest to this study corresponds to that available 
for particle attachment, in all likelihood, this surface area is underestimated by 
laser diffraction and overestimated by BET.
Figure 17 shows that the particle size distributions for both polymorphs 
are nonetheless very similar. Suggesting that the error produced by assuming 
spherical shape is a systematic one, thus allowing meaningful comparisons 
among data from the two materials. The force of detachment was calculated 
taken into account the size at 50-percentile for both polymorphs (Table 10). 
The values obtained for the force of detachment indicated that polymorph B 
required lower force than polymorph A for the separation from lactose (Figure 
30). This means that the percent of form A still adhered to lactose is higher 
than that of form B for all R.C.F.’s investigated.
Figure 30 also shows that the different types of detachment profiles 
observed seem to be more a function of drug load than of the crystal form. 
Polymorph B detaches more easily than polymorph A at all drug loads. 
However, the patterns of each polymorph at different drug loads have very 
similar shapes. This is a very significant result, because it indicates that the 
difference in particle shape between the two polymorphs (Figure 14) is not 
the determining factor in their attachment to lactose particles. Different drug 
loads result in different detachment profiles, but for a given drug load, the 
two polymorphs exhibit similar detachment profiles, and at all drug loads, 
polymorph B is more easily detached than polymorph A. The differences in
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particle geometry between polymorphs A and B are not significant enough to 
result in different detachment profiles, but polymorphs A and B are differently 
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Figure 30.
Spin rate (RPM)
Effect of centrifugation spin rate and drug load concentration on 
the percent detached from the stub in the donor compartment.
Table 11 presents the percentage of drug detached from the carrier as 
function of the spin rate for the two polymorphs, at different drug load 
concentrations. A graphical representation is shown in Figure 30. The figure 
shows that percentage of drug detached increased with the spin rate applied 
and with drug load. Detachment of the drug from the carrier was different for 
the two polymorphic forms. The extent of drug detachment for form B was
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Table 11 Percentage of drug Ro 24-5913 detached from the carrier lactose
monohydrate as function of the spin rate for the two polymorphs.
Ro 24-5913 load
Spin Rate (RPM)
1000 3000 5000 
Percentage of drug content removed
1% A Mean ND ND 1.91
s.d 0.48
1% B Mean ND ND 4.88
s.d 1.03
5% A Mean 3.03 3.14 14.87
s.d 0.30 0.48 2.69
5% B Mean 4.74 6.37 18.40
s.d 0.49 1.31 0.42
25% A Mean 6.08 13.09 17.48
s.d 1.03 3.11 0.52
25% B Mean 9.79 15.00 21.41
s.d 0.46 1 .0 2 1.29
TABLE 12 Analysis of variance for comparing centrifuge results for both 
polymorphs A and B.
25% F-value P
5000 rpm 103.2852 < 0 .0 1
3000 rpm 22.74579 < 0 .0 1
1 0 0 0  rpm 43.36239 < 0 .0 0 1
5% F-value p
5000 rpm 6.715087 < 0.025
3000 rpm 21.36375 < 0 .0 1
1 0 0 0  rpm 36.17267 < 0 .0 1
1 %
5000 rpm F-value P
27.70178 < 0 .0 1
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greater than for form A at all spin rates and drug concentrations, except at the 
lowest concentration and spin rates, where detachment for both crystal forms 
was negligible. One way analysis of variance indicated a significant difference 
in the detachment profiles for both polymorphs of the drug concentrations in the 
blend (Table 12).
The detachment profiles in Figure 30 show what could be called a 
‘break’ point (Staniforth [1981]) at 3000 RPM. This is observed here for the 
low drug loads of 1% and 5%. The data suggest that there is no weakly 
bound drug at 1% drug load for either form A or B. At 5% drug load, a low 
spin rate of 1000 RPM removed a portion of the drug, but the remaining 
portion could not be detached at 3000 RPM. These results, combined with 
the absence of a break point at 25% drug load, suggest that if sufficient 
attachment sites are available on the surface of the lactose particles (i.e., a 
sufficiently large carrier surface area available per drug particle), the drug- 
lactose interaction is considerably stronger than when the attachment sites 
on the carrier become scarce. This in turn suggests that adhesion forces are 
measurably stronger than cohesion forces for Ro 24-5913.
Adhesion and cohesion are both present at all drug load concentrations, 
and one would expect cohesion to become more significant the higher the drug 
load, while adhesion playing a major role at lower drug concentrations. The 
presence of a break point in Figure 30 supports this notion, especially because 
the detachment profiles are flat before the break. A perfectly flat detachment 
profile before the break point would be highly indicative of adhesion as the 
primary source of particle interaction. The only requirement for such a profile is 
a drug-carrier interaction strong enough as to require a threshold force to be
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overcome. Conversely, in the case of cohesion, a break point threshold 
following a flat detachment profile could only be explained by an extremely 
uniform particle size or agglomerate size of the drug, which is not the case.
The detachment profile at 5% drug load is particularly illustrative, 
because it combines the attributes of the profiles obtained at 1 % and 25% 
drug load. The profile at 5% drug load is clearly a composite one, showing 
the detachment of drug from the lactose surface above 3000 RPM as well as 
from drug agglomerates at 1000 RPM.
Spin rates in the range of 1000 to 3000 RPM have been used in the 
past in the study of DPI’s [Lord 1993]. These spin rates were insufficient for 
complete separation in the present situation, since there was a further increase 
in drug detachment at a spin speed of 5000 RPM. Travers [1975] reported 
that at low spin rates, the removal force is not enough to cause detachment, 
and particles will only rearrange to stronger adhesion sites. This explanation, 
however, is not consistent with the higher detachment values found here for 
form B over form A because the profiles for both forms are almost parallel in 
the presence and absence of the break. Travers [1975] explanation is 
consistent with a set of detachment profiles that includes both obtained here for 
1 % and 25% drug load, but precludes the patterns obtained for 5% load. At 
5% drug load, Figure 30 shows detachment at the lowest (1000 RPM) spin 
rate applied, followed by no additional detachment at the intermediate (3000 
RPM) spin rate. Lord and Staniforth [1996] have indicated that a relative 
centrifugal force of 2 0 0 0  g corresponds to the low removal forces of 
magnitude similar to that drug-carrier agglomerates in DPI devices are likely to
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experience during aerosolisation. The ‘break’ point in this study occurs at 
about half that limit, placing it well within the range of low removal forces.
The results obtained indicate that there is a consistent difference 
between polymorphs A and B in terms of their interaction with lactose. And this 
difference is more the result of different physicochemical properties than of 
different geometries of the two crystal forms.
The adhesion ability of a particle is predominantly a surface property, 
whereas the counteracting detachment force is determined by the particle 
mass. Detachment of adhered particles by the centrifuge method consists in 
breaking the balance between the force of particle attachment and the 
separation force imposed by the spin rate, i.e., the balance between a surface 
and a bulk property. The nature of particle interactions makes the nature of the 
surfaces of the interacting materials a determining factor in their behaviour. 
Kulvanich and Stewart [1987c] made surface modifications to the materials of 
their study and found that the physicochemical properties of the surfaces 
brought into contact are the primary factors determining the degree of the 
interactions produced. The particle interaction system chosen for the present 
study was used without any modifications to the materials’ surfaces. This 
situation represents the true case of the clinical development programme in a 
pharmaceutical setting. However, crystal polymorphism is a very common 
pharmaceutical occurrence, and the inclusion of two polymorphs in this study 
corresponds precisely to introducing two very well controlled surface 
modifications of Ro 24-5913.
Polymorph B, which consistently shows greater detachment than 
polymorph A, has also higher absolute density. It follows that for a given
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particle diameter, form B particles will be subjected to a greater detachment 
force than particles of form A, when subjected to the same spin rate. If the 
particle size distributions for the two polymorphs were identical, detachment 
forces on polymorph B should be consistently greater than those acting on the 
particles of polymorph A, by a factor of 1.29/1.26, the ratio of their absolute 
densities. This factor, however, corresponds to an excess detachment force 
on polymorph B of about 2.5%, too small to be measurable considering the 
experimental variation (Table 9).
If we take this analysis a bit further and consider the particle size 
distribution of the two polymorphs (Figure 17), it is evident that although very 
similar, the two distributions are not identical. Figure 31 provides an alternative 
presentation of the particle size distributions shown in Figure 17. The 
alternative presentation helps establishing whether the greater detachment 
observed for polymorph B is simply the result of denser particles than those of 
polymorph A of the same size. Figure 31 corresponds to the cumulative 
frequency of the distributions shown in Figure 17. The volume percent of 
Figure 17, however, is expressed in its numerical mass equivalent in Figure 31. 
Presented this way, the 100% percent volume allows the graphical 
representation of the different absolute densities of the two crystal forms. The 
figure is also cumulative in a reverse fashion: the frequency summation is done 
starting with the largest particle size and the smallest at the end. The reverse 
integration was done in order to facilitate data presentation for this discussion.
The application of an increasing centrifugal acceleration can be 
visualised as a threshold detachment force that sweeps from left to right in 
Figure 31. For either polymorph, the largest (having higher mass) particles will
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detach first, with increasing detachment forces being needed in order to detach 
the finer particles. The vertical line in Figure 31 corresponds to the 45 pm cut 
off diameter imposed by the mesh used in the centrifuge cell. Only particles 
smaller than 45 pm can pass to the receiver chamber of the cell. The 45 pm 
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Figure 31 Particle size distribution of polymorphs A and B. The cumulative 
frequency is expressed in its mass equivalent.
Figure 31 clearly shows that even though polymorph B has the higher 
density, polymorph A has slightly more of the larger particles. Figure 31 also 
shows that the effect of the higher density of form B resulting in stronger 
detachment forces would not be observable for particles larger than -0.86 pm,
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the point where the two profiles cross. The mass distribution among the 
particles of the two polymorphs thus favours greater detachment of polymorph 
A, contrary to the obtained results.
Microscopic analysis was conducted after centrifugation of the powder 
in order to observe the lodging position of the particles on the mesh. In 
addition, SEM analysis was performed on the particles still adhered to the 
carbon conductive stub.
The foregoing discussion indicates that neither the differences in particle 
geometry between the two polymorphs, nor their difference in density or 
particle size distributions, can account for the differences observed in their 
detachment behaviour. Polymorph A is better retained in the sample chamber 
of the centrifuge cell than polymorph B. Whether this is solely due to a 
stronger interaction with lactose (adhesion), or also to an ability on the part of 
polymorph A to form stronger aggregates (cohesion), which must also be larger 
than 45 pm, cannot be conclusively established from the present analysis. In 
either case, however, the explanation must reside on a difference between the 
intrinsic properties of interaction of the two polymorphs.
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3.2 Electrostatic charge measurements of drug-carrier dry 
powder mixtures.
Several investigators [Staniforth and Rees, 1982a; Ahmed, 1989; 
Hughes, 1989, Ahmed et a i, 1992; Lord 1993; Peart, 1996] have used 
different modifications of experimental methods designed to measure 
electrostatic charges in powders. Electrostatic forces in DPI formulations 
can be expected to play part in the attraction between drug and carrier 
particles, considering the mass to charge ratios obtained for respirable sized 
particles [Staniforth, 1994]. Electrostatic measurements on powders can be 
classified into two types, depending on the experimental setting: static or 
dynamic. Both types of experimental methods provide information on the 
charges generated upon powder movement. The static method is 
considered useful for information during mixing, pouring and filling, whereas 
the dynamic method gives useful information during fluidisation or 
aerosolisation of powders.
The static method for evaluating the electrostatic characteristics of dry 
DPI formulations is the shallow Faraday well static charge detector (SFC). 
The dynamic methods are variations of the Faraday cage dynamic charge 
detectors, these are the air stream (ASFC) and the capacitor 
interchangeable mesh (CIMFC).
The shallow Faraday well has been used to measure the electrostatic 
charge induced on powders poured from containers made of different materials 
[Staniforth and Rees 1982a], and the effect of these charges on the content 
uniformity of a binary powder system [Ahmed et al., 1992].
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Kulvanich and Stewart [1987a] adopted the “blow-off’ approach used in 
xerography [Donald and Watson, 1970; Schein and Cranch, 1975] for the 
measurements of electrostatic charges in pharmaceutical systems under 
dynamic conditions. In this type of experiments, the detector registers the 
electrostatic charges generated as the result of movement of the particles in an 
air stream.
Peart [1996] modified the dynamic cage charge system of Hughes 
[1989] for use for the first time in dynamic measurements for pharmaceutical 
aerosols. The method consisted of an inner cage cylinder with mesh on both 
ends. The net charge was measured for olactose monohydrate and lactose- 
salbutamol systems. Peart [1996] found that the electrostatic interactions 
influenced the in-vitro characteristics of dry powder formulations for inhalation.
The aerosolisation of powder formulations produced upon the 
actuation of DPI devices produces electrostatic charges. The electrical 
fields produced by the aerosol clouds of formulation-device systems have 
been measured using two different apparatuses: the electrostatic fieldmeter 
(EFM) and the transient charge monitor (TCM). These two apparatuses, 
which monitor the bipolar charging characteristics of aerosols, have been 
used and described in detail by Peart [1996].
The TCM method was specifically designed to detect bipolar charging 
characteristics of pharmaceutical powder aerosols [Balachandran et al., 
1991]. Drug detachment produced upon actuation of DPI devices can result 
in the development of both positive and negative charges on the same 
particle [Balachandran e ta l, 1991]. Such bipolarity can, in turn, have effects 
on the overall performance of powder systems, especially if aggregation of
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charged particles occurs. Particle aggregation presents the risk of the drug 
not being able to reach the parts of the airways targeted for pulmonary drug 
delivery.
The development of pharmaceutical powder formulations for 
inhalation requires the well controlled mixing of powder materials for 
complete homogeneity. Well controlled mixing is particularly critical, 
considering that small drug particles are mixed with larger particles of the 
earner. The challenges involved in achieving the homogeneous mixing of 
powder materials with particle size distributions separated by more than one 
order of magnitude, cannot be overestimated in the development of DPI 
formulations.
Table 13 shows the different experimental techniques that have been 
used by various investigators to characterise electrostatic interactions in dry 
powder mixes. The present study investigates the contribution of electrostatic 
charges to the interparticulate forces between the micronised drug, 
Ro 24-5913, in its two polymorphic forms, and a-lactose monohydrate. The 
electrostatic characterisation was carried out on the pure components as well 
as on powder blends. The static method was used for the characterisation of 
pure materials, whereas two different dynamic methods were used for the 
characterisation of powder blends.
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Table 13 Apparatuses used for the electrostatic characterisation of poured and 
fluidised powders, and aerosolised powders from DPI.
Apparatus Investigators
1). “Static” Method: Faraday Wells for poured powders
• Shallow well Staniforth and Rees, 1982a 
Ahmed, 1989; Ahmed et al, 
1993
• Deep well Lord, 1993; Staniforth, 1994
2). “Dynamic” Method: Faraday Cages for fluidised powders
• Air stream (ASFC) Kulvanich and Stewart, 1987a; 
Peart 1996.
• Capacitor Interchangeable Mesh (CIM). Hughes, 1989; Peart, 1996
3). “Dynamic” Method for powder aerosol generated from a DPI
• Electrostatic fieldmeter (EFM) Peart, 1996
• Transient Charge Monitor (TCM) Peart, 1996; Machowski, 1996
3.2.1 Materials and experimental conditions.
Micronised drug Ro 24-5913, polymorphs A and B and coarse earner 
a-lactose monohydrate were subjected to electrostatic characterisation as 
pure components and as drug-carrier powder binary blends (described in 
Chapter 2). Experiments were conducted under controlled conditions of 
temperature (T) and relative humidity {RH). Temperature of the room varied 
between 20°C and 22°C and the relative humidity between 24% to 30% 
(Honeywell T and RH room controller; RH was also continuously monitored with 
a hygrometer), unless otherwise stated. Six replicate determinations were 
carried out for each powder sample.
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3.2.1.1 Electrostatic properties from poured and fluidised powders:
Measurement of Electrostatic Forces
Among the different apparatuses used in the present study for the 
measurement of electrostatic charges, the SFC, ASFC and CIMFC are all 
essentially capacitors, in which two plates of a conductor material are 
separated from one another by a dielectric. In this study, the conducting 
material in the apparatus is brass and the dielectric materials used were PTFE 
(with the SFC and CIMFC) and PVC (with the ASFC). For all three capacitor 
devices, the inner container was connected by a shielded co-axial cable to an 
electrometer (Type 61OC, Keithley Instruments, Cleveland, OH, USA) where 
charge measurements were performed. When a charged material is 
introduced into the apparatus’ well, an equal and opposite charge is induced 
on the inner walls of the well. The induced charge is then measured by the 
electrometer.
The charge measured by the electrometer is based on the following 
equation:
C = —
. V E J
(37)
where C is the capacitance, Q is the charge and VE is the applied voltage.
The electrostatic charge measurements of powders from the different 
Faraday wells were used to obtain the average charge-to-mass ratio 
generated on the drug particles detached from the carrier. The following 
equation was used for this determination:
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e„=  ^ (38)
m
where the mean specific charge, Qsp, is obtained from the charge magnitude, 
Q, and the mass, m, of the powder. The specific charge was determined for 
SFC and ASFC. For the CIMFC, the total charge was measured rather than 
the specific charge, after Peart [1996].
Static Method: Shallow Faraday well charge detector (SFC). These 
studies were conducted by making the powders flow off chutes made from 
different materials. The chutes used were made of stainless steel, brass and 
perspex (polymethyl-methacrylate). A powder sample of approximately 0.5 
g was placed on the chute. Flow of the powder was effected by vibration of 
the chute. The chute’s vibrating frequency was adjusted such that a powder 
flow rate of 0.2 g sec’ 1 off the chute was attained. The flowing powder was 
poured into the brass Faraday well (Figure 32). At least five determinations 
were made for each powder and charge reported as mean specific charge 
(equation 38). After each determination, the chute surface was cleaned 
thoroughly in order to avoid surface contamination that could affect the 
subsequent measurements. Proper cleaning in electrostatic measurements 









P.T.F.E. Block U.H.F. Connection
Figure 32 Diagram of the Faraday cage static charge detector (after 
Staniforth, 1994).
Dynamic Methods: ASFC and CIMFC are dynamic methods that 
involve fluidisation of the powders inside the electrostatic cage; these 
methods measure the electrostatic charges generated as the result of the 
movement of particles in an air stream [Kulvanich and Stewart, 1987a; 
Staniforth, 1994/
Air stream Faraday Cage (ASFC). The apparatus used in the present 
work was similar to that used by Peart [1996], which was in turn an 
adaptation of the apparatus described by Kulvanich and Stewart [1987a]. In 
the configuration used here, the Faraday cage consists of an open brass 
cylinder equipped with a 45 pm mesh screen placed over each end. A 
mesh of this size allows the drug particles, which are smaller than 10 pm, to
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leave the cage, whereas a-lactose monohydrate particles (45 -  106 pm) 
remain within the cage. The screens are mounted on PVC o-rings, which 
insulate the cylinder from the mesh (Figure 33). Compressed air was taken 
from an air line supply filtered through of 0.2 pm (PTFE Aero 50, Gelman) 
membrane. The in-line filter was placed in order to prevent potential 
particulate impurities present in the air from entering the cage. The airflow 
rate was adjusted to 60 I min' 1 after the filter with a float-type flow meter 
(Gilmont No. 15, Reichert-Jung). The air flow meter was calibrated with a 
high-bubble generator flow calibrator for the airflow range from 2  to 80 I min' 1 
(The Gilbrator, Gilian Instruments Corporation, USA).
Peart [1996] studied the effect of sample size and airflow rate on the 
electrostatic charges developed upon detachment, and found no significant 
difference when using different sample size. However, a flow rate of 60 I 
min' 1 gave a maximal removal for drug adhered.
The sample size used in the present study was 0.5 g and the airflow 
rate used was 60 I min'1. Validation of the 45 pm mesh was earned out by 
allowing air alone to go through the mesh, this resulted in no spurious charge 
generation. The charges generated were thus due only to the aerosolization 
of the powder sample. Charge measurements were performed by placing 
an accurately weighed amount of sample powder mixture in the apparatus’ 
mesh. The sample was placed on the lower mesh of the ASFC and fluidised 
for 30 seconds. Under fluidisation, some powder left the cage, and the 
powder remaining on the mesh inside the chamber was weighed. The 





Figure 33 Air Stream Faraday Cage (ASFC) for measuring electrostatic charge 
of powders by “blow-off’ from the bottom [After Kulvanich , 1986].
Capacitor Interchangeable Mesh (CIMFC). The arrangement of this 
cage is horizontal, giving a greater opportunity for particle-cage wall 
collisions. Peart [1996] used a modified version of the apparatus described 
by Hughes [1989] for testing binary, ternary and quaternary powder systems.
The CIMFC consists of an inner brass well with interchangeable end 
caps of different mesh sizes. In this experiment, mesh screens of 45 pm in 
both ends were used for the same reason given above, namely, to entrap the 
coarse a-lactose monohydrate particles while allowing the carrier fines and 
drug particles leave the cage. Figure 34 shows a photograph of the CIMFC
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set up. The inner container is enclosed by the larger, grounded brass 
container (or outer well). PTFE was used to insulate the inner from the 
outer wells. A powder sample of 0.5 g was placed in the inner well. Two 
air jets were then applied, one at each end of the cage, in order to 
simultaneously blow the powder from both ends of the inner well. The 
compressed air was directed in such a manner as to provide a total airflow of 
60 I min'1. These settings produced optimal aerosolisation and particle 
removal from the well. The inner well was connected to an electrometer, 
which registered the resulting net charge.
Figure 34 Photograph of the CIMFC system used for measuring charges 
during fluidisation.
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3.2.1.2 Electrostatic properties of aerosol generated from DPI 
devices containing drug-lactose monohydrate powder 
mixtures.
The direct dosing dry powders by means of inhalation devices 
involves problems of powder fluidisation, flow, and dispersion [Fuchs, 1964]. 
During powder aerosolisation within the DPI device, the movement of 
particles and their collisions with the device surfaces result in the 
development of electrostatic charges. Such electrostatic charges affect, in 
turn, inter-particle interactions.
In this study, the electrostatic properties of aerosol clouds generated 
upon actuation of a DPI device have been characterised using the 
electrostatic fieldmeter (EFM) and the transient charge monitor (TCM).
Transient Charge Monitor (TCM). The TCM [Machowski, 1996] is an 
instrument designed to detect both positive and negative charges on 
powders. This is done through a number of electrodes configured in series, 
meant to “mimic” the airways of the respiratory tract [Machowski, 1996]. In 
the present study, TCM was used to explore the charging phenomena of the 
two polymorph powder systems aerosolised from two different DPI devices. 
The DPI devices selected for the delivery of the polymorph powder systems 
were the Rotahaler™ (Glaxo) and the Dryhaler™ (Dura Pharmaceuticals). 
The Rotahaler was chosen for its simplicity and availability. The Dryhaler 
was chosen for its purported de-aggregation efficiency [Hill, 1994].
The Rotahaler requires the powder to be filled into capsules, the filled 
capsules are lodged into the device prior to actuation. Hard gelatine
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capsules, size 3, were filled with 25 mg ± 0.625 mg of the 1, 5 and 25% w/w 
drug blend, and stored for a week under room ambient conditions in order to 
allow equilibration of electrostatic charges. For each run, the air supply was 
operated until a steady background signal was attained, the Rotahaler was 
then actuated, opening the capsule. Ten empty capsules were first 
discharged from the inhaler into the TCM in order to detect any possible 
signal coming from the capsule opening step. Subsequently, ten filled 
capsules of each blend were discharged from the device.
For the Dryhaler, the powder was filled directly into the device. 
Samples of 10 - 1 5  mg of each the blends containing 1, 5 and 25% w/w drug 
of each polymorph were filled into the device, followed by dispersion of the 
powders by the device into the TCM.
Experiments were conducted in an environment of temperature of 20 
to 25°C and relative humidity ranging from 55 to 60 %. Compressed air was 
generated from the exhaust outlet of a vacuum pump adjusted to a flow rate 
of 60 I min' 1 (Model 1423, Gast Manufacturing Inc., Michigan, USA). A 
vacuum cleaner (Vax 2000, Droitwich, U.K.) was used as the air supply for 
aerosolisation of the inhalation powder. When the powder is discharged 
from the device, a charged aerosol cloud of particles is formed producing an 
electrical signal as it travels along the TCM tube. The electric signal 
detected by the electrodes was simultaneously captured and stored on a 
P.C. in Excel™ (Microsoft) spreadsheet format. The experiments were 
conducted in triplicate for each powder blend.
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3.2.2 Results and Discussion
3.2.2.1 Electrostatic properties from poured and fluidised powders
The triboelectrical charges developed by the pure powder 
components following flow over chutes made of different materials is 
attributed to the samples’ crystal and chemical properties [Inculet in Moore, 
1973]. The tendency of a molecule to develop a partial charge is 
determined by its functional groups’ electronegativity. And the ability of that 
molecule’s crystal to develop a surface charge is determined by the type of 
functional groups exposed on the crystal surface. A number of functional 
groups have been ranked in a donor-acceptor series (Derjaguin, et al., 1978, 
see Chapter 1).
Table 14 shows the mean specific electrostatic charge determined by 
the static (SFC) method for the two polymorphs, and a-lactose monohydrate 
particles following flow over the stainless steel, brass and perspex chutes. 
The tabulated results show that the two drug polymorphs and cu-lactose 
monohydrate all developed negative charges following flow-off from chutes of 
all three materials tested. Lactose monohydrate being a sugar is very rich in 
one functional group: hydroxyl, the location of the single ether group in the 
lactose molecule makes it virtually inaccessible for surface to surface contact 
with other materials at the macroscopic level. The abundance of oxygen 
atoms throughout the lactose molecule provides a highly electronegative 
surface for this material, at any scale. The molecular structure of Ro 24-5913
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(Figure 5, Chapter 1) possesses carboxyl and amide functional groups that 
could also make the drug behave as an electron acceptor.
Since the two polymorphs have the same chemical structure, they will 
have exactly the same molecular electronegativity. Whether the two different 
molecular arrangements in the crystal translate into a difference in their 
macroscopic electrostatic properties, will depend on how effectively the same 
set of electronegative groups in one molecular ensemble versus another, can 
distribute a change within the ensemble. The electrostatic properties of the two 
crystal forms will also be greatly influenced by whether the electronegative 
groups of the molecule are exposed or inaccessible on one type of surface 
versus the other. Table 14 shows that the two polymorphs develop very 
similar charges. This result suggests that the two crystal modifications have 
surfaces with similar average, i.e., macroscopic, electronegativities. The fact 
that drug and carrier, i.e., the two individual components of the DPI blend 
formulation, both develop negative charges, suggests that the drug-lactose 
attraction will include a weakening element of repulsion to allow subsequent 
detachment in the blend. The larger the difference in magnitude of 
electropositive and electronegative charges of two powders, the greater the 
attraction [Ahmed, 1991]. In addition, the polarisability of the drug molecule, 
whose signs were observed in the Raman spectra of drug-lactose 
monohydrate blends, can promote particle attraction by facilitating the 
redistribution of charges on a particle.
The large surface area of the two micronised polymorphs compared 
with that of a-lactose monohydrate offers greater opportunity for particles to 
develop charges. The charge values registered following flow on the metal
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surfaces were about ten-fold greater for the micronised drug than for the 
cif-lactose monohydrate powder. This ratio is of the same order of magnitude 
as the ratio of specific surface areas. However, the charge values after moving 
through the perspex chute was only slightly higher for the micronised drug than 
for ^lactose monohydrate. This result is quite possibly explained by the fact 
that perspex is itself a material rich in electronegative (ester) groups; 
tribocharging by means of the interaction two electronegative materials is 
hindered by the inability of one of the materials to develop a stable positive 
charge.
Static measurements of the pure materials following flow on a chute are 
useful to determine the type and magnitude of charge the different materials 
are likely to develop. But the technique is somewhat limited in terms of its 
ability to highlight differences between polymoprhs A and B, since the 
magnitude and polarity determined for the two polymorphs was similar.
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Table 14 Mean specific charge for drug Ro 24-5913 and carrier a-lactose monohydrate powders 
following contact with metal and PMMA surfaces (n=5). Static method (SFC)
I Perspex (PMMA) Stainless Steel Brass
Material
Polymorph
Polarity Mean SPecific 
Charge
C x 1 ( f g 1 ±SD
Polarity Mean Specific 
Charge
C x 1 ( f g 1 ±SD
Polarity Mean Specific 
Charge




2.721 (0.179) 0.343(0.101) 0.627 (0.048)
Ro 24-5913 A 3.860(0.112) 4.020 (0.320) - 6.447 (0.318)
(micronised) B 3.676(0.139) 4.141 (0.278) - 6.676 (0.235)
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For the dynamic methods, Figures 35 and 36 show the electrostatic 
profiles obtained for each polymorph with the ASFC and CIMFC 
apparatuses, respectively. In each case, there is a significant difference 
between the two polymorphs. It is also apparent that the charge profiles 
obtained with these two dynamic methods are qualitatively very similar but 
with reversed polarity, even though the magnitude of charges evolved in the 
two apparatus are quite different. One immediately apparent difference 
between the two polymorphs is that in both the ASFC and CIMFC methods, 
blends containing polymorph A exhibit a change in polarity when the drug 
load is increased from 1% to 5%. Such a change of polarity does not occur 
in the case of polymorph B. Peart [1996] reported the bipolar behaviour of 
powder blends during investigations with the CIMFC and ASFC apparatuses. 
The reversal in charge polarity observed for polymorph A with the two 
apparatuses, indicates the bipolar behaviour of the selected powder blends.
The dielectric nature of organic materials allows the displacement of 
charges within them without flow {i.e., conduction) of charge. Organic 
materials are bipolar because the development of a net absolute charge 
would require them to be conductors, and this in turn, would produce 
extreme repulsion among the particles. Consequently, charge 
measurements on powder blends correspond to the imbalance between the 
positive and negative charges within the sample, i.e., the algebraic sum of 
the charges. Faraday cages produce a net charge by the friction of particles 
colliding in a confined space. Therefore, the cage’s geometry as well as the 
disposition of the powder within will affect the net charge that develops.
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Figure 35 Effect of drug load on the electrostatic charge developed upon 
detachment of micronised Ro 24-5913 from coarse cr-lactose 
monohydrate at 60 I min'1 (n= 6).
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Kulvanich and Stewart [1987a] proposed several possible 
mechanisms by which spurious charges associated with the environment 
surrounding the apparatus for electrostatic measurements. Factors such as 
charge accumulation in the compressed air or charge accumulation through 
carrier interactions have been proposed. For purposes of the present 
discussion, the difference in the electrostatic behaviour between the two 
crystal polymorphs within the same apparatus is far more significant than the 
difference observed from one apparatus to another. One difference worth 
mentioning between the CIMFC and ASFC apparatuses is that of sample 
mass integrity. The geometry and sample disposition in the CIMFC make it 
very difficult for drug particles to leave the cage, whereas the 
monodirectional air flow in the ASFC favours the expulsion of micronised 
drug particles through the 45-pm mesh. This difference may be partially 
responsible for the net charge reversal observed between the two devices. 
Schein and Cranch [1975] reported that the electrostatic charge produced 
upon drug detachment from the carrier substrate could be modified during 
the charge measurement within the “blow-off’ cage.
Independently of the polarity of the charge that develops, the increase 
in net charge in a dynamic measurement is an indication of drug detachment. 
Figures 35 and 36 show that with both the ASFC and CIMFC methods, 
polymorph B tends to produce greater charges than polymorph A. This 
result is consistent with the higher detachment of polymorph B observed in 
















Figure 36 Graphic representation of the electrostatic measurements by capacitor interchangeable mesh (CIMFC). 
Mesh used 45-pm (n=7)
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Centrifugation studies showed that for both polymorphs, drug 
detachment increased with drug load. Those studies also showed that for 
the two polymorphs, the extent of detachment is negligible at the 1 % drug 
load level. Therefore, the polarities observed at the 1% drug load using the 
ASFC and CIMFC methods, most likely reflect the adhesion of drug particles 
that become very much immobilised upon attachment.
The electrostatic properties of powder blends containing 1% drug 
show a dramatic difference between polymorphs A and B. However, it is 
worth pointing out that when the two polymorphs are studied individually, i.e., 
under non-interactive conditions, the two crystal forms exhibit virtually 
identical electrostatic behaviour under static conditions (SFC, Table 14), and 
not very different behaviour under dynamic conditions (CIMFC, Figure 36).
Figures 35 and 36 reveal other differences in electrostatic behaviour 
between blends containing polymorphs A and B. For drug concentrations of 
greater than 1 %, blends of polymorph B tend toward electroneutrality with 
increasing drug concentration, whereas the opposite trend is observed for 
polymorph A. A possible explanation for these differences can be given 
terms of the rearrangement of drug particles. Drug loads of 5% or higher are 
likely to give place to powder blends in which drug particles have an ability to 
move not encountered at 1% drug load. The SEM analysis presented in 
Chapter 2 showed that a drug concentration of 5% is of the order of the 
amount needed, at least compared to the 1% or 25% concentrations, to 
attain full (‘monolayer’) coverage of the a-lactose monohydrate particles. 
Drug loads in the order of 25% or more correspond to more than monolayer
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coverage. The higher the drug load, the higher the drug detachment for 
either polymorph, and consequently, the higher the frequency of inter-particle 
collisions during dynamic measurements. In the case of polymorph B, the 
downward trend in charge with increasing concentration is suggestive of 
inter-particle collisions producing a cohesive rearrangement of drug particles 
that leads toward electroneutrality. Cohesion rearrangement will be minimal 
at low drug concentrations because the very low detachment levels will 
prevent a high frequency of drug particle collisions. Higher drug 
concentrations, which produce higher drug detachment, will be accompanied 
by an increase in drug-drug particle collisions. Higher frequency of drug- 
drug particle collisions will have a very pronounced effect on charge when 
drug cohesion is a major factor. It appears that in the case of polymorph B, 
the higher detachment accompanying higher drug concentrations is 
somewhat offset by cohesion rearrangement, thus resulting in lower charges 
as the drug concentration is increased.
Polymorph A exhibits a trend that is the opposite of that of polymorph 
B. The charges generated with powder blends of polymorph A increase with 
drug concentration. In this case, the corresponding increase in drug 
detachment and the concomitant increase in inter-particle collision frequency 
result in a system with increased electrostatic imbalance. These results 
could be explained by a system in which adhesion plays an important role in 
particle rearrangement, thus disfavouring efficient charge neutralisation. 
However, it should be pointed out that for both the ASFC and the CIMF 
methods, the charge produced by polymorph B is higher than the charge 
produced by polymorph A at the same drug load, for all drug concentrations
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investigated. It is therefore possible that upon detachment, the particles of 
polymorph A undergo rearrangement that involves both adhesion and 
cohesion interactions.




1 % 58.508 < 0 .0 0 1
5% 273.129 < 0 .0 0 1
25% 158.888 < 0 .0 0 1
50% 3.118 < 0 .1 2
Tables 15 and 16 show the statistical comparison between the two 
polymorphs for the ASFC and CIMFC results, respectively. In both systems 
the two polymorphs exhibited significantly different charges (p<0.001). This 
was true at all drug concentrations investigated, with the exception, with both 
apparatuses, of the 50% drug load. It seems that when the a-lactose 
monohydrate carrier is overloaded with drug particles, as in the case of 50% 
drug load, the drug particles begin to act as a screen, masking the carrier 
particles. Under these circumstances, the differences in charge produced by 
the powders begin to reflect a combination of the differences between the 
pure polymorphs and the binary blends.
Table 16 shows that significant differences were observed between 
samples (p<0 .0 0 1 ), pure components and blends at all concentrations 
except 50%.
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Table 16 Analysis of variance for CIMFC. Two polymorphs
Pure components F-value P
Unmicronised 25.943 < 0 .0 0 1
Micron ised 40.103 < 0 .0 0 1
Blends (drug with
a-lactose monohydrate)
1 % 30.492 < 0 .0 0 1
5% 83.384 < 0 .0 0 1
25% 62.696 < 0 .0 0 1
50% 0.056 0.816
3.2.2.2 Production of aerosol from a DPI device.
The electrostatic properties of aerosols generated upon actuation from 
two dry powder inhaler devices, the Rotahaler and the Dryhaler, were 
measured using two different apparatuses: the Electric Fieldmeter (EFM) and 
the Transient Charge Monitoring (TCM) apparatus. The objective of this part 
of the study was to investigate if the differences in electrostatic behaviour 
observed between the two drug polymorphs have a significant bearing on the 
electrostatics evolved in actual pharmaceutical DPI devices.
The EFM technique has the potential to give a highly accurate 
quantification of aerosol cloud charge behaviour [Peart 1996]. However, the 
EFM measurements obtained in this investigation could not be used to 
differentiate between the electrostatic behaviour of different polymorph blends
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Figure 37 Electric field detected after aerosolisation from the Rotahaler™ of 25 mg of 
a-lactose monohydrate, and binary blends with 5% Ro 24-5913, 
polymorphs A and B, in or-lactose monohydrate (n=15).
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or of pure a-lactose monohydrate. Measurements with drug-lactose 
monohydrate blends turned out to be difficult to perform due to a high tendency 
of particles to contaminate the field meter. An example of the results obtained 
from this technique is shown in Figure 37. Measurements with the pure drug, 
regardless of crystal form, were not possible, because of the more intense field 
meter contamination. It was concluded that the EFM technique was not 
suitable for use with the powder systems chosen for this study, and its use was 
not considered further.
The Transient Charge Monitoring (TCM) apparatus consists of a series 
of circular electrodes capable of detecting either positive or negative charges. 
The apparatus is equipped with a tube where the electrodes are located along 
the tube’s length. The positions of the electrodes are arranged in a manner 
intended to roughly model the airways of the respiratory tract (Machowski, 
1996). The electrodes in the apparatus tube are numbered such that the lower 
the electrode number, the closer the electrode to the aerosol device.
Pure a-lactose monohydrate carrier showed exclusively electropositive 
properties when tested with the TCM apparatus following aerosolisation from 
the Rotahaler device (Figure 38). The magnitude of the actuation-evolved 
charge decreased as the actuated sample moved along the apparatus. Since 
TCM is modelled after the human respiratory tract, deposition within the upper 
respiratory tract is associated with low-number electrodes in the TCM 
apparatus. Figure 38 shows that the earner charge is completely neutralised 
by the time the sample exits the apparatus. Such a result is consistent with the
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deposition within the upper respiratory tract expected for the coarse a-lactose 
monohydrate particles.
Figures 39 and 40 show the TCM results obtained with the Rotahaler 
and Dura devices, respectively. In contrast to the behaviour observed for pure 
a-lactose monohydrate, the presence of drug in the mix produces an increase 
in the electrostatic charges developed upon actuation. This is true for both 
crystal forms of the drug. The TCM apparatus can provide a more detailed 
characterisation of the electrostatic behaviour of powders than other methods 
because it provides a direct observation of the bipolar behaviour of the sample 
under dynamic conditions. This type of information can be quite revealing. 
Consider for example the data obtained when polymorph B at 5% is actuated 
from the Dura device (Figure 40). The initial net charge in this case is the 
lowest observed (/.e., the closest to electroneutrality). However, the amount- 
of-charge, the distance between the positive and negative charge components, 
is the highest.
The TCM apparatus readily shows how the bipolar behaviour of the 
powder mix can bring about a net change in polarity. A change form net 
positive to net negative charge is observed in Figures 39 and 40 except in the 
case of polymorph B from the Dura device. Moreover, the change in net 
charge in all three cases was produced by a decrease in the positive 
component, accompanied by an increase in the negative one. Polymorph B 
actuated from the Dura device also produced a decrease in positive charge. In 
this case however, there was a gradual decrease in the negative component, 
but the net charge remained negative at all times. The gradual nature of this
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shift in charge is again (see CIMFC and ASFC results above) suggestive of 
charges sufficiently weak to allow them a prolonged decay.
One consistent difference between polymorphs A and B is that TCM 
profiles show polymorph B as having a greater amount-of-charge than 
polymorph A. This could be interpreted as an indication that polymorph B is 
more electrostatic than polymorph A. However, the CIMFC (previous section) 
and Centrifuge experiments (Section 3.1) show that polymorph A is more 
effective than polymorph B in neutralising its charges by forming agglomerates. 
Therefore, a more plausible explanation seems to be that polymorph B exhibits 
a greater amount-of-charge because its charge is less unstable (weaker) than 
that of polymorph A. A highly electrostatic material will generate stronger, 
highly unstable charges. If sufficiently strong, these charges can produce an 
immediate particle rearrangement toward neutralisation, and the resultant 
decay may have a time scale that is shorter than a TCM measurement.
Analysis of variance is presented in Table 17, p-values demonstrated 
significant differences in charge development between the two polymorph 
powder blends.
The TCM apparatus shows a general difference between the 
electrostatic behaviour of drug-lactose monohydrate blends containing two 
different polymorphs. The observed differences, however, are not detailed 
enough to provide direct information about the differences in dynamic 
behaviour between polymorphs. When comparing different materials, some of 
the instrumental techniques employed provide measurements that directly 
reflect a particular difference between the samples. But not all instrumental 
techniques provide the same level of differentiation, and finding which
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methodologies are more informative than others becomes part of the 
investigation. For the system studied here, the TCM method can be useful in 
providing information that is valuable but of a secondary nature. The TCM 
technique shows clear differences between the two polymorphs studied here. 
But the information obtained, although quite revealing, would have its greatest 
use helping in the understanding or interpretation of results form other 
(primary) techniques.
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Figure 38 Charges developed after aerosolisation of a-lactose 
monohydrate from Rotahaler™ (n=3).
Analysis of variance for the bipolar charges generated by the two polymorphs of Ro 24-5913 A and B (5% w/w) 
when discharging the powder from two devices: Rotahaler™ or Dryhaler™ as detected by TCM. Data shows the 
p value for the different levels (electrodes) for positive, negative and net charges.
Summary of the ANOVA analysis for the charges
Electrode Positive Negative Net
Rotahaler Dura Rotahaler Dura Rotahaler Dura
LEVEL 1 F-value P F-value P F-value p F-value P F-value P F-value P
2.218 0.25 121 < 0 .0 0 1 21.274 <0.01 29.822 < 0 .01 0.7313 0.50 52.071 < 0 .0 0 1
LEVEL 2 F-value P F-value P F-value p F-value P F-value P F-value P
5.563 <0.05 0.198 0.50 12.982 <0.01 23.242 < 0 .0 0 1 0.0036 0.953 5.054 <0.05
LEVEL 3 F-value P F-value P F-value p F-value P F-value P F-value P
4.961 <0.05 0.198 0.50 28.722 < 0.001 20.028 < 0 .01 6.490 <0.05 23.198 < 0 .0 0 1
LEVEL 4 F-value P F-value P F-value p F-value P F-value P F-value P
3.119 0.25 0.063 0.806 32.399 < 0.001 17.679 < 0 .01 127.872 < 0 .0 0 1 26.150 < 0 .0 0 1
LEVEL 5 F-value P F-value P F-value p F-value P F-value P F-value P
1.864 0.25 0.412 0.50 28.122 < 0 .0 0 1 18.819 < 0 .01 69.187 < 0 .0 0 1 20.938 < 0 .0 0 1
LEVEL 6 F-value P F-value P F-value p F-value P F-value P F-value P
0.742 0.50 1.689 0.25 25.776 < 0.001 11.691 < 0 .01 59.201 < 0 .0 0 1 15.357 < 0 .0 1
LEVEL 7 F-value P F-value P F-value p F-value P F-value P F-value P
0.328 0.50 4.807 0.1 30.675 < 0.001 7.0609 < 0.025 63.096 < 0 .0 0 1 9.8256 < 0.025
LEVEL 8 F-value P F-value P F-value p F-value P F-value P F-value P
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Figure 39 Bipolar charges developed after aerosolisation of blend 5% 
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Figure 40 Bipolar charges developed after aerosolisation of blend 5% 
polymorphs A and B from Dryhaler™ (n=3).
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4 ENERGETIC PROPERTIES OF POWDER 
SURFACES
Variations in the surface properties of materials are in general more 
difficult to detect and measure than the corresponding differences in bulk 
properties. Surface properties, however, can be as influential on product’s 
functionality, if not more, as the bulk properties of powders.
A number of methods are currently available for the analysis of surface 
properties. Among these are interfacial contact angle measurements, inert gas 
adsorption, microcalorimetry, solvent sorption isotherms, inverse gas 
chromatography (IGC), atomic force microscopy (AFM) and molecular 
modelling. Each method has specific advantages and limitations in terms of 
methodology, complexity and applicability, all of which may affect the 
usefulness of individual measurements. The above listed techniques are 
nonetheless often complementary in terms of the information they provide, and 
in combination, analysis techniques can assist in providing a more viable total 
description of the behaviour of pharmaceutical powder surfaces, than any 
individual technique could.
In this section of the present study, TAM, water uptake and IGC are 
explored in their use for the analysis of surface energetic properties of the 
polymorphic drug. With the results from these analyses, it should be possible 
to examine the interactions of the drug with lactose in a dry powder formulation 
for inhalation, in a light that permits relating the physical properties of the drug’s 
surface to its behaviour and impact on the “product’s” functionality.
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Polymorphism corresponds to differences in the crystal lattice, which are 
likely to alter the surface of the material and consequently its surface energy. 
Physico-chemical characterisation measurements performed on the two 
polymorphs (Chapter 2), established that the two crystal forms of the drug 
exhibit those physicochemical differences frequently observed between 
crystal polymorphs. However, the analysis of such differences has not been 
directed toward the surface of these materials, namely, toward the surface 
energetics of the two polymorphs and the differences between them.
To such an effect, the working hypothesis is that the surface 
energetics of the two polymorphs can be distinguished through the study of 
their interactions with a common probe. A suitable probe consists of the 
vapour of a solvent, chosen as the adsorbate in the interaction with two 
(polymorphic) surfaces. By measuring heats of adsorption, quantitative 
comparisons between the two crystal surfaces should be possible. In 
addition to the direct quantitative comparisons made possible with the use of 
a common probe with two surfaces, the results of experiments involving 
different probes and a common surface can provide an additional angle for 
comparison between surfaces. For instance, by comparing hexane and 
pentanol, which are geometrically similar but different in their interactive 
properties (one is non-hydrogen bonding and the other is both donor and 
acceptor), it is possible to study the contributions of hydrogen bonding and 
non polar interactions to the adsorption on a given surface. The information 
thus obtained can, in turn, help in better assessing the nature of the drug 
surface for purposes of formulation optimisation.
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Surface analysis. Physical adsorption at the soiid/gas interface is essentially 
the result of VdW forces. The adsorption characteristics of powders depend to 
a large extent on the surface chemistry and surface charge of the particles. 
The adsorption properties are evaluated by means of thermodynamic 
parameters: free energy of sorption (AG0*), enthalpy of sorption (AH°s), and 
entropy of sorption (AiS0*). These parameters can be obtained from adsorption 
isotherm experiments by TAM and from IGC retention data under nearly ideal 
{i.e., infinite dilution) conditions. TAM and IGC are techniques used here to 
study the surface energy of the polymorphs and to assess the impact that 
the surface could have on the interactive forces of these polymorphs with 
lactose carrier. This drug-camer interaction is what ultimately determines the 
performance of the dispersion powders for inhalation.
4.1 Isothermal Microcalorimetry (TAM)
Microcalorimetry can be used as a method for monitoring chemical, 
physical or biochemical changes. In particular, the TAM technique has been 
used for studying the rate and extent of degradation reactions (stability), 
interactions between drugs and microorganisms, as well as interactions 
between drugs and excipients (compatibility). Microcalorimetry is a very 
sensitive technique that permits measurement of the heat evolved by virtually 
any physicochemical event such as phase transitions, physisorption, 
chemisorption, etc. The output from the microcalorimeter, heat flow, 
provides quantitative information about the enthalpy and the rate of the
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process. In addition, microcalorimetry can be used to characterise the solid 
state properties of powders when exposed to different processing stresses 
(i.e., milling, crystallisation, freeze and spray drying, compression, coating, 
etc).
Recent calorimetric measurements for the analysis of solid surfaces in 
pharmaceutical systems have resulted in the increased application of highly 
sensitive microcalorimeters. Bakri [1993] reported the application of heat 
conduction microcalorimetry to study the adsorption of water vapour onto 
solid pharmaceuticals. Other authors have reported the potential of the 
technique on precipitation [Puppedi et a l, 1995] and desorption [Duddu et 
a!., 1995] processes.
In the present work, the heat of adsorption of probes of different 
vapour pressures onto the surface of Ro 24-5913 solid drug of both 
polymorphs was measured using a heat conduction microcalorimeter (TAM). 
The effect of vapour pressure on the powder is studied by means of the 
accurate sorption isotherms of probe vapour on the polymorph obtained with 
this technique.
4.1.1 Methodology
Micronised Ro 24-5913 polymorphs and (solvent vapour) probes of 
different polarity were used for these experiments.
Microcalorimetrv: The integral heats of adsorption were 
measured using a heat conduction microcalorimeter (Thermal Activity
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Monitor, TAM, Thermometric AB Sweden) with a Thermometric RH perfusion 
ampoule (accessory Model 2255) adapted with Kalrez O-rings. The control 
of the vapour pressure above a solid sample was similar to the one originally 
designed by Bakri [1993], which is now commercially available as an 
accessory to the TAM. A schematic of the RH perfusion accessory as used 
for the TAM set up, shown in Figure 41.
The system creates and accurately maintains (within 0.1%) a user- 
selected value of relative humidity, or vapour pressure, in the sample 
chamber by mixing dry nitrogen and nitrogen pre-saturated with probe 
vapour. The instrument is equipped with Gas Pressure Controller device 
(GPCD) that accurately controls the relative humidity/vapour pressure. The 
GPCD delivers the set relative vapour pressure of the gas phase to which 
the sample is exposed. The relative humidity (RH) can be controlled from 
0% to 100% RH  within about ±0.1 %. During the calorimetric experiments, a 
flow controller connected to a switching valve delivers the dry nitrogen gas. 
The high purity Nitrogen used here was further dried by passing it through a 
drying tube containing Drierite™ (anhydrous CaS0 4 ), prior to feeding it into 
the TAM. The flow controller has a valve that continuously alternates 
between two positions. In one position, the valve delivers dry gas directly to 
the sample ampoule. In the other position, dry gas is passed over two 
humidifier reservoirs in thermal contact with the calorimetric bath. The gas 
delivered from the valve in the second position is thus saturated with the 
solvent vapour before reaching the measuring ampoule. Both dry and 
solvent saturated gas pass separately through heat exchanges for thermal 
equilibration prior to entering the measuring cell of the instrument. The
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incoming RH to the sample can be controlled from a valve and varied from 0 
to 100% by mixing appropriate ratios of dry and wet gas [Bakri 1997]. The 
RH accessory’s software permits the use of any predefined RH. The RH  
delivered via switch valve of the TAM was verified using 100% RH  and 
temperature probes by placing pure water in the humidity chamber. A 
humidity probe was then connected at the gas outlet and to a Rotronic 
Hygrometer. The HT125 Humidity-Temperature transmitter (Rotronic 
Instrument Corp. NY) produced a signal reading the generated humidity. In 
addition, standard %RH solutions (25, 50, 80 and 95%) were placed into the 
ampoule and checked in similar manner in order to verify the relative 
humidity that the microcalorimeter (TAM) delivered. When setting a specific 
%RH value to be delivered by the microcalorimeter, it gave a precise match 
to the corresponding RH  standard solutions. A humidity calibration curve at 
25°C for the TAM was also performed using the Rotronic Hygrometer. The 
data are presented in Table 18 and Figure 42. The variation of about 2% 
was due to the difference in temperature between the measuring cell within 
the instrument and the room where the instrument was located. The 
instrument cell was set at 25°C whereas the thermocouple/probe was 
exposed at the room’s temperature, 21 °C.
The gas pressure delivered from the cylinder to the instrument’s inlet 
was set to 2  atm with a gas gauge controlling the flow rate of the dry gas 
system. In addition, a gas flow controller for gas chromatography was used 
to control the gas flow into the measuring cell. The total flow rate of the 
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Figure 41. A schematic of the RH perfusion cell.
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Table 18. Calibration %RH set in TAM monitored by the Rotronic 
Hygrometer Room Temp. = 21.3 ° C
% RH Temperature °C
TAM Rotronic
Set Measured Measured
Mean (n=7) s.d. Mean (n=7) s.d.
0 2.474 0.092 21.166 0.199
10 12.613 1.973 21.170 0.201
20 23.139 1.398 21.424 0.244
30 32.816 1.493 21.444 0.173
40 42.281 1.382 21.477 0.300
50 51.423 2.095 21.474 0.291
60 61.593 2.110 21.601 0.176
70 71.456 2.611 21.497 0.243
80 79.940 2.368 21.233 0.142
90 85.577 0.628 21.294 0.167
100 96.079 0.313 21.384 0.222
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Figure 42. Humidity calibration curve for the TAM at 25°C.
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Sorption experiments: An accurately weighed sample of
approximately 30 mg of each polymorphic drug was placed in a 4 ml 
stainless steel sealed ampoule. The ampoule, which is a component of the 
TAM instrumentation, was then attached to the RH perfusion unit (Figure 41), 
and slowly lowered into the calorimeter’s measuring position of the. Prior to 
calorimetric analysis, the sample was dried overnight under dry nitrogen flow 
(0% RH) until a signal of zero heat flow was attained. For each solvent 
probe and temperature, a blank experiment was conducted in an identical 
manner with no sample in the ampoule. The calorimetric adsorption 
experiments were conducted at four temperatures (20, 25, 35 and 45 °C).
The incoming vapour pressure was set to increase in 10% steps up 
to 1 0 0 %, a positive response was recorded until equilibrium was reached, 
i.e. no heat flow (P^=0). The time integral of the recorded heat flow (PA) 
gives the enthalpy of the process under study. The area under curve of 
each adsorption peak was calculated using the baseline fitting programs in 
Origin™ 5.0 (Microcal, MA).
4.1.2 Results
Figure 43 shows a typical calorimetric response to the adsorption of 
MEK (methyl ethyl ketone) vapour on a sample of drug polymorph A. The 
reproducibility of the response was good (CV typically less than 2% with 
different solvent probes).
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Figure 43 Typical calorimetric power/time curves and reproducibility.
The high sensitivity of the calorimeter permits detection, even at low 
humidities, of heat flow due to interaction of solvent vapour with the solid. 
Results of the integration of calorimetric power/time curves are the heat of
159
adsorption ( < )  of the various organic probe vapours (an example is 





where: dQadsfdt and AHods are the rate and enthalpy of adsorption, respectively, 
and n denotes the number of moles adsorbed. This equation is related to two 
aspects of the process having place during interactions, a thermodynamic 
aspect (what interactions will occur, extent of adsorption) and kinetic aspect 
(how fast, rate of adsorption).
Values of Qads are presented in Figures 44-45 as a function of vapour 
pressure at three experimental temperatures. For a given polymorphic drug 
quantity, Qads, is given by [Bakri 1997]:
where AHods is the adsorption enthalpy of the organic probe vapour on the
polymorphic drug, and n is the quantity of sorbed water.
AHods can be obtained directly from the calorimetric data at the four 
temperatures investigated. Adsorption is considered a reversible process, and 
desorption experiments were conducted at the end of the adsorption 
experiments by making decrements of vapour pressure of 1 0 % until reaching 
0%. It was observed that the area under the curve of the adsorption peak was 
equal in magnitude, but opposite in sign, to the area under the corresponding
(40)
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desorption peak, thus indicating the reversibility of the process. Since the 
adsorption process is a reversible one, van’t Hoff law is applicable:
dQnK) = AHads
d(l /T)  R [ '
where K  is the equilibrium constant. AHads may vary with the vapour pressure 
since the adsorption sites may be different. It is also important to recall that 
van’t Hoffs equation is a general one and does not require AHads to be 
constant with respect to temperature.
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Figure 44 Micronised drug exposed to different solvent vapours at 20°C
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Polymorphs are distinctly different materials with identical chemical 
composition. All bulk physicochemical and physicomechanical differences 
between crystal polymorphs arise from the different physical arrangement of 
the same molecule. Consequently, the crystal forms’ interactive properties can 
be expected to be reflected in the polymorphs interaction with a probe 
molecule. Crystal parameters can describe the exact physical structure of the 
surface in a perfect crystal. And the excess free energy inherent to surfaces is 
bound to produce variations on the crystal surfaces beyond the unit cell 
parameters for the two polymorphs of study. Such surface variations play a 
significant role in the sorption properties of surfaces; excess free energy at a 
surface site translates into a higher thermodynamic activity for that site. The 
nature and resulting interactive properties of a non-perfect (real) crystal are 
thus a composite of the physical nature of and the type and number of defects 
on the surface. One of the premises of the present study is that the crystalline 
structure of the materials selected is reflected on their surface properties. 
Consequently, the differences between the polymorphs’ surfaces can in turn be 
used to explain differences in the polymorphs’ behaviour during processing.
The interaction of the two crystal forms with different probe molecules 
was investigated. The probe molecules selected for the study can be divided 
into three categories: Hydrogen bond donors, hydrogen bond acceptors and 
non-hydrogen bonding.
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Figures 44 and 45 show that in the case of non-hydrogen bonding 
probes such as toluene and heptane, the heat of adsorption is the most similar 
between the two polymorphs. This result indicates that the type and nature of 
non-hydrogen bonding adsorption sites are similar on the two surfaces studied, 
making the two polymorphs energetically equivalent in terms of their 
hydrophobic interactive properties.
Figures 44 and 45 also show that the two polymorphic surfaces are not 
quite equivalent when the adsorption of the probes involves interactions of 
more specific nature. The heat of adsorption obtained with ail hydrogen 
bonding probes shows more differences between the two polymorphs than 
those obtained with the non hydrogen bonding solvents.
It is noteworthy that in ail cases, solvent adsorption on polymorph B 
involved higher energy of the interaction. The only, and quite prominent 
exception is water. The heat of water sorption was greater for polymorph A 
than for B, at all temperatures studied. Among the different solvent probes 
selected for this study, water occupies a central role, not only because its 
singular observed behaviour, but also because its ubiquitous nature and 
common use in pharmaceutical processing.
4.1.3.2 Water Uptake
The water uptake of the two polymorphs of Ro 24-5913 was determined as a 
function of relative humidity (RH) at different temperatures. Figure 46 shows
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the sorption isotherms obtained for the two polymorphs at 20°C, 25°C, 35°C 
and 45°C.
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Figure 46. Comparison of the water sorption isotherms obtained for Polymorph 
_________ A and B at different temperatures.____________________________
The isotherms in Figure 46 show that polymorph A sorbs greater 
quantities of water vapour than polymorph B at the different temperatures 
investigated. It is noteworthy that Figure 46 also shows that the isotherms of 
form B gave substantially less variability than those of form A, particularly at 
25°C and 35°C. Water uptake measurements were done under the exact 
same conditions for the two polymorphs. Therefore, the difference in 
uncertainties about the isotherm points between the two polymorphs is
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attributed to the inherent differences between the materials studied and not to 
experimental variation perse. Polymorph A produces water sorption isotherms 
with wider variability about points, suggesting that polymorph A has a more 
heterogeneous surface than polymorph B. These results is are at first glance 
consistent with form A being thermodynamically metastable in the temperature 
range selected. A less stable crystal is expected to have greater number of 
energetic sites which favour water sorption [Zografi and Tam, 1976].
Figure 46 also shows that hysteresis is particularly significant at 45°C 
for both polymorphs. In fact, the profiles obtained at 45°C can be interpreted 
as suggestive of condensation taking place at such temperature.
Although all the information relative to the water uptake of the two 
crystal forms is contained in Figure 46, data presentation as isotherms may not 
be the optimal for purposes of comparison. In this situation, isobars offer a 
more intuitive means of data presentation. Figure 47 shows the sorption 
portion of data of Figure 46 as isobars, specifically as relative isobars, i.e., as 
lines of constant relative humidity.
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Figure 47. Comparison of the water sorption relative isobars obtained for 
__________ Polymorph A and B as a function of temperature.______________
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Data presentation as relative isobars makes it an easier task to separate 
the effects of temperature and those of relative humidity on the sorption 
behaviour of water vapour on the surfaces of two different polymorphs.
Each line in Figure 47 corresponds to a constant level of RH, the lines 
are termed relative isobars because each line corresponds to a constant value 
of water vapour pressure relative to the water saturation pressure at the same 
temperature. The relative isobars presented in the figure correspond to RH 
ranging from 10% (bottom) to 95% (top), with increments of 5%. Thus, moving 
upward in the figure at constant temperature corresponds to a linear increase 
in water concentration in the vapour phase. In addition to being linear, such an 
increase in vapour phase water concentration represents also a degree of 
freedom in terms of Gibbs phase rule; it is controlled directly by the 
experimenter. Moving along a relative isobar with increasing temperature also 
corresponds to an increase in the vapour phase water concentration, with the 
ratio of the water vapour concentration to its saturation concentration remaining 
constant. But unlike moving along the ordinate, the change in water vapour 
concentration along an isobar is non-linear and does not represent a degree of 
freedom; it is fixed by the temperature. The increase in vapour phase water 
concentration along the relative isobars follows from the fact that the water 
saturation pressure (P°) increases with temperature. An increase of 10°C in 
temperature along a relative isobar corresponds to an increase of 70% to 80% 
in water concentration in the vapour phase [Martin, 1999].
Figure 47 shows that polymorph A not only sorbs a greater amount of 
water than polymorph B, but also that sorption by form A exhibits greater
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variability as a function of both temperature and relative humidity. The relative 
isobars of polymorph A are almost isosteric, whereas the isobars of polymorph 
B show a definite increase in sorption between 35°C and 45°C. At a given 
temperature, sorption by polymorph B tends to increase in a fashion that is 
more or less proportional to the increase In RH. Polymorph A on the other 
hand, exhibits increases in sorption that are not proportional to the increase of 
RH  for RH  values greater than 70%, particularly at the lower temperatures. It 
should be noted that individual isotherms showed a slight but consistent jump 
in sorption at 70% RH, especially at 20°C and 25°C. Such a jump is not 
directly appreciable in Figure 47, although its effect still appears as a change in 
the general curvature of the isotherms. It appears that around 70% RH, the 
water adsorption of polymorph A presents some sort of threshold that triggers 
or enhances a different mode in the sorption of water vapour. Investigations in 
the semiconductor field [Vilan etal., 1998] have produced evidence of two-site 
adsorption mechanism for organic molecules. Form A possibly has a 
threshold RH value at which a second type of sorption sites start becoming 
occupied.
It is important to note that at a given RH, increasing temperature 
produces two counteracting effects on water sorption. On the one hand, 
because water sorption is an exothermic process, it is disfavoured the higher 
the temperature. On the other hand, as discussed, the increase in P° produced 
by higher temperatures increases the water concentration in the vapour phase, 
which could favour sorption if the adsorbing surface is energetically 
heterogeneous. Increased sorption produced by increasing temperature at 
constant RH can also result if condensation of the adsorbate takes place. It
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should be pointed out that sorption-induced condensation need not be 
condensation of the bulk liquid, as it is apparently the case at 45°C in this 
study. Water sorption on activated carbons results in the formation of water 
clusters at fairly low RH. In these cases, surface phenomena control the 
sorption process at relative humidities of 30% or less. Surface heterogeneity 
results in different sorption sites, some of them acting as primary adsorption 
centres. Population of the primary sites then initiate the process of cluster 
formation [Salame etal., 1999].
The interplay between the two counteracting effects described above is 
more clearly observable if data are presented as the distribution of water 
between the two phases. Consider a system consisting of water vapour 
molecules distributed in equilibrium between the vapour phase and the surface 
of the adsorbant. The distribution coefficient, KD, for this system is given by:
where Cs and Cv are the water concentrations in the sorbed and vapour 
phases, respectively. Figure 48 shows the distribution coefficients obtained 
from Equation 42. The Cs values used are in moles of water per square 
meter of adsorbant, and the Cv values used are given in moles of water per 




v "  100 R T
(43)
where P° is the saturation pressure at the absolute temperature T, and RH is 
the relative humidity selected by the experimenter, and R is the ideal gas 
constant. The values of P° (in torr) were in turn calculated as follows [Martin, 
1999]:
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Figure 48. Comparison of water distribution coefficient relative isobars for 
Polymorphs A and B as a function of temperature.
Figure 48 shows the distribution coefficient of water for the two 
polymorphs as a function of temperature. The two polymorphs exhibit a net 
decrease in the distribution coefficient with increasing temperature. Figure 58 
also reveals that the increase in sorption by polymorph B observed from 35°C 
to 45°C (Figure 48), can be accounted for, simply by the corresponding
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increase in P° with temperature. This is an important result, because it means 
that no new process of water uptake is triggered at 45°C, even though this 
corresponds to the only temperature for which significant hysteresis was 
observed (Figure 46).
Figure 48 shows that the distribution coefficient profile of polymorph B is 
consistent with that expected from a system in which the sorption sites on the 
surface are for the most part energetically equivalent. In such case, the 
distribution coefficient is expected to increase in proportion to an increase in 
RH at a given temperature. Such a system is also expected to exhibit an 
exponential decrease in equilibrium sorption with increasing temperature, as 
predicted by the van’t Hoff equation. Figure 48 shows that for polymorph A, 
the span of KD values is the widest at 20°C and becomes more narrow as the 
temperature increases. This result is indicative of a surface on which the 
sorption sites are not energetically equivalent. The span of Kd values in Figure 
48 is not only wider for polymorph A, it also varies more with temperature than 
for polymorph B. Water sorption results for polymorph B can be considered as 
being closer to an ideal behaviour than the results for polymorph A. This is 
apparent by considering both the change in water uptake as a function of RH at 
a given temperature (Figure 47) as well as by the change of the sorption 
coefficient as a function of temperature at constant RH (Figure 48).
The existence of sorption sites of different nature on inorganic crystal 
surfaces has been established in the past. In fact, work on catalysis research 
has shown that the surface of zirconium dioxide crystals contains adsorption 
sites of different nature: acidic, basic, oxidising and reducing. Moreover, 
zirconia polymorphs exhibit different adsorptive properties due to different
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nature and density of adsorption sites on their surface, which in turn is the 
direct result of their different crystal structures [Bachiller-Baeza e ta i, 1998].
The foregoing discussion establishes that the surface of polymorph A 
crystals is more heterogeneous than the surface of polymorph B. The 
statements concerning the energetics of sorption are based on the effects that 
temperature have on the distribution coefficient. The common format for 
analysing the energy of sorption would be to plot the data on a van’t Hoff type 
plot. The slope of such a plot corresponds to the enthalpy of the process 
(normalised to the ideal gas constant). However, van’t Hoff plots are well 
suited for ideal or nearly ideal systems, i.e., homogeneous surfaces giving 
place to an enthalpy of the process that is invariant with temperature. This is 
not the case for either polymorph in this study.
4.1.3.3 Heat of Adsorption
In the present study, the analysis of the energetics of water sorption was 
taken one step further by directly measuring the heat evolved by the water 
uptake for each polymorph under different relative humidities, and at the same 
temperatures as the sorption measurements. The heat of adsorption was 
measured by microcalorimetry using the TAM instrument equipped with the 
flow cell system to control relative humidity. Figure 49 shows the heat of 
adsorption, presented as relative isobars, for each polymorph.
173
Figure 49. Comparison of heat of adsorption of water for Polymorphs A and B 
_________ as a function of temperature. Data presented as relative isobars.
Temperature CC)Temperature (*C)
From bottom to top, the relative isobars in Figure 49 correspond to 20% 
to 90% RH, with 10% increments. The figure shows that the two polymorphs 
show more similarity in terms of the energy profile obtained than in terms of 
their water distribution coefficients. The heat of adsorption for polymorph A is 
significantly higher at all relative humidities and temperatures investigated. 
However, the two polymorphs qualitatively follow similarly shaped profiles. 
Most notably, there is a significant increase in the heat evolved upon 
adsorption at 25°C and high relative humidity.
The sharp increase in heat of adsorption seen in Figure 49 indicates 
that the two polymorphs have heterogeneous surfaces. Both crystal forms 
appear to have a portion of their surface covered with less energetic, less 
specific sites which get occupied at 25°C, as a result of the increase in vapour 
phase water concentration produced by increasing temperature at constant 
RH. This effect could be the result of partially crystalline or even amorphous 
regions produced by the milling process. But the lower heat of sorption 
observed at 20°C compared to that at 25°C is difficult to explain in terms of
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amorphous regions. Because such an explanation would require a liquid-liquid 
(super cooled liquid in the case of the amorphous drug) hydrogen bond 
interaction that is stronger at 25°C than at 20°C. A more plausible, albeit 
speculative explanation would be a scenario similar to the sorption of water 
vapour on activated carbons. Sorption at secondary (weaker) sites which 
allows mobility to the adsorbed molecules, and consequently water-water 
(exothermic) interactions. At 35°C, the temperature is too high for sorption at 
these weaker sites, and net decreases in both energy of sorption and water 
distribution coefficients are observed.
Figures 48 and 49 are greatly informative in differentiating between the 
two polymorphs in terms of their interaction with water vapour. However, the 
information in these figures is still somewhat limited because both water uptake 
and energy of adsorption are given relative to the amount of adsorbant present. 
In order to establish the inherent differences in surface energetics between the 
two polymorphs, it would be more informative to look into the energy evolved 
when a water molecule “lands” on one type of surface or the other. Figure 50 
combines the information in Figures 47 and 49. This figure shows the specific 
heat of adsorption, i.e., the heat of adsorption relative the amount of water 
sorbed instead of to the amount of crystalline adsorbate present. The specific 
heat of adsorption is more informative about the energetics of sorption. It 
centres on the water and the energy that such water evolves upon sorption, 
without the confounding effects of whether a unit mass of from A is equivalent 
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Figure 50. Comparison of the specific (normalised to the amount of water 
sorbed) heat of adsorption of water for polymorphs A and B. Heat 
___________ of adsorption.____________________________________________
Figure 50 shows that the energetic differences water molecules will 
encounter when lodging on one polymorph surface or the other. The 
differences between polymorphs in terms of their surface energetics are 
observable on the specific heat of adsorption at different RH values, as well as 
on its variation with temperature for each polymorph. The specific heat of 
adsorption is very similar for the two polymorphs at 20°C and somewhat 
greater for polymorph A at 45°C. Between 25°C and 35°C however, the 
specific heat of adsorption of water on polymorph B is considerably higher than 
for polymorph A.
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The data in Figure 50 point toward a fundamental difference between 
polymorph A and polymorph B. At 25°C, both the total heat of adsorption and 
the amount of water sorbed are greater for form A than for form B. However, 
the specific heat of adsorption is greater for form B. This result is strong 
indication of a very different type of interactive surface in each case. More 
water can sorb onto form A than on form B by occupying a greater number of 
sites on the crystal surface of A that are weaker than the sites on the surface 
of form B, in terms of their interaction with water. Weaker, less specific 
sorption sites on the surface of form A can also account for the much wider 
variation in water uptake and distribution coefficients observed for this 
polymorph at 20°C and 25°C, as a function of RH. Water sorption at the 
weaker sites is overcome at sufficiently high temperatures, as observed at 
35°C for polymorph A. The significance of these findings rests on the fact that 
they present different pictures of the surfaces of the two polymorphs. 
Polymorph A exhibits an “excess” sorption at lower temperatures. Such 
excess is evidenced in the sorption profile shown in Figure 58 and is the result 
of water adsorbing on sites which are weaker than those mostly occupied at 
35°C. Polymorph B also shows evidence of excess sorption, but it is not 
directly observable as with polymorph A. Evidence of weaker active sites on 
the surface of form B is given in the energy profile of Figure 49. It is important 
to point out that the peak in heat of adsorption observed at 25°C for the two 
polymorphs is most likely due to a similar effect. And that because the 
mechanism of water adsorption is hydrogen bonding (which is significantly 
weakened the higher the temperature), the excess sorption with temperature 
has to be the result of the increased collision frequency of the water vapour
molecules onto the crystal’s surface and other water molecules. It follows that 
the “excess” sorbed molecules should have greater mobility over the surface, 
than the molecules adsorbed at the primary (stronger) sites.
In the range of temperatures typical of pharmaceutical processing, 
polymorph A thus offers a greater ability to interact through a greater number of 
weaker active sites on its surface than those present on polymorph B. This 
situation translates into the energetic equivalent of surface “fuzziness” in the 
case of polymorph A. A crude but useful analogy on these lines would be to 
consider the surface of particles of polymorph A as consisting of a material 
such as Velcro®. In contrast, the surface of polymorph B would consist of a 
material covered with snap press buttons. Site by site, the interactions of the 
fuzzy surface are weaker, but they are more numerous and less restrictive in 
terms of orientation. The net effect is that an energetically fuzzy surface will 
result in a greater cohesion and/or adhesion energy for the particle as a whole. 
This explanation is also consistent with the greater detachment from drug- 
lactose blends, observed for form B (Chapter 3, section 1), as well as with the 
greater tendency of polymorph A to form particle aggregates determined by 
electrostatic measurements (Chapter 3, section 2).
Recent Atomic Force Microscopy studies with cimetidine have shown 
that the surfaces of the polymorphs of this drug are distinctly different. The 
differences in crystal polymorph surfaces are significant enough as to allow 
their differentiation by AFM even in polymorph mixtures. [Danesh et a i, 2000]. 
But form the present discussion’s standpoint, a very significant development is 
that Danesh et a/., [2000] found that for one of the polymorphs, adsorbed water 
on the crystal surface actually produced changes in the AFM surface image
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obtained. For one of the two polymorphs studied, the surface properties 
observed by AFM were in fact dependent on the relative humidity under which 
the AFM analysis was conducted.
The surfaces of the two polymorphs of the present study are 
energetically different to sufficient degree, as to allow direct and reliable 
measurements in terms of their interaction with a common probe such as 
water. These differences can in turn be related to the differences in behaviour 
between the two crystal forms observed in the study of drug-lactose blends 
studied by the centrifuge method and by electrostatic measurements. 
Furthermore, the discussion presented here about the differences in surface 
energetics between the two polymorphs could also help to support the 
explanation given in Chapter 5 for the different deposition behaviour these 
materials exhibit when studying their detachment from lactose upon actuation 
from DPI devices.
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4.2 Inverse gas chromatography (IGC).
The need to predict the behaviour of powders in terms of their 
dispersive characteristics during aerosolisation has resulted in a resurgence of 
research on vapour-phase sorption. The use of gas chromatography (GC) as 
a tool to investigate material interactions and compatibilities offers the potential 
advantages of control over the chemical and physical environments in the 
powders under study. Gas chromatography provides accurate control over a 
wide temperature range encompassing the conditions under which the solid of 
interest undergoes interactions in pharmaceutical development. In addition, 
the ability to introduce immediate and precise temperature changes, from sub­
ambient to above ambient, makes GC techniques very useful in gathering 
information about the interactive properties and energy of interaction of powder 
surfaces.
IGC probe analysis has proven to be successful as a tool in studying 
structure changes in biopolymers [Carrillo et al., 1988; Gilbert and Roshdy 
1989]. Ahmed [1989] determined the solubility parameters of sodium starch 
glycollate (Explotab) using IGC, in order to calculate the interaction parameter 
(<[>) and relative intensities of the cohesive and adhesive interactions in ternary 
and quinary systems. The IGC technique has also been used in the 
determination of solubility parameters of pharmaceutical materials such as 
lactose, salbutamol, cefalexin [Ticehurst et al., 1994 and 1996; Egawa et al., 
1992], in studies that characterised the surface properties of such materials 
before and after processing operations.
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In the study reported here, IGC was used to explore the properties of 
the surfaces of the two crystal polymorphs of Ro 24-5913 and to study the 
binding energies of a common set of solvent vapour probes onto the two types 
of surfaces. Powder of the drug was packed as stationary phase into a gas 
chromatography column. A series of solvent vapour probes of different polarity 
were injected into the column under different temperature conditions. The 
resulting elution data were used to calculate the probes’ sorption coefficients 
and other thermodynamic parameters including the enthalpy, entropy and free 
energy of sorption. The sorption properties of the probes used in IGC are used 
to examine and compare the hydrophilicity/hydrophobicity properties of the two 
polymorphs of the drug Ro 24-5913.
4.2.1 Experimental probe analysis of IGC
Selection and preparation of organic probes. The selection of different 
organic probes for the present study was based on a range of polar and non­
polar reactivity. Table 19 provides a list of the different probes used in this 
study.
Table 19 Reactivity of the probes.
Solvent Reactivity
Methane non-interacting probe
2-Propanol (2-POH) H-Bond donor/acceptor
Methyl Ethyl Ketone (MEK) Carbonyl H-bonding
Ethyl Acetate (EA) Carbonyl H-bonding
Toluene (TOL) ;r-bond
Hexane, Heptane (alkanes, HX, HEP) non-hydrogen bonding
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Methane (Scott Speciality Gases) was used to determine the dead 
volume of the column in the probe analysis [Lipson and Guillet 1982]. All other 
probes were obtained from Fisher Scientific. The IGC technique requires 
probes to be injected at infinite dilution. In order to achieve this condition, the 
procedure described below was followed with all solvent probes used: Six 
separate vials of each probe were prepared, 1 0 0  pi of the selected organic 
solvent probe were placed each into 2 0 -ml, 2 0 -mm neck, head-space glass 
vials (Wheaton). The vials were capped with 20-mm Teflon® faced butyl septa 
(Supelco) and crimped with aluminium seals (Supelco). The sealed head­
space analysis vials containing the solvent probes were then placed under 
-10°C conditions. At this temperature, the probe concentration in the 
overhead vapour phase is reduced, making it possible to withdraw 
considerably and consistently smaller masses of solvent than would be 
withdrawn at room temperature using standard GC sampling syringes,. This 
very practical procedure is remarkably effective in obtaining consistent, close to 
infinite dilution conditions without the need of specially designed accessories. 
Five different injection volumes, 5, 10, 25, 50 pi, of organic probe were used. 
Vapour samples for injection were withdrawn from the head-space of the glass 
vial containing the solvent probe, and injected into the GC. Using this 
technique, any possible concentration dependence of retention time could be 
resolved by extrapolation to zero concentration [Hatzidimitriu 1987]. For each 
injection volume, triplicate injections were made using gas-tight syringes with 
luer tip cemented conical needles of 10, 25 and 50 pi volume (Hamilton). A 
syringe Chaney adapter was also used (Hamilton) for better reproducibility.
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The rubber septum at the injection port was changed every 20-25 injections in 
order to avoid leaking.
The amounts of probes injected into the GC were calculated using the 
ideal gas law:
PV  = nRT (45)
where P  is the pressure of the organic solvent vapour, V is the injection volume, 
n is the number of moles, R is the gas constant and T  is the temperature 
(-10°C) expressed in °K.
From equation 45, the mass of vapour injected into the GC ranged from 
1.13 x 10'7 to 7.32 x 10'6 g for the different solvent probes. Care was taken to 
ensure that the probe was introduced instantaneously as a “plug” into the 
column [McNair and Bonelli 1969]. It took about 15 minutes for the entire 
probe volume injected to elute from the column to the point at which a 
chromatogram baseline was re-attained, and this elution time covered all the 
probes used. Therefore, in order to ensure consistency and reproducibility for 
all data generated, a time interval of 15 minutes between injections was set.
IGC setting conditions. A Perkin Elmer AutoSystem gas chromatograph was 
used to measure retention volume. The GC was equipped with a Flame 
Ionisation Detector (FID) and a flow control system to set pressure and gas 
flow rate. A column oven was fitted to maintain the column temperature by 
circulating air. The temperature was maintained constant with a variation of 
± 0.5 °C from the set temperatures.
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High purity grade helium was used as the earner gas. The gas carrier 
gas was further dried and purified before use by passing it through moisture 
and oxygen traps installed in the gas line feeding the GC. The flow rate for 
helium was set at 30 ml min'1. A two-stage regulator located on the cylinder 
was used to set the inlet gas pressure to 80 psi.
The flow rate of the earner gas was measured at room temperature 
(25°C) at the outlet of the detector using a soap bubble flow meter (HP Soap 
film flowmeter) and stop watch. The flow rate measurements were confirmed 
with an electronic flow meter AccuRate™ 1000, Intelligent Flow Meter (JHW 
Fison Scientific, Folsom, CA). The variation of the outlet column flow rate 
through experimentation was less than 0.5%.
The inlet earner gas pressure was measured with a U-shaped mercury 
manometer (1 mm Hg precision) and verified with a Chromopack hand held 
pressure gauge (0.1 psi precision). The outlet carrier gas pressure was 
assumed to be at atmospheric conditions and measured using a mercury 
barometer.
The gases necessary for the detector were air and hydrogen (high purity 
grade). The flow rate for air was set at 450 ml min' 1 and for hydrogen was 45 
ml min"1. The operating temperatures for IGC probe analysis are shown in 
Table 20.
Table 20. Operating temperatures for IGC probe analysis.




Preparation of the Column. Varsano and Gilbert [1973] reported that the 
specific retention volume is not affected by operating variables such as 
column length and amount of stationary phase, but that specific retention 
depends exclusively on the thermodynamic variables of the system. 
Kontominas et a/., [1985] have shown that the effects of temperature and 
the nature of the stationary phase are considerably more critical than the 
effect of particle size of the stationary phase. The same authors have 
determined an optimum column length of 0.635 cm i.d., 11 cm long, particle 
size of about 75 pm and loading amount of hydrophilic/hydrophobic packing 
material. These parameters result in feasible conditions for differentiating 
the retention in the column of the inert agent (Methane) and the probes. 
Rhue and Rao [1990] used 10-cm long columns to measure retention times 
for several organic compounds injected into a column packed with 250 pm 
size fraction soil or aquifer materials.
Experiments in the present study used pre-cleaned instrument grade 
stainless steal tubing as the body for the columns, the length of the columns 
was 11 cm with a 0.639 cm o.d. A space of 0.5 cm. was left free at each end 
of the column in order to place silane-treated glass wool inserts (Supelco, Inc.). 
The amount of drug powder filled into the column as packing material was 
determined by weighing the column before and after packing. The column 
was held in a vertical position and, with the aid of a small funnel, the powder 
was poured, falling by gravity into the column. Vacuum between 0.5 -  1.0 
mm Hg of pressure was then applied to the column outlet, at the same time a 
mechanical vibrator was used to shake the column while filling, in order to 
achieve uniform and tight column packing. Drug micronised in the range of
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0.5 -  7.0 pm fraction size was filled into the column. Three columns were 
prepared for each of the drug polymorphs, A and B. Even though the flow 
properties and surface area of the two polymorphs are slightly different, the 
mass of powder filled was 0.43g for both forms, due to the fact that the bulk 
density of the micronised polymorphs is similar. The sample column was 
separated from the heated injector and detector by two 0.315 cm. o.d. x 20 cm 
length pieces of copper tubing connected by swage-lok™ fittings. Prior to any 
sample injections, the column was conditioned by passing dry helium at the 
experimental column temperature. Depending on the material of interest, 12 
or 24 hours are typically necessary for equilibration and to remove possible 
water picked up during the packing process [Apostolopoulos, 1990]. In the 
experiments reported here, 12 hours were sufficient at the 25°C under helium 
flow to condition the column.
4.2.2 Data treatment.
In the gas-solid system, a series of assumptions have to be considered
to calculate the thermodynamic parameters [Young 1968; Lipson and Guillet
1982; Hatzidimitriu 1987]:
a. The gas phase behaves as an ideal gas, i.e., no interactions in the gas phase 
(solute-solute, carrier-carrier or solute-camer) take place.
b. Henry’s law is operative. This definition of ideality for the behaviour of the 
vapour can be satisfied with the injection of small amounts of solute or probe.
c. The molar volume of the probe does not vary greatly with pressure, i.e., 
equation 45 is applicable.
d. The mobile and stationary phases are in continuous equilibrium. As the solute 
(adsorbate) vapour moves along the column, sorption equilibrium is attained 
instantaneously.
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e. The retention volume, and consequently the equilibrium constant, are not 
affected by the concentration of the adsorbate.
f. The column is isothermal.
g. The adsorbate’s adsorption coefficient is constant at the temperature of the 
experiment.
It is evident that there is some redundancy and overlap among the 
assumptions listed above. Some assumptions are a prerequisite for, or the 
direct consequence of another. The explicit long list is provided for 
convenience.
From IGC experiments, the retention time for a probe or solute on a 
given column at a given temperature is a property of the solute and its 
interactions with the stationary phase. The amount of time a solute spends 
on the column (stationary phase) is the retention time of the probe, tr. A non­
retained probe (e.g., Methane) has a particular retention time, tm. The value 
of tm is a characteristic of each column, and corresponds to the physical 
travel of the gas from one end of the column to the other, under a given set 
of experimental conditions. The value of tm contains no thermodynamic 
information per se; tm is the direct result of the instrumental configuration 
used. However, tm is a parameter that must be known in order to make the 
necessary corrections to obtain meaningful thermodynamic parameters from 
the IGC data. Gas chromatography experiments provide measurements of 
retention time. However, time has no direct application for purposes of the 
thermodynamic treatment of the data. For a given set of chromatographic 
conditions, each retention time (tr) value has a corresponding retention 
volume, Vr. Retention volume is a thermodynamically meaningful quantity 
that measures the amount of mobile phase required for the probe sample to 
elute from the column. The net retention volume is given by:
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K = K - v n (46)
where Vn is the net retention volume, Vr is as defined above and Vm is the 
column’s dead volume, i.e., the retention volume of a non-retained probe 
(K=Vm when tr =tm).
Net retention volume is the fundamental parameter measured in IGC. 
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where Vg is the specific retention volume and Ws is the weight of the stationary 
phase present in the column. There is no fundamental difference between Vn 
and V* the latter however, is the working parameter used in IGC because it 
allows for comparison of data obtained from more than one column.
The calculation of the thermodynamic parameters from IGC data can be 
performed from the V„ (or Vg) values obtained. An alternative treatment of the 
data consists in the use of the partition (sorption) coefficient, Ks:
V V
K s = — z—  = ^ ~  (48)
W s A n  A n  sp sp
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where Av  the specific surface area of the powder in the column. As stated, the 
values of Ks or Vg are obtained from IGC data and either parameter could be 
used for studying the properties and explaining the behaviour of the surfaces 
of powders. For instance, Carrillo et a i, [1988] related Vg to the degree of 
‘openness’ of structures and to the number of exposed active sites of the 
sample. A higher value of Vg represented more accessible active sites. 
Some authors [York et ai, 1998] prefer to use Ks for explaining the surface 
properties and behaviour of powders such as a-lactose monohydrate and dl- 
propanolol hydrochloride, in terms of the binding energy of adsorption.
In order to make Henry’s law operative, Vg and Ks are calculated at 
infinite dilution. The equilibrium constant in this sorption treatment 
corresponds to the probe’s partition coefficient between the gas and adsorbed 
phases.
4.2.2.1 Adsorption thermodynamic parameters: Evaluation of Free 
Energy, Enthalpy and Entropy of Sorption.
The values of Ks obtained from equation 48 can be used to calculate 
various thermodynamic parameters such as the free energy, enthalpy and 
entropy of sorption. In the present study, the calculation of the standard free 
energy of adsorption, AG/, is based on deBoer’s [Meyer, 1980] arbitrary 
standard states for the adsorbed (;r) and vapour ip) phases. For the standard 
vapour state of 1 atm, the value is 101 kN*m‘2, and 0.338 mN-m' 1 for the 
standard surface pressure:
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The numerical value of AGs° will be dependent on the choice of 
standard states as well as on the units used to express p  and n. The ratio of 
the standard states’ pressures appears explicitly in equations 49 and 50 
because the sorption process involves partitioning of the solute probe between 
a three-dimensional (volume) and a two-dimensional (surface) phases. The 
situation of equations 49 and 50 is analogous to that encountered when 
solubility is the equilibrium constant, which can be expressed in different 
concentration units.
Enthalpy is a quantity whose value is indicative of the overall balance 
between binding (exothermic) or repulsive (endothermic) forces prevailing in 
the system under study. The enthalpy of sorption can be obtained from the 
following equation:




where AHs° is the enthalpy of sorption and C is dependent on the chosen 
standard states.
The entropy of sorption reflects geometrical factors related to the 
possible energetically equivalent configurations of the probe on the stationary 
phase. During sorption, entropy usually decreases due to the localisation of 
probe molecules at specific active sites of the drug particles’ surface. The 
entropy of sorption is not a directly measurable quantity; it is a calculated 
parameter whose value is also affected by the choice of standard states, much 
the same as the free energy:
where ASs° is the entropy of sorption and its numerical value is consistent with 
that of A G / (equations 49-50).
The thermodynamic treatment of GC data presented in equations 48 
through 53 is the most commonly used and reported in the literature. Lin 
[1993] and Rhue and Rao [1990] showed that the free energy of sorption is 
sufficient to differentiate polar from non-polar interactions between vapour 
probes and solid surfaces. The spreadsheet created for the calculation of the 
parameters of equations 48 through 53 is given in the Appendix. Detailed 
discussions on the derivation of thermodynamic parameters from GC data can
(53)
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be found in Meyer et ai, [1973], Meyer [1980], Lipson and Guillet [1982], 
Gilbert [1984], Rhue and Rao [1990], Lin [1993].
4.2.3 Results and Discussion
Retention time in chromatograms. For the range of concentrations used with 
the different solvent vapour probes, the peaks showed sharp front profile and 
diffuse tailing. Skewed peaks in IGC are fairly common, and the peak 
maximum provides a measure of the retention at infinite dilution. When the 
peaks show deviation from symmetrical (Gaussian) shape, several methods 
have been used for determining the retention time of the peak [Conder et ai., 
1986]. One of these methods is peak maximum (PM), i.e., retention time is 
measured at the maximum of the skewed IGC peak. The same 
methodology was used in this study to obtain the retention time.
Figure 51 shows how the sorption coefficient, Ks for both polymorphs 
changes as a function of probe polarity under isothermal conditions. Overall, 
polymorph B exhibited greater Ks values for the different probes at the different 
temperatures investigated. The only exception being 2-POH (a hydrogen bond 
donor) at 25°C. The figure also shows that at the lower temperatures (25°C 
and 35°C), the sorption coefficient of the non-hydrogen bonding probes was 
considerably higher for polymorph B. This difference between the two 
polymorphs prevails at 45°C, although not as pronounced. These results 
indicate that dispersion interactions are stronger on the surface of polymorph B 
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Figure 51 Sorption coefficient for various probes and
temperatures for polymorphs A and B (n=18).
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Another difference between the two polymorphs observable from Figure 
51 is that for polymorph B, the Ks values obtained can be practically used to 
rank the probes into two groups, hydrogen bonding and non-hydrogen 
bonding, the latter giving the higher Ks values. A similar contrast cannot be 
made with the Ks values obtained from polymorph A.
It should be noted that the Ks values show that the surface polymorph B 
has a stronger affinity for non-polar probes than the surface of polymorph A. 
However, the higher affinity of polymorph B for non-polar probes is not 
accompanied by a greater affinity of polymorph A for the polar probes. 
Polymorph B also exhibits somewhat greater affinity for the polar probes. 
These results are a strong indication of a composite surface having separate 
polar and non-polar sites for adsorption.
Figures 52 and 53 show the change in Ks with temperature observed for 
polymorphs A and B. The data from non-polar and polar probes are shown in 
Figures 52 and 53, respectively. The figures show that for the majority of the 
solvent probes, Ks values were lower the higher the temperature. The two 
alkanes were the exceptions, the sorption coefficient for hexane remained 
constant with temperature for the two polymorphs. In the case of heptane the 
sorption coefficient decreased with temperature for polymorph B, while 
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Figure 52. Sorption coefficient for non-polar probes for the two 

























'E  x  6 .0 0  -
c °E, Q.







Figure 53 Sorption coefficient for polar probes for the two 
polymorphs as a function of temperature (n=18).
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The values of the thermodynamic parameters of sorption, namely, AG/, 
AHs° and AS/ obtained form the IGC data are provided in Tables 21,22 and 23, 
respectively. Free energy values obtained form IGC data are more reliable 
than values obtained for enthalpy or entropy. This is so because in IGC, the 
free energy value is obtained in a very direct way from tm (via Vg), the very 
measurement of IGC.
Table 21. Free energy of adsorption of solvent probes on Ro 24-5913, 
polymorphs A and B, at 25°C, 35°C and 45°C (n=18).


























The enthalpy of sorption data listed in Table 22 show an important 
difference between polymorphs A and B. Toluene gives the highest enthalpy 
of sorption for polymorph B, whereas for polymorph A, it was the adsorption of 
2-propanol what gave the highest enthalpy value. Interestingly, the values of 
AHs for the adsorption of toluene on the surface of polymorph B and the 
adsorption of 2-POH on the surface of polymorph A, are of comparable 
magnitude. These results show an important difference between the surfaces 
of the two polymorphs: the most exothermic interaction for polymorph A is 
obtained from the adsorption of a hydrogen bond donor (and acceptor), 
whereas for polymorph B, the most exothermic interaction results from the 
adsorption of a non-hydrogen bonding probe.
Table 22 Enthalpy adsorption of solvent probes on Ro 24-5913, 
polymorphs A and B (n=18).










The IGC data obtained cannot be used to make reliable assessments of 
the enthalpy of adsorption of hexane with both polymorphs and hexane with 
polymorph A. The reason for this situation is visually apparent in Figure 52. 
Equation 51 calculates the enthalpy based on the change of sorption with
temperature (van’t Hoff calculation), and as Figure 52 shows, the equilibrium 
constant was invariant with temperature in the case of hexane, as well as for 
heptane and polymorph A. But even if the enthalpy of sorption cannot be 
calculated in these cases, the constancy of Ks with temperature is in itself quite 
revealing.
The adsorption of a vapour onto a surface is an exothermic process, 
and in its simplest form, one manifestation of the exothermic nature of 
adsorption is a decrease in Ks with temperature (the fundamental relationship is 
given in Equation 51). Consider the Ks values obtained for hexane (see Figure 
52), which remain constant with temperature for the two polymorphs. The 
practically flat profiles of Ks vs. T could be the result of very low heats of 
adsorption, not resolvable with the error inherent to the experimental 
methodology used. But such an explanation would not be convincing, 
because it must reconcile adsorption coefficients of similar scale as those 
obtained with other (measurably exothermic) adsorbates, but without the 
evolution of any heat. A more plausible explanation would be that there is an 
additional component to sorption on these surfaces. The additional sorption 
component would be necessarily athermal; excess sorption resulting of excess 
free energy at the adsorbent’s surface. The excess free energy at the surface 
could in turn be explained in terms of imperfections or defects on the crystal 
surface, giving place to a predominantly athermal (less negative entropy 
change) excess sorption. Evidence of excess sorption was also observed with 
water as the probe under conditions far removed from infinite dilution (Chapter 
4, section 1).
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Table 23 lists the values of entropy of adsorption obtained from the IGC 
results. The limitations encountered when calculating the enthalpy change are 
earned over (through Equation 53) into the calculation of ASs°. This is 
particularly true for the adsorption of the alkane probes on polymorph A. The 
ASs° for hexane and heptane on polymorph A are obvious overestimates, since 
adsorption is accompanied with, thus disfavoured by, a negative entropy 
change.
Table 23 Entropy of adsorption of solvent probes on Ro 24-5913, 
polymorphs A and B (n=18).
Probe Polymorph A Polymorph B
A£°
(Equation 50) 























One of the concluding remarks of Chapter 4 (section 1) reads as 
follows: “The surfaces of the two polymorphs of the present study are 
energetically different to sufficient degree, as to allow direct and reliable 
measurements in terms of their interaction with a common probe such as 
water.” The same statement can be made about the results from IGC 
obtained here with all solvent probes investigated. It is important however, not 
to take the IGC data as simply another technique capable of showing 
differences between the two polymorphs of Ro 24-5913. Because the infinite 
dilution conditions used in IGC experiments, make the obtained results 
uniquely informative about the nature of the surfaces under investigation.
As discussed in Chapter 2 (section 2), the two polymorphic materials 
were subjected to a milling process in order to reduce the particle size of the 
crystals, from a few hundred microns (Figure 13) to the particle size distribution 
shown in Figure 17, which has a mean particle size smaller than 5 pm. Milling 
produces a significant increase in the surface area of the crystals. However, 
the exposure of the original crystals to the mechanical stress of the milling 
process, raises questions about whether or not the surface of the micronised 
crystals retains the crystalline character of the native (unmilled) material.
The existence of crystal defects, even at the core crystalline phases is 
well established, and to such a degree that the subject has been covered in 
some classical works [Kitaigorodskiy, 1967]. Because of the inherent excess 
free energy of surfaces and interfaces, crystal surfaces can be expected to 
have a higher incidence of defects than the core of the corresponding crystal. 
After all, the “carrier” of the excess free energy of a surface is the surface 
molecules themselves. Recall that an excess amount of free energy
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corresponds to a gain in enthalpy of the molecule and/or a gain in entropy. A 
gain in enthalpy reflects a weaker interaction of the molecule with its 
neighbours, whereas a gain in entropy reflects a wider level of variation in the 
molecule’s position or orientation relative those of a molecule in the core 
crystal.
It is widely accepted that the mechanical energy applied to the 
crystals during micronisation results in a reduction in the level of crystallinity 
of the surface, compared with the crystallinity of the un-milled crystal surface. 
The highly intuitive appeal of this concept, in addition to the experimental 
evidence in support of it, can easily lead to the presupposition that the 
crystalline nature of the surface of the two polymorphs used here, was 
obliterated during milling, such that the differences observed between the two 
(milled) materials no longer reflect the crystalline character of their surfaces. 
The IGC technique is particularly well suited for addressing such a question, as 
will be done next for Ro 24-5913.
The adsorption data of hexane in Figure 52 strongly support the concept 
of defects present at the surface of the two micronised polymorphic materials. 
As discussed, the apparently athermal adsorption of hexane onto both 
polymorphs can be explained as the result of some degree of molecular 
disorder at the crystal’s surface. But the question at hand is not so much 
about the presence of molecular disorder on the crystals’ surfaces, after all, 
even un-milled crystals are expected to exhibit some degree of molecular 
disorder at their surfaces. The question here is about the extent of molecular 
disorder on the surface of the micronised crystals, and its effects on surface 
interactions. It should be recalled that the crystalline character of a surface is
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not an either/or attribute; surface molecules need not be either crystalline or 
amorphous. The crystalline character is a rather gradual attribute, determined 
by the free energy content of the molecules at the surface. Surface molecules 
can have the free energy of the (super-cooled liquid) amorphous or crystalline 
states, as the high and low extremes, respectively, and any value in between.
The presupposition that micronisation makes the surface of the resulting 
crystals lose its crystalline character bears implications worth examining under 
the light of the experimental evidence from IGC data. If milling produces 
changes on the particles’ surface such that the surface no longer corresponds 
to either polymorph A or B, the crystalline structure would have to be totally 
disrupted at the surface, giving place to a predominantly amorphous surface. 
The amorphous content of a surface, being thermodynamically more energetic 
in relation to the crystal, results in more (energetically) active sites for 
adsorption. A factor critical to the present discussion is that IGC experiments 
are done under infinite dilution conditions. Since the most active adsorption 
sites of the adsorbent are the first to be populated [Vemulapalli, 1993], infinitely 
diluted vapour probes will adsorb onto the most active sites available at the 
surface. The IGC-derived adsorption coefficients (Figure 51) are thus 
measurements of vapour adsorption restricted to the most active sites available 
at the surfaces of the two polymorphs investigated. It follows that if the 
amorphous content of the polymorphic surfaces after milling were the 
determining factor in the powders’ observed interactions, the infinite-dilution 
adsorption coefficients would have to be the same for polymorphs A and B, 
with all vapour probes, under all temperatures investigated. For if the two 
polymorphs produce the same amorphous phase, and their interactive
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behaviour does not reflect their crystalline character, they should be 
indistinguishable as adsorbents under infinite dilution conditions. But the two 
polymorphs are clearly distinguishable as adsorbents, in fact, even for the 
adsorption of hexane, which shows clear evidence of the effects of molecular 
disorder at the surface (Figure 52), the adsorption coefficients for polymorphs A 
and B are still distinctly different.
Another finding from IGC relevant to the present discussion is the fact 
that one of the two surfaces investigated (polymorph B) showed stronger 
affinity for both polar and non-polar vapours. This result is also in conflict with 
the presupposition of crystal disruption, which attributes a disordered, non­
crystalline character to the surface of the powder particles as the result of the 
micronisation process. An amorphous phase is in essence a super-cooled 
liquid, and a surface that exhibits stronger interactions with both polar and non­
polar adsorbates than another surface of exactly the same chemical 
composition, requires a degree of structural order characteristic of crystals, not 
liquids.
Any physical model put forth to envisage a system under study starts 
based on a hypothesis or a presupposition. But in the end, the physical model 
must be backed up by, and consistent with experimental evidence. The 
presupposition that the milling process somehow masked the crystalline 
differences between polymorphs A and B, requires a non-crystalline surface. 
But the fact that that the infinite dilution adsorption coefficients obtained with 
the two polymorphs (for all vapours investigated) are different, requires in turn 
that upon milling, each polymorph gave place to a different non-crystalline 
phase. Two different amorphous phases of identical chemical composition
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have been found to exist. But such a phenomenon, observed with a mixture of 
metal oxides, is extremely rare, and by no means easily achieved in the 
laboratory [Angell, 1995].
A physical model in which the particles of the two polymorphs retain 
their crystalline character at their surfaces, even after milling, is a more 
plausible explanation for the differences observed between the two crystal 
forms. It is very likely that the degree of molecular disorder at the surface of 
the micronised particles is greater than that of the original crystals. However, 
the results obtained indicate that the extent of molecular disorder produced 
upon milling is not sufficient to mask or obliterate the crystalline character of the 
surfaces under study. Adherence to the presupposition that the differences 
demonstrated between the powders are due to surface differences introduced 
during micronisation, rather than due to the surfaces’ crystalline character, 
would require the scientist either to dismiss the collected experimental 
evidence in favour of the lack of experimental evidence supporting the 
applicability of the above-stated presupposition to the system under study, or to 
fit the obtained results to a border-line fantastic physical model that requires 
“poly-amorphism” of Ro 24-5913 in order to be consistent with the data. The 
fact remains that the surfaces of the two polymorphs are different when 
scrutinised under infinite dilution conditions and also under conditions far 
removed from ideality (Chapter 4, section 1). And, the experimental evidence 
indicates that the surfaces’ behaviour predominantly reflects their crystalline 
character, even if the polymorphs are not (and they need not be, before nor 
after milling) perfect crystals at the surface.
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5. IN VITRO DRUG DEPOSITION CHARACTERISTICS
An investigation of the in vitro drug deposition characteristics of the 
powders of the two polymorphs was conducted. The practical significance of 
the drug-drug and drug-carrier interactions, as determined in earlier chapters, 
is examined here within the framework of their functionality as dry powder 
formulations for inhalation, by investigating the in vitro drug deposition 
characteristics of the binary dry powder formulations of the two polymorphs. In 
this section of the study, the investigation will focus on how the differences 
observed between the two polymorphs would be expected to affect the 
powders’ behaviour in dry powder formulations. An attempt is made to 
establish a connection between emitted fine particle dose and the interactive 
adhesion or electrostatic forces present among the particles in binary dry 
powders for inhalation.
5.1 Materials and Methods
Binary powders mixes of drug with a-lactose monohydrate of different 
drug concentrations, as described and characterised in Chapter 2, were used 
for each polymorph.
The fine particle and emitted doses of powder blend formulations were 
determined using a modified twin stage liquid impinger (TSI) described as 
apparatus A in the British (1988) and United States (1992) Pharmacopeias. 
Powder was aerosolised from a dry powder inhaler prototype Dryhaler ™(Dura
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Pharmaceuticals) at a flow rate of 60 I min' 1 and collected from each of the two 
stages of the TSI (Figure 54). At a flow rate of 6 0 1 min'1, stage II of the device 
is known from pre-calibration data, to collect fine particles with aerodynamic 
diameters smaller than 6.4 pm. Stage I collects particles having an 
aerodynamic diameter greater than 6.4 pm. Drug particles that penetrate into 
stage II are considered to be fine enough to have the potential to penetrate into 
the lung. The amount of drug collected in stage II was thus defined as the fine 
particle dose.
Replicate experiments of six measurements were conducted under 
controlled conditions of relative humidity (24% RH) and temperature (18°C). 
A load of 10 mg of the powder blend from each of the formulations was used 
for each measurement with either polymorphic form of the drug. Powder 
blends were weighed and then added directly into the sample compartment 
of the Dryhaler. The DPI was attached to the glassware mouthpiece inlet 
using a specially moulded PTFE mouthpiece adapter. The TSI Apparatus 
was set up using a volume of 5 ml of diluent solution (ACNihfeO, 50:50) 
which was placed into the round bottom flask in stage I of the impinger 
apparatus. In order to ensure that the TSI was operating at 60 I min' 1 with 
the DPI device in position, a custom-made airflow calibration glass housing 
(ACGH) was fitted as shown in Figure 55. After adjusting the flow rate to 60 
I min*1 using a flowmeter (Gilmont), the ACGH was removed from the TSI 
set-up. The formulated powder was discharged from the DPI device over a 
four-second period using a three way solenoid-operated valve timer (ASCO 
Products, NJ. No. 8300D724) activated at a flow rate of 60 I min'1, using an 
appropriately set vacuum pump. After the discharge period, the DPI device
207
was carefully removed from the mouthpiece adapter. The Dryhaler DPI was 
re-weighed and any weight loss was accurately recorded using an analytical 
balance (Mettler AE260, Delta Range. Mettler-Toledo Inc.). The TSI was 
disassembled and the powder samples collected in stages I and II were 
separately washed out with the diluent solution. Each wash-out sample was 
analysed by HPLC as described in Chapter 2.
The washing of the TSI apparatus is a critical part of the analytical 
procedure and was therefore performed with the required meticulous care. 
Stage I of the glassware (throat, neck tube and the upper impingement 
chamber) was rinsed with solvent and placed into a 50 ml amber volumetric 
flask. Stage II of the TSI glassware was also rinsed with the diluent solution 
and collected in a 25-ml amber volumetric flask. The collected washing 
solutions were then filled up to the mark with the same diluent solution and 
mixed thoroughly. The solution from each volumetric flask was filtered 
through a 0.45 pm membrane and transferred into HPLC amber glass vials 
with PTFE-lined caps. Samples were analysed using the HPLC
methodology described in Chapter 2. The DPI device was thoroughly 
cleaned with a cotton swab dampened with Methanol, in readiness for the 
next set of experiments. Clean TSI glassware and terminal filter (glass fibre 
filter from Gelman Sciences type A/E 47 mm with stainless steel holder) set 




Figure 54 Modified Twin Stage Liquid Impinger.
Figure 55 Photograph showing the air flow calibration housing set-up.
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The powder blend formulations used for the in vitro evaluation of their 
performance cover a drug concentration between 1% and 50% (w/w) for each 
polymorph of Ro 24-5913. However, the information obtained from the 
evaluation of both polymorphic formulations, would be more useful if examined 
from a common reference framework for the two crystal forms. The monolayer 
coverage concentration can be used as a common concentration reference 
point for the two polymorphs, allowing objective comparisons between them. 
The monolayer coverage corresponds to the drug concentration in the blend, 
necessary to completely cover the earner particles. The number of drug 
particles, N, needed to completely cover one ce-lactose monohydrate particle is:
where TL is the total surface area of an cu-lactose monohydrate particle and Ad 
is the cross-sectional area of a drug particle:
(54)
Tl = 4k (55)
and
AD = n (56)
2 )
where dD and dL are the diameters of the drug and o-lactose monohydrate 
particles, respectively. Each of the N  drug particles is a circular “tile” used to
cover the surface of one particle of the carrier. The mass of a group of N  drug 
particles, MD, is given by:
M d = N V d Pd (57)
where pD is the drug’s absolute density and VD is the volume of a drug 
particle:
r.-r4 (d (58)
In this calculation, an amount of drug weighing MD is used to cover one particle 
of of-lactose monohydrate, which has a weight, MLt as follows:




where pL is the absolute density of of-lactose monohydrate.
The weight percent drug needed for the complete coverage of a lactose 
particle, FD, is thus given by:
Fd = — ^ 2 — 100
m d + m l
(60)
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An alternative treatment [Clark, 2001], gives the following expression:
drug mass fraction = ------——-------------------------------------  (61)
l tii£L
4 dD pD
Table 24 gives the calculated drug concentration for monolayer 
coverage of ct-lactose monohydrate as well as the parameter values used for 
the calculations (Equations 55-60). The monolayer coverage concentration 
values obtained are 9.4% w/w and 8 .8 % w/w for polymorphs A and B, 
respectively.










a-lactose 1.52 75 —
monohydrate 
Form A 1 .2 1 2.4 9.37
Form B 1.27 2 .2 8.84
5.2 Results and Discussion
The emitted and fine particle dose (ED and FPD) were determined for 
two polymorphs of the drug, A and B. The performance of each blend with the 
Dryhaler was measured in terms of three parameters: device emptying, fine 
particle fraction (FPF) and formulation/device performance. Device emptying
212
corresponds to the ratio of ED to the nominal dose (ND). The fine particle 
fraction (FPF = FPD/ED) is a parameter useful as a way to assess the 
“dispersion” ability of powders. The formulation/device performance is 
calculated as FPD/ND x 100.
Micronised drug Ro 24-5913. Since in formulating powders for inhalation 
there is the option to use 100% of the active ingredient, neat Ro 24-5913 was 
loaded into the DPI device. Table 25 shows the deposition characteristics, 
emitted, fine particle and dispersion percentages for the pure micronised Ro 
24-5913 drug. When neat Ro 24-5913 was emitted from the DPI, it was 
observed that the device emptying was approximately 50%, of which, about 
65% (32.5% of the total dose) was in the size range of less than 6.4 pm. 
Nevertheless, some practical problems were encountered resulting from the 
highly cohesive and electrostatic nature of the drug. A weight of 2 mg of 
drug proved to be a difficult sample size to weigh and handle, as the powder 
is light, bulky and easily charged. For these reasons, Ro 24-5913 was 
blended with a carrier (cu-lactose monohydrate), in order to ensure accurate 
dosing.
Table 25 Deposition Characteristics for drug alone Ro 24-5913 emitted 
from Dura Dryhaler at 60 I min' 1 and powder load in the DPI of 2 
mg. Values in parentheses are standard deviations for n=3.
Batch FPD/ED % ED/ND% FPD/ND%
Ro 24-5913 drug polymorph A 65.36 (4.96) 47.67 (2.14) 31.12(2.29)
Note: FPD=fine particle dose; ED=emitted dose; ND=nominal dose
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5.2.1 Blends of Ro 24-5913 polymorph A
Four blends of Ro 24-5913 polymorph A with a-lactose monohydrate 
were prepared, the concentrations of the blends were 1,5 ,25 and 50% w/w, as 
described in Chapter 2. Table 26 gives the fine particle and emitted dose data 
for the blends of Ro 24-5913 polymorph A with ^lactose monohydrate 
formulations emitted from the Dryhaler. At the low drug concentration of 1 %, 
Ro 24-5913 was found to have a low fine particle fraction and high device 
emptying. At a drug concentration of 25% w/w in a-lactose monohydrate, 
Ro 24-5913 was found to have slightly higher fine particle fraction than at 1% 
w/w, but device emptying efficiency was considerably lower. At the high drug 
concentration of 50% w/w, intermediate values were obtained for both the 
percent of fine particles and device emptying. However, at this high drug 
concentration, the resulting powder blend was very cohesive and highly 
charged, presenting problems similar to those encountered when using the 
neat drug. The 5% w/w mix showed high fine particle percentages and device 
emptying.
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Table 26. Deposition characteristics for blends of Ro 24-5913 Form 
A/a-lactose monohydrate emitted from the Dryhaler at 60 I 
min"1 and powder load in the DPI of 10 mg. Values of 












Mean 1 27.14 88.56 24.08
Std Dev. 2.62 6.87 3.38
Mean 5 33.70 73.19 24.69
Std Dev. 2.98 0 .8 6 1 .1 0
Mean 25 30.19 39.55 1 2 .0 1
Std Dev. 1.34 2.45 1.94
Mean 50 25.87 60.18 15.46
Std Dev. 2.63 5.74 0.77
At 5% w/w drug concentration, the interaction between drug and earner 
was near optimal for purposes of effective detachment of drug from carrier and 
also in terms of the flow properties of the drug-carrier powder blend, resulting in 
higher deposition characteristics when compared to the other three drug 
concentrations. These results are in agreement with the results obtained with 
a similar blend system described by Ahmed et a l [1994], whose study also 
included the effect of the carrier-to-drug ratio under two different airflow rates 
(30 and 60 I min-1). Those authors’ results showed that the fine particle 
percent values were constant and independent of flow rate for the 5 and 25% 
w/w blends.
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5.2.2 Blends of Ro 24-5913 polymorph B
Aerosol testing was also conducted with blends of Ro 24-5913, 
polymorph B, with a-lactose monohydrate, using the same drug concentrations 
as for polymorph A, i.e., 1, 5, 25 and 50% w/w. Table 27 shows the results 
obtained for emitted dose, fine particle fraction and formulation/device 
performance for the blends of Ro 24-5913 polymorph B.
The effect of drug concentration in blends of polymorph B, as shown in 
Table 27, was found to be optimal at 25% w/w. Although the device emptying 
was higher at the 5% drug level than at 25%, powder blends containing 5% of 
polymorph B produced nonetheless the lowest fine particle fraction values.
Table 27. Deposition studies for blends of Ro 24-5913 Form Bla- 
lactose monohydrate, emitted from the Dryhaler at 60 I 












Mean 1 28.14 47.91 15.29
Std Dev. 6 .2 2 12.92 5.06
Mean 5 13.80 79.49 10.93
Std Dev. 1.03 4.28 0.26
Mean 25 43.35 53.94 23.36
Std Dev. 2.69 3.76 1.76
Mean 50 28.51 57.09 16.19
Std Dev. 2.69 4.19 0.70
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5.2.3 Comparison of performance between polymorphs A and B of 
Ro 24-5913.
Figures 56, 57 and 58 show the device emptying efficiency (ED/ND), 
the powder formulation/device performance (FPD/ND) and fine particle dose 
percentage (FPD/ED), respectively, as a function of crystal form and drug 
concentration for the two polymorphs.
The greatest difference in device emptying between the two polymorphs 
was observed at 1% drug concentration, as shown in Figure 56.
120.00
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[Ro 24-5913] (% w/w)
Figure 56. Device emptying represented by ED/ND for binary powder 
blends of Ro 24-5913 polymorphs A and B in a-lactose 
monohydrate (n=6).
Figure 57 shows the ratio of fine particle dose to nominal dose 
(FPD/ND) for blends of the two crystal forms of Ro 24-5913. The FPD/ND 
ratio is a measure of the amount of drug loaded into the device that was
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emitted as particles of size smaller than 6.4 pm. The FPD/ND ratio can also 
be seen as a measure of the ability of the powder formulation/device system to 
produce powder in discrete particles viable for delivery into the deep lung; the 
higher the ratio the more effective the powder’s performance. The 
performance of a powder formulation is dependent upon a combination of the 
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Figure 57. Formulation/Device performance (FPD/ND) for formulations 
of Ro 24-5913, polymorphs A and B, in a-lactose 
monohydrate (n=6).
Dispersion of the powder into discrete particles is achieved through the 
application of mechanical energy to the powder in an amount sufficiently high 
to overcome the cohesive forces between drug particles and adhesive forces 
between carrier and drug particles [Byron, 1986]. The energy applied was the 
same for both polymorphs, A and B, of Ro 24-5913, since the same DPI device
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and airflow rate were used. Therefore, the differences in performance 
observed between the two crystal forms are the result of the polymorphs’ 
different physical properties.
Figure 58 shows that the optimal dispersion of the drug into fine 
particles occurs at drug concentrations of 5% and 25% for polymorphs A and 
B, respectively. It is worth noticing that between the 5% and 25% 
concentrations, there is a relative reversal in optimal dispersion efficiency 
between the two polymorphs. At a drug concentration of 5%, polymorph A 
shows more efficient dispersion into fine particles than polymorph B, whereas 
at the 25% drug level, polymorph B shows more efficient particle dispersion. 
Another difference between the two polymorphs is that in the case of 
polymorph A, a decrease in dispersion efficiency takes place when the drug 
concentration is increased from 5% to 25%. Conversely, in the case of 
polymorph B, the same change in drug concentration results in an increase in 
dispersion efficiency. The 5% and 25% drug concentration levels roughly 
correspond to half and two-and-a-half times, respectively, the drug 
concentration needed for monolayer coverage of the carrier particles with the 
drug. Polymorph A shows optimal dispersion efficiency at a concentration 
below the monolayer level, that is, at drug levels where dispersion involves 
predominantly overcoming adhesion forces. Polymorph B in contrast shows 
optimal dispersion at a concentration where cohesion interactions play a very 
significant role in the formulation behaviour. Polymorph A produces better 
dispersion into fine particles at the lower concentration because of its weaker 
adhesive properties. These findings are consistent with the weaker adhesive
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interactions of polymorph A observed in the surface probing studies of Chapter 
4. Polymorph B, on the other hand produces more efficient dispersion into fine 
particles at the lower concentration because of its weaker cohesive properties, 
compared with polymorph A. These results are consistent with the stronger 
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Figure 58. In vitro drug deposition data for binary powder blends of 
Ro 24-5913, polymorphs A and B, in a-lactose monohydrate 
(n=6).
Table 28 gives the comparison of the removal forces by centrifugation 
with the fine particle fraction. The table shows that there is no discernible 
correlation between drug detachment by centrifugation and the emitted fine 
particle dose for either polymorph. In each case where detachment was 
measured by the centrifuge method, polymorph B showed the greater value
2 2 0
between the two crystal forms. A plausible explanation for such a bias in the 
centrifuge data is the stronger cohesive nature of polymorph A. Cohesion of 
particles of polymorph A may produce agglomerates that are sufficiently large 
and stable to remain in the sample chamber of the centrifuge cell, thus 
accounted as undetached drug. Drug detachment in both the TSI and 
centrifuge methods occurs upon the application of a detachment force. But 
the mechanics of the applied detachment force in each case is different at least 
in one respect: in the centrifuge method, a mono-directional centrifugal 
acceleration is applied throughout the experiment, the result is a mono- 
directional detachment force whose magnitude depends on the mass of the 
particle experiencing the force. In the TSI set-up, drug detachment occurs by 
placing the powder blend particles into a turbulent flow. Needless to say, in 
the TSI experiment, the accelerations experienced by the particles vary widely, 
and the resulting detachment forces are anything but mono-directional.
Table 28. Comparison of the removal forces with fine particle dose.
Conditions: 
% Drug




Form A Form B
TSI: fine particle percent of the 
emitted dose (n=6 )
% FPD/ED (fine particle ) 
Form A Form B
1 1.91 4.88 27.14 22.65
5 14.87 18.40 33.70 13.80
25 17.48 21.41 30.19 43.35
50 ND ND 25.87 28.51
The centrifuge method gives detachment values that are considerably 
lower than the corresponding TSI deposition values. This is most likely
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explained by the unavoidable wedging of the particles in the mesh of the 
centrifuge cell, which combined with the mono-directional detachment, 
significantly restricts the amount of drug collected in the receiving chamber of 
the cell. Only a portion of the drug particles, those attached to the cross- 
sectional area facing the cell’s collecting chamber can be detached. Another 
significant difference between the centrifuge and TSI methods is that the size 
of the particle plays a different role in each case. In the centrifuge method, the 
size of the detached particle affects the detachment force by reason of its 
mass. And the cut-off value of 45 pm, set by the mesh in the cell allows the 
collection of any detached drug powder satisfying such a dimension, whether a 
single particle or an agglomerate. In contrast, the basis for particle size 
analysis within the TSI resides in the aerodynamic diameter of the powder 
material that is the key particle property for characterising the respiratory 
deposition of airborne particles. Particle size analysis by laser light 
scattering of micronised drug showed that form A and B have a median 
volume diameter of 2.5 and 2.2 pm, respectively, with a very similar particle 
size distribution (Figure 17). Particle shape may also influence the 
deagglomeration of the powder blend during aerosolisation within the DPI, 
recall that particle geometry is a determining factor of the aerodynamic 
diameter.
Peart [1996] proposed the measurement of electrostatic detachment 
forces as a suitable tool for the prediction of drug deposition characteristics. 
The same author reported that a reduction in the detachment charge is 
mirrored by an increase in the emitted fine particle dose suggesting a
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correlation between the two parameters. The cited exercise was undertaken 
with the intention of discriminating between gravitational and electrostatic 
effects on the performance characteristics of DPIs.
In the present work, combination of the electrostatic properties of 
powder blends upon detachment and TSI deposition characteristics indicated a 
trend based on the drug load. Table 29 and Figure 59 show the fine particle 
fraction from the emitted dose for both polymorphs at different drug 
concentrations and the correspondent electrostatic charge as measured by the 
airstream Faraday apparatus. The data show that in the case of polymorph A, 
the profile of charge as a function of drug concentration obtained very closely 
resembles the profile of TSI drug deposition. In the case of polymorph B, 
there is no similarity between electrostatic charge and drug deposition, 
especially at the lower drug concentrations. It is evident that polymorph B 
exhibited a greater fluctuation in detachment charge than polymorph A.
Table 29. Comparison between emitted fine particle dose and
electrostatic detachment charge for blend of polymorphic drug 
with cif-lactose monohydrate (n=6 ).
% Drug
Fine particle percent of emitted 
dose(%)
Form A Form B
Detachment charge 
(C-g-1 x109) 














0.906 8 .1 2
1.193 5.023
0.846 1.047
Electrostatic charge data obtained with the air stream Faraday 
apparatus and with the capacitor interchangeable mesh (Chapter 3) indicate 
that polymorph A is the more electrostatic of the two forms. Because of their
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greater charge, dispersed particles of polymorph A undergo rearrangement 
toward charge neutralisation in a shorter time scale than do particles of 
polymorph B. An interesting consequence of this situation, is that precisely 
because polymorph B is the less electrostatic of the two, the effects of its 
slower charge decay are more readily manifested during particle deposition as 
observed in Figure 59. The deposition charge of polymorph A shows a 
reversal in polarity when increasing the drug concentration from 1% to 5% in 
the blend. But the electrostatic nature of polymorph A and its fast charge 
decay manifest themselves in a cohesive effect on the particles, more than on 
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Figure 59 Comparison between emitted fine particle dose and 
electrostatic detachment (n=6).
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The obtained results indicate that the two crystal forms of Ro 24-5913 
exhibit different in vitro deposition behaviour, and the differences can, in turn, 
be attributed to differences in the adhesive and cohesive properties of the 
two polymorphs. Polymorph A is less adhesive but more cohesive than 
polymorph B. Consequently, at low drug concentrations in the blend, a case 
where the frequency of collisions among detached drug particles is low, form 
A exhibits a greater efficiency in dispersing into fine particles. Conversely, 
the less cohesive polymorph B exhibits greater efficiency dispersing into fine 
particles at higher drug concentrations, i.e., in cases where drug-drug 
particle collisions are more frequent.
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6. CONCLUSIONS
The physical and physicochemical properties of drug particles of two 
different crystal forms were studied in terms of their observable effects on the 
nature and strength of the interactive forces between the drug particles and 
lactose, in dry powder mixes. The relationship between physicochemical 
properties and particle interactions was studied from two different 
perspectives and scales, each requiring different instrumentation and 
techniques. The surface energy characteristics of the drug were determined 
at a microscopic level and related to macroscopic behaviour in a powder mix, 
such as ease of metering and dispersing.
The drug used in this study exists in two, well characterised, 
polymorphic forms. This type of system was chosen in order to investigate 
the interactive properties of two different surfaces with identical chemical 
composition. The basic hypothesis of this study was that two polymorphs of 
the same drug, will exhibit measurable differences in their interparticle 
cohesive/adhesive interactions. The differences in interparticle interactions 
between the two polymorphs, which manifest themselves macroscopically as 
processing performance qualities of the mix, should in turn be the result, at a 
molecular level, of differences between the surface energetics of the two 
polymorphs.
Physical characterisation of the two polymorphs was carried out on 
crystals with the same particle size distribution for each form. In addition, the 
two crystalline forms used were treated in such way that the two materials 
used in the study had virtually the same particle size distribution, determined
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by laser light diffraction, as well as similar surface areas, as determined by 
BET gas adsorption measurements. These measures were taken in order to 
minimise, as much as possible, the potential confounding effects that size 
and shape may bring to the cohesive/adhesive behaviour of the drug. 
Physical characterisation of lactose, the material selected for use as a carrier 
was also performed. Drug-lactose mixes were prepared with each 
polymorph and characterised in terms of their deposition characteristics.
Measurement of the adhesion forces by the centrifuge method 
showed that the stable crystal form, polymorph B, detached more easily from 
the carrier than the metastable form, polymorph A, for all the drug loading 
levels. These results indicate stronger adhesion forces for the metastable 
polymorph were formed in contact with lactose than equivalent lactose 
bonding to the stable polymorph.
The electrostatic charges developed upon drug detachment, 
measured by two methods, show that both polymorphs are bipolar. The 
charges developed by the detachment of the drug were found to be higher in 
the intermediate range of drug concentration loading explored (5% w/w and 
25% w/w) for each polymorph. At the low and high extremes of drug loading 
studied, 1% and 50%, the charges developed upon drug detachment were 
lower, suggesting that charge screening produced by aggregation can result 
in charges similar to those obtained at low loads. Even though the profiles of 
drug load versus charge obtained for both polymorphs are similar, form B 
consistently developed higher charge than form A. However, measurement 
of charges developed by the neat drug showed that polymorph A is more 
electrostatic but also exhibits faster charge decay. These results suggest
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that the greater electrostatic nature of polymorph A favours the formation of 
agglomerates of this crystal form.
The physical reactivity of the drug surface was probed using physico­
chemical methods through the adsorption of organic solvents of different 
polarity and different hydrogen bonding properties. Inverse gas 
chromatography (IGC) measurements were used to obtain adsorption 
coefficients, whereas microcalorimetry (TAM) provided direct measurements 
of the energy (i.e., enthalpy) of interaction under equilibrium conditions.
Adsorption coefficients calculated from IGC experiments for different 
organic solvents are in most instances higher for polymorph B than for A. 
This is true for non-hydrogen bonding solvents, whether polarisable (toluene) 
or non-polarisable (hexane and heptane) as well as for hydrogen bonding 
solvents, whether acceptors (ethyl acetate and methyl ethyl ketone) or donor 
(2-propanol). IGC experiments also revealed that the surface of both 
polymorphs is essentially non-polar or hydrophobic, and the fact that one 
polymorph exhibited stronger interactions with both polar and non-polar 
probes is indicative of the composite nature of the surface as well as of a 
degree of order characteristic of crystals.
But the IGC methodology provided a key piece of information for the 
present study. Since IGC experiments were done under infinite dilution 
conditions, the obtained adsorption data correspond to the interaction of the 
vapour probes with the most active sites for adsorption available on the 
surface of either polymorph. The IGC data provided experimental evidence 
for the presence of molecular disorder at the surface of the two polymorphs’ 
powders. The same methodology also revealed that the degree of such a
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molecular disorder (quite possibly enhanced by the milling process) was not 
sufficient to mask or obliterate the crystalline character of the surfaces under 
investigation. Such that the differences demonstrated between the powders 
are due to the fact that the two materials (including their surface) are two 
different crystal phases.
Electrostatic interactions seem to play a significant role in the 
deposition behaviour of the drug. The effect, however, is a rather indirect 
one: Polymorph A being the more electrostatic material tends to self- 
neutralise the charges on its surface, creating more agglomerates, as 
observed by SEM. After an initial charge decay, the overall charge of the 
two polymorphs is approximately the same. However, the aggregation of 
polymorph A particles allows this material to behave as larger virtual particles 
of its components particles’ combined mass, requiring higher forces for their 
removal from lactose (as measured by the centrifuge method).
The surfaces of the two polymorphs are energetically different to 
sufficient degree, as to allow direct and reliable measurements in terms of their 
interaction with a common probe such as water. These differences can in turn 
be related to the differences in behaviour between the two crystal forms 
observed in the study of drug-lactose blends studied by the centrifuge method 
and by electrostatic measurements. Furthermore, the discussion presented 
here about the differences in surface energetics between the two polymorphs 
also supports the explanation given above for the different deposition 
behaviour that these materials exhibit during the development of a DPI product.
Despite efforts to eliminate the effects of surface geometry, the results 
suggest that the shape of the drug particles continues to play some role,
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although not necessarily dominant, in the aerosol deposition properties of 
powder mixes. Nevertheless, the major purpose of this study was to explore 
the relationship between the energetics of interaction of dry particles inhaler 
particles and deposition in a realistic pharmaceutical situation. The system 
chosen for this study is a true pharmaceutical new chemical entity for 
pulmonary delivery, tested in the clinic, and the results of the present study 
should provide a pharmaceutically relevant, representative picture of the 
power and limitations of the type of analysis employed.
The results obtained by TAM and IGC are in agreement showing that 
the surfaces of the two polymorphs are not equivalent, and these results are 
consistent with the original working hypothesis of this project. When the 
vapour probe-surface interaction involved hydrogen bonding, the two 
surfaces exhibited differences under nearly ideal (infinite dilution) conditions, 
as well as under conditions removed from ideality (TAM). For non-hydrogen 
bonding probes, IGC results show differences between the two polymorphic 
surfaces, whereas TAM results show them more or less equivalent. One 
important aspect regarding these techniques is that whereas IGC gives 
values of the adsorption (equilibrium constant) coefficient, TAM gives direct 
measurements of the enthalpy of interaction. The adsorption coefficient is 
directly related to the free energy of the process, which includes the enthalpy 
as one of its terms. It follows that the differences between the polymorphs 
detected by IGC but not by TAM for non-hydrogen bonding probes must be 
the result of an athermal (i.e., entropic) contribution to sorption not detectable 
during TAM experiments. The combined results from TAM and IGC thus 
offer a more complete (than TAM alone) and more detailed (than IGC alone)
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picture of the properties of, and differences between, the surfaces under 
study. When adsorption of the probe molecule is controlled by dispersion 
forces, the enthalpy involved is comparable for the two polymorph surfaces 
and differences are essentially athermal, and only observable through the 
measurement of an equilibrium constant. Future work aimed to test the 
above hypothesis can be based on the measurement of sorption isotherms 
of non-hydrogen bonding probes at different temperatures. Instrumentation 
capable of running such experiments is now commercially available. 
Experiments of this type will provide both the equilibrium constant and the 
thermal component of the process, making the athermal component 
obtainable by difference. When adsorption of the probe molecule involves 
hydrogen bonding, whether the probe is a donor of simply an acceptor, the 
thermal component becomes dominant, and the differences between the two 
polymorphic surfaces are readily measurable.
Molecules do not have sharp boundaries, and descriptions of surfaces 
at the molecular level cannot be meaningfully made without taking into 
account the nature of the probe used. The most accurate description (at a 
molecular level) of a surface is a description of its interactions. The 
interactions between water and each of the polymorphs used in this study 
present qualitative similarities and quantifiable differences. The heat of 
adsorption of the two polymorphs shows a peak at 25°C, relative to the 
immediate lower and higher temperatures studied. The 25°C calorimetric 
peak did not have a corresponding commensurate peak in microgravimetric 
adsorption. This additional thermal component had to be explained without 
adding more water. The possibility of water molecules populating stronger
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(more exothermic) adsorption sites was discarded because it would require 
an exothermic process favoured with increasing temperature. Instead, an 
explanation involving the formation of water clusters and adsorption onto 
secondary, weaker sites was proposed. Such explanation comes from an 
analogy of the experimental results with the known mechanism of water 
adsorption on activated carbon surfaces.
Between 25°C and 35°C, the surfaces of polymorphs A and B interact 
with water in different fashion. Polymorph A adsorbs greater amounts of 
water and produces a greater heat of adsorption. But the net balance 
between amount of water adsorbed and the corresponding heat evolved 
revealed that polymorph A adsorbs water through a greater number of 
weaker interactions than those of polymorph B, under the same conditions. 
This attribute of the surface of polymorph A, relative to that of form B, was 
interpreted as the energetic equivalent of surface fuzziness, for lack of a 
better term. And the reader is kindly asked to put up with the use of such 
term during the present discussion. It should be stressed that the fuzziness 
of a surface is not a physical attribute in a conformational sense, but a 
manifestation of the interactive properties of that surface. Polymorph A is in 
fact an abrasive material; such property is always taken into account when 
milling the drug. The same material is nonetheless anecdotally referred to as 
waxy to the touch, by personnel handling it. The fuzz produced by a weakly 
bound layer of adsorbed water fits a qualitative explanation for reconciling 
these attributes of form A. The surface of polymorph A is fuzzy in its 
interaction with water, and also in its interaction with a richly hydrogen 
bonding surface such as that of lactose. Although such observations do not
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necessarily imply that polymorph A will exhibit the properties of a fuzzy 
surface in its interaction with a non-hydrogen bonding probe or surface.
There is little doubt that Atomic Force Microscopy will prove a very 
powerful tool in future studies of surfaces. Danesh et al. [2000] have already 
proven that AFM can discriminate the surfaces of cimetidine polymorphs. 
The same authors have also shown that relative humidity produces 
significant changes on the AFM-determined surface of cimetidine’s 
polymorph A, whereas the AFM-determined surface of cimetidine’s form B is 
unaffected by relative humidity. AFM should prove to be a powerful tool in 
elucidating the molecular nature of the so-called surface fuzziness discussed 
in the present study.
It seems however, that the level of resolution obtained from AFM in 
pharmaceutical applications needs to be developed further, before its full 
potential can be achieved. Louey et al. [1999] have conducted adhesion 
force measurements on lactose surfaces using AFM. The same authors 
found that the detachment force from lactose of a colloidal silica probe can 
be described by a log-normal distribution. Let us consider the smaller, 5 pm 
diameter, colloidal probe used by Louey et al. [1999], and a scanner 
displacement (z distance) of 100 nm. Under these conditions, the colloidal 
probe will present a cross sectional interaction area of about 1.5 pm2. Such 
a small area is sufficient to fit about 7.5x106 sites for water adsorption. 
Louey et al. [1999] scale is still too coarse to make inferences regarding 
active sites for sorption. But this is by no means a limitation of Atomic Force 
Microscopy as a technique. AFM work in non-pharmaceutical fields of 
research [Zambelli et al., 1997], have produced gas adsorption images at the
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mesoscale level, with resolutions higher than 50 A. At such resolution, 
individual atoms are observable. Work like that of Zambelli et al. [1997] has 
produced microphotographic evidence of gas adsorption, of adsorbate 
cluster formation, and of the non-random distribution of adsorption sites.
The nature, the origin, and the incidence - the existence - of surface 
fuzziness is a question that remains open, and one worth exploring. Surface 
fuzziness may be a property of the native crystal; a characteristic of one 
crystal phase but not the other. The work of Danesh et al., [2000] showed 
that interaction with water vapour produces changes on the AFM-determined 
surface for one cimetidine polymorph, but not the other. It is also possible 
that the surface fuzziness observed in the present study is the manifestation 
of surface defects brought about by the milling process. However, in 
considering the latter possibility, the reader is referred to Figure 13 of the 
present report. The figure in question shows equiscalar microphotographs of 
polymorphs A and B before milling. Since the two materials were milled to 
the give same particle size distribution (Figure 17), it is evident from the 
figure that polymorph B had to undergo the more intense particle size 
reduction through milling. Yet it was polymorph A and not B, the form that 
exhibited surface fuzziness. It is also pertinent to recall that the surfaces of 
the two polymorphs retained their crystalline character after milling; fuzziness 
is thus an attribute of the crystalline surface. If fuzziness was produced by 
milling, it is likely that some materials (like polymorph A) have a propensity 
toward it, whereas others (like polymorph B) do not.
The answer to the question about fuzziness posed above is not out of 
reach in today’s state-of-the-science. And addressing the question for
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Ro 24-5913 would require to grow crystals of the two polymorphs having the 
particle size distribution of Figure 17, such that comparison between the two 
surfaces could be made on the native crystals, without the need of any 
milling. Such a comparison would clarify if the so-called fuzziness is a 
property of the crystal surface or simply a propensity of the phase toward an 
effect of the milling process.
Growing crystals with the extremely tight particle size distribution of 
Figure 17 is a proposition that would be fiercely (and understandably) 
opposed by the Chemical Production scientists of a company whose 
intention is to stay in business. Traditional schemes for crystallisation at 
large scale would render the pursuit of such goal prohibitively expensive and 
quite possibly futile. However, the work of York and his co-workers [York et 
al., 1998a; Beach et al., 1999; Yu Shekunov et al., 1999] has shown that 
super-critical fluid technology can be successfully applied to control more 
than the crystal form obtained; super-critical fluid technology also allows a 
tight control over particle size and morphology of the particles obtained. 
Since super-critical fluid technology can be applied as a continuous process, 
the technique is suitable for small as well as industrial scale production. It 
should be said that even with the use of super-critical fluid technology, 
growing crystals of Ro 24-5913 (polymorphs A and B) with the required 
particle size distribution would be a major undertaking. But the use of super­
critical fluid technology would bring the pursuit into the realm of feasibility. 
And from the results of the present investigation, this author will make a 
prediction that could serve as one more of the possible hypotheses to test in 
future investigations: the use of unmilled crystal powders, having the desired
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particle size (Figure 17), would result in more pronounced differences 
between the powders than those observed here with micronised materials. 
Micronisation of the powders did not mask or obliterate the crystalline 
character of their surfaces, and the differences between the two crystalline 
surfaces are presented quantitatively in the different chapters of this work. 
However, as discussed in Chapter 4, micronisation is likely to have reduced 
the magnitude of the differences between the two polymorphs’ surfaces, 
giving the basis for the above-stated prediction.
The present study has explored the connection between surface 
properties of a crystal and the macroscopic behaviour of the powder. The 
obtained results show that the two polymorphs used in this study are indeed 
different in terms of their powder processing characteristics and of the 
resulting product attributes. Polymorphism produced two different materials 
without necessarily making one polymorph a better choice than the other. At 
low drug concentrations, powder formulations for inhalation using polymorph 
A are more efficient in terms of dispersion into fine particles, due to the 
weaker adhesive properties of polymorph A compared with polymorph B. 
Conversely, at higher drug concentrations, because of its weaker cohesive 
properties, polymorph B in the formulation results in better dispersion into 
fine particles. This means that different sets of requirements for the final 
product could make either polymorph the material of choice for 
pharmaceutical development.
The impact of crystal polymorphism on pharmaceutical development 
is a subject that has received increasing attention in the industry. In fact, 
polymorphism screening is one of the standard activities in the early
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development of any new chemical entity intended for a solid dosage form. It 
is rather unfortunate, but there seems to be a trend in the industry by which 
the subject of crystal polymorphism is acquiring some sort of stigma. Crystal 
polymorphism is a natural phenomenon, which despite being extremely 
common in the pharmaceutical field, frequently triggers a “panic button”; 
metastable forms are often seen as potential problems, seldom as 
exploitable opportunities. Patent protection is perhaps the one consistently 
exploited venue among the potential opportunities offered by polymorphism. 
The results of the present investigation support the widely spread notion that 
crystal polymorphism can occupy a central place in Particle Engineering, a 
sub-discipline that has yet to materialise as a widespread programme in 
pharmaceutical development. The pharmaceutical industry has been the 
stage for some costly, highly publicised mishaps involving crystal 
polymorphism [see for example lAPAC’s Norvir® (Abbott) Advisory of 1998]. 
But rather than a potential deterrent, these incidents should serve as a 
reminder that polymorphism presents some risks that demand due diligence, 
just as any other technical opportunity does. Not every polymorph is suitable 
for pharmaceutical development, far from it. But by the same token, not 
every metastable polymorph warrants being discarded as candidate for the 
physical form selected for product development. The criteria for selection of 
suitable crystal forms are based on a set of fixed and unambiguous rules. 
And even when at times the necessary juxtaposition of data from various 
instrumental techniques makes it seem more intricate, polymorph 
qualification is in reality more a fact-finding exercise than anything else. The 
key lies on observing the rules that Nature set up in advance.
7. GLOSSARIES
7.1 Glossary to Chapter 1
A Area
Af Helmholtz free energy
Ah Hamaker coefficient
B Empirical constant. Lennard-Jones potential
C Empirical constant. Lennard-Jones potential
D Dipole separation distance
E Induced dipole interaction energy
Em Average molar energy
F Total adhesion force
Fe Contact potential force
Fim Coulombic interaction force
Fs Surface tensional force





Pf Isothermal heat flow
Po Saturation vapour pressure
Electric charge
Q Partition function
r Distance: Intermolecular, interatomic, intercharge
R Universal gas constant






X Amount of vapour solvent sorbed
X , X i Mole fraction, mole fraction of species i
z Distance between attracting plane and sphere
a Molecular polarisability
AHf Enthalpy of melting
AGS Free energy of sorption
AHs Enthalpy of sorption
ASs Entropy of sorption
So Permitivity in vacuum
<P Electron work function
(/> IGC Interaction parameter
7 Surface/interfacial tension
G Gibbs free energy
Mi Chemical potential of species i
M- Standard chemical potential of species /
y o Electron orbiting frequency
e Contact angle
atm atmospheres
DPI Dry powder inhaler
DSC Differential Scanning Calorimetry
IGC Inverse gas chromatography
TAM Thermal Activity Monitor
vdW van der Waals
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7.2 Glossary to Chapter 2
A UCsn Chromatographic peak area of standard solution
Cp Heat capacity
Cstd Concentration of standard solution
dv10 Particle diameter at the 10-percentile of the distribution
dv50 Particle diameter at the 50-percentile of the distribution
dv9o Particle diameter at the 90-percentile of the distribution
R Universal gas constant
R.F. Chromatographic response factor
2-9 X-ray angle of diffraction
AH/ Enthalpy of melting
AFM Atomic Force Microscopy
BET Bennet-Emmet-Teller
DPI Dry powder inhaler
NIST National Institute of Standards and Technology
RPM Revolutions per minute
XRD X-ray diffraction
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7.3 Glossary to Chapter 3
a Centrifugal acceleration
As Specific surface area
C Capacitance
d Inter-particle distance
D i,D Particle diameter -  Laser diffraction
F Force of attachment
F det Detachment force
F i Weight force
g Acceleration of gravity
I Radius of rotation
m Mass
*i Number of particles of diamter Dt
Pt,P Frequency (volume fraction)
Q Electrical charge








ASFC Air stream Faraday cage dynamic charge detector
CIMFC Capacitor interchangeable mesh charge detector
EFM Electrostatic field meter
rad Radians
R.C.F. Relative centrifugal force
RPM Revolutions per minute
SFC Shallow Faraday well static charge detector
TCM Transient charge monitor
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7.4 Glossary to Chapter 4
Asp Specific surface area
C Arbitrary integration constant
Cs Water concentration in the sorbed phase
Cv Water concentration in the vapour phase
K  Equilibrium constant
Kd Distribution coefficient




Qads Heat of adsorption
R Universal gas constant
RH Relative Humidity
T  Temperature
tfff Interaction-free retention time
tr Retention time
V Volume
Vg Specific retention volume
Vm Column’s dead volume
V„ Net retention volume
Vr Retention volume
Ws Weight of adsorbent sample
AHods Enthalpy of adsorption
AGg Standard free energy of adsorption
AH f  Standard enthalpy of adsorption
ASs° Standard entropy of adsorption
(j> Interaction parameter
7i Surface pressure
FID Flame ionisation detector
IGC Inverse Gas Chromatography
PM Peak maximum
TAM Thermal Activity Monitor
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7.5 Glossary to Chapter 5
Ad Drug particle cross-sectional area
dp Drug particle diameter
dL Lactose carrier particle diameter
Fd Weight percent of drug for monolayer coverage
Md Mass of a group of N  drug particles
Ml Mass of one lactose carrier particle
N Number of drug particles to form a monolayer
RH Relative Humidity
Tl Lactose carrier specific surface area
vD Volume of a drug particle
Pd Drug absolute density
Pl Lactose carrier absolute density
ACGH Airflow calibrated gas housing
DPI Dry powder inhaler
ED Emitted dose
FPD Fine particle dose
FPF Fine particle fraction
ND Nominal dose
TSI Twin stage impinger
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1 ND 2.857 7.143 ND 3.448 12.500 2.353 12.121 16.902
2 ND 3.448 6.780 ND 2.439 11.111 1.408 13.953 17.464
3 ND 2.778 5.128 ND 3.226 12.647 1.587 18.519 17.397
4 ND 3.030 5.263 ND 3.448 11.111 2.273 14.894 18.155
average ND 3.028 6.078 ND 3.140 11.842 1.905 14.872 17.479
s.d. ND 0.299 1.032 ND 0.479 0.846 0.477 2.690 0.515
Form B
rpm 1000 3000 5000
Drug concn. 1% 5% 25% 1% 5% 25% 1% 5% 25%
run #
1 ND 5.263 9.667 ND 7.692 15.667 5.333 17.857 21.729
2 ND 5.000 10.286 ND 5.882 13.771 6.122 18.647 19.931
3 ND 4.167 10.000 ND 7.143 15.979 4.082 18.286 23.000
4 ND 4.545 9.222 ND 4.762 14.568 4.000 18.810 21.000
average ND 4.744 9.794 ND 6.370 14.996 4.884 18.400 21.415
s.d. ND 0.486 0.457 ND 1.313 1.016 1.026 0.423 1.289
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Table A2 Electrostatic charge measurements of powders on Air Stream
Faraday Cage (ASFC, n=5).
Conditions: -  21 °C/30%RH; airflow rate = 60 I min'1
System n Charge to avg. s.d. c.v
mass ratio
________________________ Cg'1109_______________________ %_





______________________________________ 0.764 0.124 16.27






______________________________________ 1.275 0.204 16.00








System n Charge to avg. s.d. c.v
mass ratio
_________________________Cg'110*_______________________ %_






______________________________________ 0.906 0.157 17.34






______________________________________ 8.120 0.864 10.64






______________________________________ 1.193 0.135 10.96




























Table A3 Pure components. Electrostatic charge measurements of powders on Capacitor
Interchangeable Mesh Faraday Cage (CIMFC, n=7).














1.78 1.32 3.87 2.58
- 1.62 - 1.37 - 3.79 - 2.58
" 1.55 - 1.05 - 4.20 - 2.40
- 1.52 - 1.50 - 4.00 - 2.40
- 1.92 - 0.92 - 3.95 - 2.62
- 2.28 - 0.86 - 5.19 - 2.85
- 1.86 - 1.22 - 3.43 - 2.96
n= 7 _ 7 _ 7 _ 7
avg= 1.79 1.18 4.06 2.63
s.d.= 0.26 0.24 0.55 0.21
rsd = 14.78 20.30 13.59 7.99
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Table A4 Ro 24-5913 -  Lactose monohydrate blends. Electrostatic charge measurements of powders
on Capacitor Interchangeable Mesh Faraday Cage (CIMFC, n=6).
Conditions: -  20 °C/26%RH; airflow rate = 60 I min"1
1% Ro 24-5913 in lactose 5% Ro 24-5913 in lactose 25% Ro 24-5913 in lactose 50% Ro 24-5913 in lactose
monohydrate monohydrate monohydrate monohydrate
A B A B A B A B
Polarity Charge Polarity Charge Polarity Charge Polarity Charge Polarity Charge Polarity Charge Polarity Charge Polarity Charge
C x 10 C x 10 C x 1 0 9 C x 10 C x 109 C x 109 C x 109 C x 109
+ 3.177 1.052 2.725 9.836 3.398 6.569 4.80 -/+ 3.80
+ 2.800 - 1.000 1.616 - 9.000 3.518 6.590 - 4.80 + 5.20
+ 3.529 - 1.270 2.781 - 7.947 3.750 5.364 - 5.60 -/+ 3.40
+ 3.320 - 1.032 2.626 - 10.265 2.980 5.255 - 4.00 -/+ 3.80
+ 2.911 - 1.430 2.630 - 10.423 2.557 5.248 - 3.20 -/+ 3.70
+ 3.618 - 1.176 1.480 - 10.774 2.392 6.159 + 5.00 + 4.90
n= 6 6 6 6 6 6 6 6
avg= + 3.226 - 1.160 2.310 - 9.708 3.099 5.864 - 4.57 _ 4.13
s.d.= 0.328 0.167 0.594 1.056 0,547 0.650 0.84 0.73
rsd = 10.17 14.37 25.73 10.88 17.65 11.08 18.46 17.69
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Table A5 Electrostatic properties of aerosolised lactose monohydrate, 25 mg powder in a gelatin capsule measured
using TCM after actuation of the rotahaler (n=4).




U pos U neg U net
M
Shot 2
U pos U neg U net
M
Shot 3
U pos U neg U net
M
Shot 4
U pos U neg U net
M
Electrode Potential 
U net avg s.d.
M
1 2.00 0.00 2.00 2.80 0.00 2.80 2.10 0.00 2.10 2.80 0.00 2.80 2.43 0.43
2 1.20 0.00 1.20 1.20 0.00 1.20 1.20 0.00 1.20 1.80 0.00 1.80 1.35 0.30
3 0.40 0.00 0.40 0.60 0.00 0.60 0.60 0.00 0.60 0.80 0.00 0.80 0.60 0.16
4 0.30 0.00 0.30 0.30 0.00 0.30 0.50 0.00 0.50 0.50 0.00 0.50 0.40 0.12
5 0.20 0.00 0.20 0.20 0.00 0.20 0.05 0.00 0.05 0.10 0.00 0.10 0.14 0.08
6 0.10 0.00 0.10 0.05 0.00 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.05
7 0.00 0.00 0.00 0.00 0,00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
8 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
V sum [V] 4.20 0.00 4.20 5.15 0.00 5.15 4.45 0.00 4.45 6.00 0.00 6.00 4.95 0.81
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Table A6 Electrostatic properties of aerosolised 5% Ro 24-5913 form A in lactose monohydrate, 25
mg powder in a gelatin capsule measured using TCM after actuation of the rotahaler (n=3).




U pos U neg U net
M
Shot 2
U pos U neg U net 
M
Shot 3 
U pos U neg U net
M
Electrode Potential
U net avg s.d.
M
1 3 -0.4 2.60 4 -0.8 3.20 4.2 -0.4 3.80 3.20 1.20
2 1.8 -0.6 1.20 2.8 -0.8 2.00 3 -0.8 2.20 1.80 0.44
3 1.2 -1.6 -0.40 2 -1.8 0.20 2 -1.6 0.40 0.07 1.51
4 1 -1.6 -0.60 1.5 -2 -0.50 1.8 -1.6 0.20 -0.30 2.18
5 1 -1.8 -0.80 1.2 -2.4 -1.20 1.6 -2 -0.40 -0.80 2.92
6 0.8 -1.6 -0.80 1.1 -2.2 -1.10 1.4 -1.8 -0.40 -0.77 3.40
7 0.8 -1.6 -0.80 1 -2.2 -1.20 1.4 -1.8 -0.40 -0.80 3.91
8 0.8 -1.4 -0.60 1 -2 -1.00 1.4 -1.6 -0.20 -0.60 4.31
V sum [VI 10.40 -10.60 -0.20 14.60 -14.20 0.40 16.80 -11.60 5.20 1.80 2.96
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Table A7 Electrostatic properties of aerosolised 5% Ro 24-5913 form B in lactose monohydrate, 25
mg powder in a gelatin capsule measured using TCM after actuation of the rotahaler (n=3).
Conditions: -  22 °C/60%RH; air flow rate = 60 I min'1
Electrode
Number
Shot 1 Shot 2 Shot 3 Electrode Potential
U pos U neg U net U pos U neg U net U pos U neg U net U net avg s.d.
M  M  M M
1 10.00 -2.00 8.00 3.00 -1.50 1.50 7.50 -2.50 5.00 3.25 3.25
2 7.00 -6.00 1.00 2.50 -3.00 -0.50 6.00 -5.50 0.50 0.00 0.76
3 5.00 -8.50 -3.50 1.00 -4.00 -3.00 4.00 -6.50 -2.50 -2.75 0.50
4 4.00 -8.00 -4.00 0.50 -4.00 -3.50 3.00 -6.00 -3.00 -3.25 0.50
5 3.00 -8.50 -5.50 0.25 -4.00 -3.75 2.50 -6.00 -3.50 -3.63 1.09
6 2.00 -8.00 -6.00 0.00 -4.00 -4.00 2.00 -5.50 -3.50 -3.75 1.32
7 2.00 -7.50 -5.50 0.00 -4.00 -4.00 2.00 -5.50 -3.50 -3.75 1.04
8 2.00 -7.00 -5.00 0.00 -3.50 -3.50 2.00 -5.00 -3.00 -3.25 1.04
V sum [V] 35.00 -55.50 -20.50 7.25 -28.00 -20.75 29.00 -42.50 -13.50 -17.13 4.12
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Table A8 Electrostatic properties of aerosolised 5% Ro 24-5913 form A in lactose monohydrate, 25
mg powder in a gelatin capsule measured using TCM after actuation of the dryhaler (n=3).




U pos U neg U net
M
Shot 2
U pos U neg U net
M
Shot 3
U pos U neg U net
M
Electrode Potential 
U net avg s.d.
M
1 11.50 -5.00 6.50 12.00 -2.50 9.50 12.00 -5.00 7.00 7.67 1.61
2 4.00 -10.00 -6.00 3.50 -6.00 -2.50 4.75 -8.50 -3.75 -4.08 1.77
3 5.00 -9.00 -4.00 4.00 -5.50 -1.50 5.00 -8.00 -3.00 -2.83 1.26
4 3.50 -8.00 -4.50 2.50 -5.00 -2.50 3.50 -7.00 -3.50 -3.50 1.00
5 3.00 -8.00 -5.00 2.25 -5.00 -2.75 3.00 -7.00 -4.00 -3.92 1.13
6 2.75 -7.00 -4.25 2.00 -4.75 -2.75 2.75 -6.50 -3.75 -3.58 0.76
7 2.75 -6.50 -3.75 2.00 -4.50 -2.50 2.75 -6.00 -3.25 -3.17 0.63
8 2.75 -6.00 -3.25 2.00 -4.25 -2.25 2.50 -5.50 -3.00 -2.83 0.52
V sum [V] 35.25 -59.50 -24.25 30.25 -37.50 -7.25 36.25 -53.50 -17.25 -16.25 8.54
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Table A9 Electrostatic properties of aerosolised 5% Ro 24-5913 form B in lactose monohydrate, 25
mg powder in a gelatin capsule measured using TCM after actuation of the dryhaler (n=3).




U pos U neg U net
M
Shot 2
U pos U neg U net
M
Shot 3
U pos U neg U net
M
Electrode Potential 
U net avg s.d.
M
1 10.00 -8.50 1.50 10.00 -11.00 -1.00 10.00 -11.50 -1.50 -0.33 1.47
2 4.00 -8.50 -4.50 3.00 -13.00 -10.00 3.50 -13.00 -9.50 -8.00 5.58
3 4.00 -8.50 -4.50 4.00 -12.50 -8.50 4.00 -11.50 -7.50 -6.83 5.20
4 3.00 -7.00 -4.00 2.50 -10.50 -8.00 2.50 -10.00 -7.50 -6.50 5.54
5 2.50 -7.00 -4.50 2.25 -10.50 -8.25 2.00 -10.00 -8.00 -6.92 6.20
6 2.00 -5.25 -3.25 2.00 -9.50 -7.50 1.50 -9.00 -7.50 -6.08 6.37
7 2.00 -4.50 -2.50 2.00 -9.00 -7.00 1.50 -8.00 -6.50 -5.33 6.49
8 2.00 -4.50 -2.50 2.00 -9.00 -7.00 1.50 -8.00 -6.50 -5.33 6.96
V sum [V] 29.50 -53.75 -24.25 27.75 -85.00 -57.25 26.50 -81.00 -54.50 -45.33 18.31
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Table A10 Values used In IGC calculations
Pi, Pressure at column inlet = 1.5 atm = 22.04 psi 
Pi = mm Hg 1140
Po, Pressure at column outlet = 1 atm = 14.696 psi 
Po = mm Hg 760
j = 3/2 [(Pi/Po)A2-1/(Pi/Po)A3-1] 0.789473684
j = Martin-James compressibility factor 
j = 0.7895
k\ capacity factor 
K, partition coefficient 
beta, Vn/Vs
Fc, corrected flow rate
(average flow rate along the column)
Fo, measured flow rate at the outlet 30
Tc, column temperature (°K) 298.15
Ta, ambient temperature (25°C = 9K) 298.15
P, atmospheric pressure at Ta = 1 atm 760
Pw, vapor pressure of water at Ta = mmHg 23.756
Fc = Fo [(Tc/Ta)*((P-Pw)/P)] 29.0623
Fc = 29.0623 ml/min
Standard states as per deBoer, 1953
Standard vapor state (pg) 1.01325 x 105 N m
Standard surface pressure (ps) 3.38000 x 10*4 N m*1
Pg/Ps, r= 0.29978 x 109m'1
299.7781 x106 m'1
R = 8.314 J mol*1 °K*1












Table A11 Average of specific retention volume for polar and non-polar 
















Hexane 25 21.644 0.561 34.280 0.523
Hexane 35 21.449 0.124 35.095 0.228
Hexane 45 24.512 0.409 32.277 0.221
Heptane 25 36.384 0.185 54.209 0.397
Heptane 35 36.596 0.056 48.728 0.098
Heptane 45 38.639 0.561 39.466 0.513
Toulene 25 37.358 0.301 64.266 0.127
Toulene 35 28.690 0.063 52.176 0.496
Toulene 45 27.129 0.152 42.962 0.308
MEK 25 38.698 0.210 40.194 0.169
MEK 35 26.092 0.170 39.941 0.185
MEK 45 24.381 0.225 32.514 0.275
EA 25 30.503 0.313 41.928 0.206
EA 35 26.671 0.188 33.605 0.113
EA 45 22.709 0.225 32.922 0.246
2-Propyl OH 25 47.059 0.245 39.113 0.128
2-Propyl OH 35 30.213 0.135 35.743 0.266
2-Propyl OH 45 25.616 0.317 28.673 0.251
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Table A12 Deposition characteristics for micronised Ro 24-5913 polymorph A blended with 45-106 pm lactose monohydrate.
Powder hand loaded into the Dura device (~ 10 mg). Conditions: 21°C and 50% RH; Q=601 min’1.
Sample
ID
STD H = 52.88 ug/ml 
STD L = 11.11 ug/ml
[Ro 24-5913] Gravimetric 




















1A-1 1 0.97 10.9 105.73 69.47 28.37 97,84 28.99 92.53 26.83
1A-1 10.9 105.73 68.50 22.64 91.14 24.84 86.20 21.42
1A-2 11.0 106.70 72.20 27.25 99.44 27.40 93.20 25.54
1A-3 11.9 115.43 79.53 32.53 112.05 29.03 97.07 28.18
1A-4 10.0 97.00 53.86 22.52 76.38 29.49 78.74 23.22
1A-4 10.0 97.00 62.39 18.73 81.12 23.09 83.63 19.31
Mean 27.14 88.56 24.08
Std Dev. 2.62 6.87 3.38
5A-1 5 5.03 10.6 533.18 264.99 128.08 393.07 32.58 73.72 24.02
10.6 533.18 262.79 127.43 390.22 32.66 73.19 23.90
5A-2 9.7 487.91 231.03 125.88 356.91 35.27 73.15 25.80
9.7 487.91 220.24 128.81 349.04 36.90 71.54 26.40
5A-3 10.3 518.09 256.72 124.48 381.20 32.65 73.58 24.03






Sample [Ro 24-5913] Gravimetric Nominal (ND) Stage I Stage II Emitted RD/ED ED/ND RD/ND
ID Theor. Exp. Load wt. Theoretical Dose Resp
% w/w mg M9 M9 M9 M9 % % %
25A-1 25 25.05 10.3 2580.15 685.58 266.78 952.36 28.01 36.91 10.34
10.3 2580.15 713.32 284.87 998.19 28.54 38.69 11.04
25A-2 10.7 2680.35 764.43 383.43 1147.85 33.40 42.82 14.31
10.7 2680.35 743.48 392.63 1136.11 34.56 42.39 14.65
25A-3 10.1 2530.05 690.53 267.63 958.16 27.93 37.87 10.58
n R
10.1 2530.05 697.11 280.62 977.72 28.70 38.64 11.09
II O
Average 30.19 39.55 12.00
Std Dev. 2.97 2.45 1.94
50 A-1 50 49.97 10.00 4997.00 1761.21 602.45 2363.66 25.49 47.30 12.06
10.00 4997.00 1772.08 613.74 2385.82 25.72 47.74 12.28
50A-2 10.00 4997.00 1909.29 484.63 2393.92 20.24 47.91 9.70
10.00 4997.00 1903.73 492.13 2395.86 20.54 47.95 9.85
50A-3 11.10 5546.67 2068.29 845.78 2914.06 29.02 52.54 15.25
11.10 5546.67 2092.35 851.03 2943.38 28.91 53.07 15.34
50A-4 11.20 5596.64 2669.76 912.39 3582.14 25.47 64.01 16.30
11.20 5596.64 2680.36 921.77 3602.13 25.59 64.36 16.47
50A-5 10.10 5046.97 2445.49 741.75 3187.24 23.27 63.15 14.70
10.10 5046.97 2487.97 741.50 3229.46 22.96 63.99 14.69
n 10
Average 25.87 60.18 15.46
Std Dev. 2.63 5.74 0.77
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Table A13 Deposition characteristics for micronised Ro 24-5913 polymorph B blended with 45-106 pm lactose monohydrate.







Gravimetric Nominal (ND) 
















1B-1 1 1.020 10.9 111.13 42.37 24.38 67.75 35.99 60.96 21.94
10.9 111.13 42.25 23.92 66.16 36.15 59.53 21.52
1B-2 11.0 112.15 41.13 14.19 55.32 25.64 49.32 12.65
11.1 113.17 44.06 14.15 58.21 24.31 51.44 12.51
1B-3 10.9 111.13 43.89 14.06 57.95 24.27 52.15 12.65
11.2 114.19 41.28 11.97 53.25 22.48 46.63 10.48
n 6
Average 6.00 28.14 47.91 15.29
Std Dev. 6.22 12.92 5.06
5B-1 5 4.98 11.8 587.64 368.25 65.43 433.68 15.09 73.80 11.13
11.8 587.64 375.66 65.75 441.40 14.90 75.11 11.19
5B-2 11.1 552.78 379,76 60.03 439.79 13.65 79.56 10.86
11.1 552.78 385.29 61.57 446.86 13.78 80.84 11.14
5B-3 11.0 547.80 397.40 58.02 455.41 12.74 83.13 10.59
11.0 547.80 404.41 58.51 462.92 12.64 84.51 10.68
n 6
Average 13.80 79.49 10.93


























25B-1 25 25.05 12.0 3006.00 858.11 733.49 1591.60 46.09 52.95 24.40
12.0 3006.00 832.13 631.89 1464.02 43.16 48.70 21.02
25B-2 11.5 2880.75 992.64 652.75 1645.39 39.67 57.12 22.66
11.6 2905.80 998.43 713.35 1711.78 41.67 58.91 24.55
25B-3 11.7 2930.85 853.16 750.22 1603.37 46.79 54.71 25.60
n C





Std Dev. 2.69 3.76 1.76
50B-1 50 50.215 11.6 5824.92 2061.96 948.10 3010.06 31.50 51.68 16.28
11.6 5824.92 2064.03 950.03 3014.06 31.52 51.74 16.31
50B-2 10.0 5021.48 2130.13 848.99 2979.12 28.50 59.33 16.91
10.0 5021.48 2127.59 850.49 2978.08 28.56 59.31 16.94
50B-3 10.4 5222.34 2343.77 801.90 3145.67 25.49 60.23 15.36
10.4 5222.34 2343.48 802.47 3145.94 25.51 60.24 15.37
n
Average 
Std Dev,
28.51
2.69
57.09
4.19
16.19
0.70
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